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The prevalence of antibiotic resistance is increasing at an alarming rate in South Africa, as 
well as globally. In particular, multi-drug resistant pathogens such as Staphylococcus aureus 
(MRSA) are a significant health concern, as these are responsible for the majority of 
hospital- and community-acquired infections. The human innate immune system is the first 
line of defense against such pathogens. An important component of these defenses is the 
chemical attacks lodged by various white blood cells; these attacks include the release of 
oxidising reagents such as hydrogen peroxide (H2O2) and hypochlorous acid (HOCl), the 
latter also being the active component of domestic bleach. In order to protect itself against 
these attacks S. aureus uses a network of redox enzymes and low molecular weight (LMW) 
thiols, many of which have been shown to play crucial roles in defending against reactive 
oxygen species. However, the manner in which the effects of HOCl is counteracted is not as 
well understood. This project set out to characterize enzymes of unknown function that 
appear to be involved in oxidative stress resistance. In addition, the mechanism by which 
selected LMW thiols protect a key metabolic enzyme in S. aureus from oxidative damage 
was also investigated.  
The results of the study uncover for the first time the activity of a previously uncharacterized 
enzyme that is conserved in several pathogenic bacteria, and identify it as a key actor in S. 
aureus’s defence mechanisms against HOCl, as well as the reactive chlorine species that 
form in the human body when it is released by neutrophils. Furthermore, a small collection of 
compounds were synthesized and examined as potential mechanism-based inhibitors of this 
enzyme. Considering the enzyme’s importance as a bacterial defense mechanism at the 
human-microbe interface, this discovery provides an exciting opportunity for novel drug 
development focused on the host-pathogen interaction.  
The results of this study also demonstrate for the first time the moonlighting role of 
coenzyme A (CoA) — usually a central metabolic cofactor — in protecting enzymes under 
oxidative stress conditions. In addition, a novel function of S. aureus CoA disulfide reductase 
was proposed. Finally, the mechanism whereby the LMW thiol bacillithiol is recycled in S. 
aureus was also explored.  
Taken together, the results of this study demonstrate the importance of understanding basic 
molecular mechanisms at the host-pathogen interface that may provide new insight and 




Die voorkoms van antibiotiese weerstandbiedendheid in Suid-Afrika, sowel as wêreldwyd, 
styg teen 'n kommerwekkende tempo. In die besonder, multi-dwelm weerstandbiedende 
patogene soos Staphylococcus aureus (MRSA) is 'n belangrike gesondheidsorg, aangesien 
dit verantwoordelik is vir die meeste hospitaal- en gemeenskapverworwe infeksies.  Die 
menslike aangebore immuunstelsel is die eerste lyn van verdediging teen sulke patogene. 'N 
Belangrike komponent van hierdie verdediging is die gebruik van chemiese aanvalle deur 
verskeie witbloedselle; hierdie aanvalle sluit in die vrystelling van oksideermiddels soos 
waterstofperoksied (H2O2) en hipochloorsuur (HOCl), die aktiewe komponent van 
huishoudelike bleikmiddel. Ten einde homself te beskerm teen hierdie aanvalle, produseer 
S. aureus 'n netwerk van ensieme en lae molekulêre gewig (LMW) thiols, waarvan baie
gewys word om belangrike rol te speel in die verdediging van reaktiewe suurstofspesies.
Die manier waarop HOCl verset word, is egter nie so goed verstaan nie. Hierdie projek het
betrekking op ensieme van onbekende funksie wat blykbaar by oksidatiewe stresweerstand
betrokke is. Daarbenewens is die meganisme waardeur geselekteerde LMW-tiole 'n
belangrike metaboliese ensiem S. aureus van oksidatiewe skade beskerm, ook ondersoek.
Die resultate van die studie onthul vir die eerste keer die aktiwiteit van 'n voorheen 
ongekarakteriseerde ensiem wat in verskeie patogene bakterieë bewaar word, en 
identifiseer dit as 'n sleutelaktor in S. aureus se verdedigingsmeganismes teen HOCl en die 
reaktiewe chloorspesies wat in die menslike liggaam vorm wanneer dit deur neutrofiele 
vrygestel word. Verder is 'n klein versameling verbindings gesintetiseer en ondersoek as 
potensiële meganisme gebaseerde inhibeerders. Met inagneming van die belangrikheid van 
hierdie ensiem as 'n bakteriese verdedigingsmeganisme by die mens-mikrobe-koppelvlak, 
bied dit 'n opwindende geleentheid vir nuwe geneesmiddelontwikkeling, sowel as die 
vergroting van die begrip van hoe HOCl en reaktiewe chloorspesies moontlik in S. aureus 
verwerk kan word. 
Die resultate van hierdie studie toon ook vir die eerste keer die maanliggingsrol van 
koënsiem A (CoA) — gewoonlik 'n sentrale metaboliese kofaktor — in die beskerming van 
ensieme onder oksidatiewe stres toestande. Daarbenewens is 'n nuwe funksie van S. 
aureus CoA disulfide reduktase voorgestel. 
Ten slotte word die meganisme waarvolgens die LMW-thiolbacillithiol herwin word, S. aureus 




belangrikheid van die verstaan van basiese molekulêre meganismes by die gasheer-
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1.1 Antimicrobial resistance – A global health concern 
One of the most pressing medical problems facing mankind is the exponential rise of 
antimicrobial resistant organisms and the lack of novel classes of antibiotics. Since the first 
discovery of the “wonder drug” penicillin in the 1940’s, antibiotics have proven to be very 
useful in saving many lives. Figure 1.1 shows antibiotic discovery and the emergence of 
antibiotic resistance over the past few decades. 
 
Figure 1.1 Timeline of antibiotic discovery and resistance. Redrawn and adapted from [1, 2]. 
 
According to the WHO 2014 AMR Global Report on Surveillance, the BRICS (Brazil, Russia, 
India, China and South Africa) countries have seen the greatest rise in occurrence of 
antimicrobial resistance. In addition, it is predicted that by the year 2050 the major cause of 






~ 2 ~ 
One of the leading factors contributing to antibiotic resistance is the inappropriate use of 
antibiotics in both human disease and in agricultural practices. Furthermore the lack of 
regulation or proper control of antibiotic usage in many countries is also a global concern [4]. 
Antibiotics either kill or stop a pathogen’s growth. However, some bacteria develop the ability 
to survive exposure to antibiotics [5-8]. The known molecular mechanisms that allow survival 
include reducing cell membrane permeability to antibiotics, chemical/structural changes of 
drug targets, antibiotic efflux and inactivation [9, 10]. Broadly speaking, the major classes of 
antibiotics primarily target bacterial protein synthesis, cell wall biosynthesis, DNA/RNA 
replication and folate related pathways [8, 11]. Over the past 50 years, despite the 
development of new antibiotics through chemically modified derivatives of existing scaffolds, 
inevitably antibiotic resistance towards these next generation antibiotics still occurs [12, 13]. 
Furthermore, many pharmaceutical companies have abandoned their research and 
development into antibiotics mainly due to the low returns when compared to chronic 
medications or lifestyle drugs [1, 14, 15]. In the past 10 years, less than 10 new antibiotics 
have been FDA approved against the difficult to treat human pathogens also known as the 
“ESKAPE” pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter 
species). Many of these antibiotics are in fact not new classes of antibiotics and target 
existing bacterial target components [12, 16-22].  
Although efforts have been made in developing “new” antibiotics there is an urgent need to 
identify novel molecular targets in the development of new classes of antibiotics. In 
particular, understanding bacterial defense mechanisms at the human-microbe interface 
may provide unique insight and opportunity for novel drug development. An example of an 
attractive treatment option that takes advantage of the interplay between the human host 
and the bacterial pathogen entails either augmenting the host’s own immune response, or 
compromising the pathogen’s defenses against the human immune system to such an 
extent that the infection is cleared by the host.  
It is within this context that current study finds its main aim and objectives. First, it focusses 
on a conserved enzyme which has been shown to be upregulated in the important human 
pathogen S. aureus when it is challenged with neutrophils, one of the white blood cells that 
is crucial to the innate immune response. However, the function of the enzyme remains 
unknown, and its potential for being exploited for the treatment of bacterial infections remain 
unexplored. Second, the study explores the mechanisms by which low molecular weight 
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attack by the innate immune system. LMW thiols form a crucial part of the bacterial defense 
mechanisms against oxidative stress, but must be efficiently recycled to remain effective. 
Currently, our understanding of how this is achieved in S. aureus remains limited.  
To provide a broader context for this study, the remainder of this introductory chapter 
focusses on the host-pathogen interface with particular focus on the mechanisms by which 
the consequences of oxidative stress are averted and neutralized. 
1.2 The human pathogen S. aureus and antistaphylococcal agents 
Described as the “Killer Bug” by Fortune and Time Magazines, S. aureus is perhaps one of 
the most dangerous human pathogens of our time [23, 24]. In addition to the emergence of 
multi-drug resistance strains, the high prevalence and spread of S. aureus is attributed to the 
fact that 30% of the global population are asymptomatic carriers of the organism [25]. S. 
aureus is also notorious for its ability to adapt to changes in environmental condition [26]. It 
is now the leading cause of hospital- and community-acquired infections — a particularly 
alarming situation in developing countries where poor sanitation, overpopulated towns and 
comorbidities with viral infections (AIDS and/or SARS) is rife [27, 28].  
S. aureus is a Gram-positive organism that forms part of the Micrococcaceae family. It is the 
cause of “minor” skin infections, as well as more serious life-threatening infections causing 
septicemia and pneumonia. It is visually unique from many others in the Micrococcaceae 
family due to the presence of the pigment staphyloxanthin that imparts the characteristic 
gold hue in colony formation [26, 29-31]. Under the microscope in Gram’s stain, they appear 
as clusters of micrococci.  
Currently a meagre 10% of S. aureus strains remain susceptible to penicillin while many 
other isolates show increasing resistance to methicillin, vancomycin, and quinolones [32]. 
The current treatment strategies include the mono- or mixed- use of β-lactams, rifampins, 
glycopeptides & glycosides, -cyclines, fluoroquinolones and the fairly newer classes such as 
oxazolidinones, streptogramins, current generation lipopeptides, glycopeptides, 
sulfonamides and cephalosporins [7, 11, 33, 34]. These classes of antibiotics and their 
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Table 1: General antibiotic classification and mechanism 
Antibiotic Class Mechanism of Action / Target 
β-lactams Cell wall - Disruption of peptidoglycan synthesis 
Fluoroquinolones DNA replication – DNA gyrase 
Glycopeptides Cell wall - Disruption of peptidoglycan synthesis 
Glycosides Protein synthesis  
Lipopeptides Cell membrane depolarization 
Oxazolidinones Protein synthesis 
Rifampin RNA polymerase 
Sulfonamides Folate synthesis 
Cyclines Protein synthesis 
 
Many bacteria, including S. aureus, rely on a number of mechanisms to counteract the effect 
of antibiotics upon treatment. These mechanisms include: acquisition of resistance genes, 
genomic mutations rendering altered or inactive protein targets, production of enzymes that 
either alter specific chemical groups on the antibiotic to prevent binding of the target, or 
which destroy it completely, mutations on specific enzyme targets abolishing antibiotic 
binding, bypass of the target through overproduction of enzymes that overwhelm antibiotic 
binding, changes in cell wall composition and increased permeability and efflux of antibiotics 
[32, 35].     
Resistant S. aureus strains that have appeared more regularly in the clinical and community-
acquired setting are quinolone-, methicillin- and vancomycin-resistant S. aureus (QRSA, 
MRSA and VRSA, respectively). Quinolones bind to DNA gyrase inhibiting further DNA 
replication. With S. aureus, quinolone resistance occurs through point mutations in grlA, the 
gene encoding the GyrA subunit of the gyrase, thereby preventing the binding of quinolones. 
S. aureus also upregulates NorA which is a known multidrug efflux pump [36, 37].  Methicillin 
and vancomycin were once treatments of last resort, but are now becoming the norm to 
combat resistant strains. With MRSA, the organism has acquired the mecA gene through 
horizontal gene transfer which encodes for penicillin binding protein 2a (PBP2a) which is 
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of antibiotics [7]. VRSA on the other hand occasionally has the mecA gene but also has 
acquired a transposon encoding the vancomycin resistance gene vanA. The vanA gene 
originated from vancomycin-resistant Enterococci which have been shown to transfer this to 
S. aureus. The characteristics of VRSA is the over-thickening of the cell wall and hence 
reducing permeability of many antibiotics, including vancomycin [38].  
It is these types of resistant mechanisms that allow S. aureus to persist even when 
challenged with antimicrobial treatment, and has made many common antibiotics ineffective.  
1.3 It takes two to tango - the immune system & Staphylococcus 
aureus 
1.3.1 The immune response 
Although mankind has discovered and developed many useful compounds in an attempt to 
treat bacterial infections, the human body has its own natural way of defending against 
infections – the immune system. 
The immune system is the primary host defense mechanism that is activated upon 
encountering pathogens. The immune system can be divided into the quick acting innate 
immune response and the slower developed adaptive immune response [39, 40]. When S. 
aureus invades the host cells the first line of defense is the innate immune response, which 
specifically entails the recruitment of polymorphonuclear leukocytes (PMNs), also known as 
neutrophils. This highly specialized type of white blood cell accounts for the majority of white 
blood cells circulating in the blood. It is these neutrophils that are adapted to quickly detect 
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Figure 1.2 Phagocytosis and enveloping of S. aureus into the phagolysosome vesicle. This is followed by 
the oxidative burst involving the formation of major reactive oxygen species (ROS), namely superoxide 
and hydrogen peroxide by neutrophils’ membrane-bound NADPH-dependent oxidase (NOX) and 
superoxide dismutase (SOD) respectively. Further oxidation is provided by myeloperoxidase-containing 
granules that oxidise chloride ions to form reactive chlorine species (RCl), the major component being 
HOCl which is released into the phagolysosome. Image adapted and redrawn from [41].  
 
The engulfed bacteria are then retained in a phagosome, a vesicle which fuses with 
cytoplasmic granules to form a protected destructive compartment called a phagolysosome 
[40, 42, 43]. There are four types of granule vesicles that together contain 
myeloperoxidases, antibiotic proteins, proteases, NADPH-dependent oxidases and other 
signaling molecules that modulate the immune response. In addition to granules, it has been 
shown through studies involving S. aureus that the neutrophil produces interesting 
chromatin-based structures called neutrophil extracellular traps (NETs) which play a role in 
bacterial entrapment and neutrophil killing mechanisms in a wide range of engulfed 
pathogens [41, 44].  
The formation of the phagolysosome initiates the first step in neutrophil killing mechanisms, 
namely the oxidative burst (respiratory burst). This is followed by a series of non-oxidative 
killing mechanisms. 
1.3.2 Neutrophil killing mechanism - the oxidative burst 
The respiratory burst starts with the multicomponent membrane-bound NADPH oxidase 
(NOX). Although there are a number of forms of NOX, NOX-1/2 appears the most crucial in 
producing the variety of oxidants in the phagolysosome [41]. The importance of NOX in the 
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whose ability to clear common infections is severely impaired due to multiple mutations in 
the enzyme [45]. 
NOX is the major initiator of reactive intermediates that together constitute the oxidative 
burst produced by the neutrophil. As shown in Figure 1.3, NOX-2 catalyzes one one-electron 
reduction of oxygen to form reactive species such as superoxide anion (O2●-). Finally the 
dismutation of superoxide results in the formation of H2O2 which constitutes the major 
oxidative species produced by these cells.  
 
Figure 1.3 Membrane associated NOX showing the generation of oxygen radicals and ultimately H2O2. 
The NOX-2 catalyzed reduction of oxygen results in the formation of superoxide which inturn dismutates 
either non-enzymatically (N-E) or via the action of SOD to ultimately form H2O2. Adapted and redrawn 
from [41]. 
 
From activated (Flavin adenosine dinucleotide-containing) NOX-1/2, these reactive species 
pass into the phagolysosome which then react with the heme-containing protein 
myeloperoxidase (MPOs). MPOs are relatively abundant, accounting for 25% of the protein 
in the phagolysosome [46].  MPO’s are able to form a number of complex intermediates (I-
III) which allows the oxidation of a variety of biological substrates and perform a number of 
different radical and non-radical reactions. The reactions of MPOs include the oxidation of 
chloride, organic substrates (using H2O2) and superoxide formation [41, 42, 47-49]. However 
the major product of MPO-catalyzed reactions is the formation of HOCl (hypochlorous acid). 
This is not unexpected considering that the amount of chloride in the neutrophil is in the mM 
range [50-54]. Although there are also other halogens such as bromide and thiocyanate ions 
in the neutrophil that may form HOBr or HOSCN respectively, they are minor components 
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The HOCl formed in this manner is an extremely strong oxidant and reacts with nearly all 
compounds within its proximity in some manner. It is a very short-lived oxidant, is 
membrane-permeable and predominantly targets the sulphur atoms of cysteine, methionine 
and the amino functional groups of amino acids and nucleotides [41, 56, 57].  
Another oxidant product of the neutrophil is nitric oxide (NO) and its derivative peroxynitrite 
(formed from the reaction of nitric oxide with superoxide). The formation of the NO and 
peroxynitrite are plausible reactive nitrogen species (RNS) that have been implicated in a 
number of disease states, signaling pathways, cardiovascular system and inflammation [58]. 
The formation of RNS is also complicated by the fact that they can also occur in consort with 
the NOX system [58]. Out of the many RNS, peroxynitrite is shown to have strong oxidant 
and antimicrobial properties. The potential antimicrobial effects of peroxynitrite and NO 
range from reactions with metalloproteins [59], bacterial respiration [60, 61], inactivation of 
ribonucleotide reductase [62], nitration of tyrosine and DNA damage [63, 64]. In the last 
decade there is growing evidence that the formation of RNS appears to play a more 
prominent role in antimicrobial defense, whether alone or in combination with ROS, than 
previously thought. 
1.3.3 Non-oxidative neutrophil killing mechanisms 
Other than the abovementioned oxidative killing mechanisms, the non-oxidative killing 
mechanisms executed by neutrophils depend mainly on the effects exerted by released 
small peptides and larger proteins. These include short antimicrobial peptides, proteases, 
defensins, cathelicidines, collagenases, gelatinases, lysozymes and lactoferrins [42, 48, 65-
67]. These biomolecules are known to elicit longer acting effects when compared to the 
short-lived quick reacting oxidants produced by NOX and MPOs [41, 48]. As the molecular 
targets and consequences of non-oxidative killing mechanisms are not the focus of this 
study they will not be discussed further here. 
1.3.4 Neutrophil-derived oxidants – H2O2 and HOCl 
In the context of neutrophils killing the bacterial pathogens that they have engulfed, it is clear 
that H2O2 and ultimately HOCl are crucial in antimicrobial defense. Both HOCl and H2O2 are 
shown to pass through the bacterial cell membrane. The targets of H2O2 and/or superoxide 
include oxidation of Fe-S clusters that would generate radical species via Fenton/Haber-
Weiss chemistry (Figure 1.4) and in turn ultimately cause damage to bacterial DNA as well 

















 + OH- + OH
 
Figure 1.4 Oxidation of Fe3+/Fe2+ via Haber-Weiss/Fenton reactions [70]. 
 
HOCl is known to chlorinate bacterial proteins, specifically causing side chain oxidation and 
protein unfolding [71-75]. Moreover, Fe-S clusters are also vulnerable to HOCl-mediated 
oxidation [71, 76]. However, due to its unstable nature and reactivity towards molecules in 
the immediate vicinity (such as cysteine, methionine and amines), it is unlikely that all the 
HOCl produced by the neutrophil will enter into the bacterium. It is more likely that HOCl 
would react with molecules on the bacterial outer membrane leaflet, or with compounds in 
the phagolysosome. The products of these secondary reactions would then enter the 
bacterium to elicit their combined antibacterial effects in the cytoplasm [41].  
While HOCl has significant antibacterial activity as outlined above, it has also been shown to 
have negative impacts on the neutrophil itself. It has been shown in a number of studies that 
amino acids within the phagolysosome as well as components of the phagolysosome 
membrane itself are chlorinated by HOCl, supporting the notion that it reacts with molecules 
in its immediate surroundings [41, 67, 77, 78]. While self-chlorination may seem 
counterproductive (and possibly even detrimental) to the neutrophil, it appears that some 
chlorination of phagolysosomal components may result in the formation of signaling 
molecules that modulate the immune response as well as the overall fate of the neutrophil 
[51, 52].  
1.3.5 HOCl and protein damage 
There are a number of molecules with thiol groups present within the neutrophil as well as 
the engulfed pathogen that may react with HOCl. These include low molecular weight (LMW) 
thiols as well as cysteine and amine functional groups on proteins. Depending on the extent 
of thiol oxidization, it may be a reversible or irreversible process [49, 55, 79]. When oxidized 






~ 10 ~ 
1.5A). The sulfenyl chlorides may also react with LMW thiols either directly, or after having 
undergone hydrolysis to form sulfenic acids. This leads to intra- or inter molecular disulfide 
formation. The sulfenic acids can be oxidized further to sulfinic acids and finally sulfonic 
acids, the last step being irreversible (green boxed species).  
Met residues can also undergo oxidation to sulfoxides or sulfones (Figure 1.5B). There is 
also evidence that HOCl oxidizes N-terminal methionine residues to irreversibly form 
dehydromethionine [80-82]. HOCl can also react with amines to form chloramines (Figure 
1.5 C). The chloramines of α-amino acid are unstable and decompose to form aldehydes 
and ammonia which are also able to react with cellular components such as Fe-S clusters 
[56, 71, 83-88]. However, the chloramines of β-amino acids are much more stable, and 
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Figure 1.5 Reactions of thiols and amines with HOCl. (A) Thiols are oxidized to varying degrees by HOCl. 
The formation of sulfonamides and sulfonic acids are irreversible (Green boxed species). Protein 
disulfides are regenerated by thioredoxin/thioredoxin reductase system (B) The oxidation of methionine 
predominantly results in the formation of methionine sulfoxide which can be repaired by methionine 
sulfoxide reductase. (C) The oxidation of amines results in the formation of chloramines. Amino acid 
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1.3.6 The role of taurine and its chloramine 
In the context of the neutrophil environment, amino functional groups are far more abundant 
than cysteines or methionines [41]. One of the major amine-containing targets of HOCl is 
taurine, an abundant non-proteogenic sulfonated β-amino acid that is found in all types of 
human cells, with particularly high concentrations up to 20–50 mM being found in leukocytes 
such as neutrophils and eosinophils [89-94]. The physiological functions (both speculative 
and experimentally determined) of taurine include involvement in osmoregulation, calcium 
modulation, phospholipid and protein interactions, bile conjugation, antioxidant properties, 
inflammation and modulation of the immune response and signaling molecules [92, 95].  
When HOCl reacts with taurine it forms a stable (compared to other chloramines) reactive 
































Figure 1.6 Reaction of taurine with HOCl. NCT is the predominant product however a small amount of 
NCT can undergo further chlorination to form N,N-dichlorotaurine (NDCT). NDCT is unstable and quickly 
reverts back to NCT [96]. 
 
NCT has been shown to have antimicrobial activity against a number of different pathogens 
[96-140]. NCT can react with thiols, amino acids and ascorbate but not amides nor alcohols 
[41, 71, 126]. Its antibacterial mode of action is proposed to act via the chlorination of 
components of energy metabolism, over-oxidation and chlorination of sensitive protein-
based thiols, DNA damage and cell membrane disruption (ammonia chloramine) [41, 56, 
57]. NCT also reacts with a number of neutrophil components (cytokines, chemokines, 
prostaglandin, tumor necrosis factor alpha, nitric oxide, interleukins, and collagenase) that 
downregulate the pro-inflammatory response [141-150].  
In addition to mono-chlorinated taurine, a small amount of unstable di-chloro taurine species 
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1.4 Mechanisms by which S. aureus directly counteract ROS and 
RCS  
In light of the arsenal of ROS and RCS produced in the neutrophil, bacteria have developed 
a number of ways to resist and counteract the effects of oxidative stress. Figure 1.7 provides 
a graphical overview of mechanisms by which S. aureus avoids and neutralizes host-
generated oxidative species, and counteracts their effects. The mechanisms are described 
in more detail in the following subsections. 
 
 
Figure 1.7 Mechanisms by which S. aureus protections itself against oxidative damage from the oxidative 
burst. 
 
1.4.1 Direct elimination of ROS 
In response to oxidative stress, S. aureus produces a number of enzymes that act directly on 
ROS. The first of these are two superoxide dismutases (SODs), SodA and SodM, which 
convert superoxide to H2O2 and O2 (Figure 1.8) with the help of a manganese cofactor [151-
155]. SodM and SodA not only protect S. aureus from superoxide damage but also prevent 
the indirect formation of hydroxyl radicals via Fe3+-dependent Haber-Weiss reactions [156]. 
Superoxide is impermeable to most membranes and thus both SodA and SodM are present 
as extracellular membrane-bound or secreted proteins. The expression of SOD increases 
dramatically upon neutrophil phagocytosis (regardless of increase in H2O2 production) as 
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resistant to oxidative stress, and when it is deleted or inactivated its pathogenicity and ability 







H2O + O2  
Figure 1.8 Reactions involving superoxide dismutase (SOD) and catalase (KatA). 
 
The H2O2 resulting from SOD catalysis—if not removed—will result in further oxidative 
damage towards S. aureus. Thus KatA, a heme-containing catalase, is expressed that 
converts H2O2 to H2O and O2 (Figure 1.8) [152, 161]. The reaction mechanism of KatA is a 
two-step reaction that involves the formation of an oxyferryl species which further combines 
with a second H2O2 molecule to generate H2O and O2 [162]. KatA has extremely high 
tolerance for H2O2 and is only inactivated at H2O2 concentrations of ~400–500mM [162]. Like 
SOD, KatA is highly upregulated during neutrophil phagocytosis and the presence of H2O2 
[152, 163]. Interestingly the inactivation of catalase in S. aureus causes increased sensitivity 
towards H2O2 only when competing bacteria are present such as streptococci found in nasal 
cavities [163, 164].  This is most likely due to the finding that alkyl hydroperoxide reductase 
(AhpC) can compensate for the lack of a KatA. Furthermore AhpC also plays a role in S. 
aureus pathogenesis [152, 164], and functions together with the help of protein partner 
AhpF, converting H2O2 to H2O or organic peroxide molecules to alcohols and H2O (Figure 
1.9) [165].  
 
Figure 1.9 General mechanism of alkyl hydroperoxidase AhpF/C. Organic peroxide molecules (1) are 
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Unlike SOD or KatA, AhpF and AhpC makes use of cysteine residues as part of their 
mechanism to render oxidants (H2O2 or organic peroxide molecules) unreactive. The detailed 
catalytic mechanism (Figure 1.10) involves AhpF, a flavin adenosine dinucleotide (FAD)-
dependent NADH disulfide reductase which reduces the disulfides of peroxiredoxin AhpC. 
Before AhpF reduces AhpC, a number of steps and domain rotations are involved, the 
details of which are described in Figure 1.10. 
 
Figure 1.10 Catalytic cycle of AhpF/AhpC. An initial priming reaction of AhpF initiates the cycle where by 
NADH reduces FAD followed by a domain rotation.  Electrons are then transferred to AhpF C-terminal 
thiols followed by another domain rotation in the opposite direction. Further reduction of FAD by another 
round of NADH results in reducing the N-terminal domain (NTD) thiols. The C- and N- terminal domain 
thiols undergo dithiol-disulfide interchange followed by another domain rotation. This final rotation 
orientates the NTD thiols for interaction with AhpC which itself reacts with substrate (depicted as ROOH) 
[166].  
Poole and co-workers have shown in detail that an intrasubunit pathway occurs during the 
catalytic mechanism, affording the reduction of the appended N-terminal redox-active 
disulfide containing domain (NTD) of AhpF. This facilitates catalysis towards the incoming 
AhpC [167-172]. In addition, they also showed for the first time a high resolution view of the 
thiol-thiolate hydrogen bond which had for some time been speculated to play a role in 
catalysis, but for which experimental evidence was lacking [167].  
Together AhpF/AhpC are up regulated in response to ROS [173]. In E. coli AhpFC shows a 
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clear if RCS upregulates AhpF/AhpC or by what mechanism AhpF/AhpC protects S. aureus 
due to RCS-induced stress [71].  
Another enzyme involved in ROS detoxification is flavohemoglobin (Hmp). As the name 
implies, Hmp contains both a heme and FAD cofactor that are involved in the de-
oxygenation of NO to form nitrate [175]. Hmp are found in a number of bacteria, including S. 
aureus that are shown to detoxify RNS, ROS (H2O2) and organic peroxide molecules [175-
179].  
1.4.2 Direct elimination of RCS 
The wealth of information that is available on bacterial responses to ROS stands in stark 
contrast to what is known regarding responses towards RCS. Most of the H2O2 produced in 
the neutrophil is used by MPOs to form one of its major products, the potent oxidant HOCl 
[46, 48, 57, 71-73, 77, 79, 152, 180]. As indicated previously, the primary targets of HOCl 
include sulfur-containing compounds and amine functional groups that subsequently form 
reactive aldehydes (Figure 1.5) [48, 71]. As part of their bacterial killing mechanism, HOCl 
and chloramines have also been shown to react with bacterial cell components such as 
membranes to form chlorinated lipid species [51, 181]. Specifically 
phosphatidylethanolamine is targeted in this manner. Moreover, the chlorination of 
nucleotides of DNA/RNA also occurs widely [182].  In response to HOCl-initiated lipid 
peroxidation and the formation of reactive aldehydes, bacteria upregulate a number of 
aldehyde dehydrogenases which are involved in their detoxification [183-189]. If not 
rendered inactive, the accumulation of aldehydes such as methylglyoxylate cause damage 
to bacterial cellular proteins, Fe-S clusters and DNA nucleotides [190-192]. To date no 
mechanism for the removal of HOCl or chloramines has been reported which is likely due to 
the chemical reactivity of these compounds. 
Another mechanism that has shown to be protective against low doses of RCS is the 
pigment staphyloxanthin [29, 31, 180, 193, 194]. Winterbourn and co-workers have 
investigated the role staphyloxanthin and enterobactin (a siderophore found in Gram-
negative bacteria) in the protective effects against exposure to HOCl and chloramines. 
Overall it was concluded that staphyloxanthin was able to protect some S. aureus strains 
against neutrophil killing; however enterobactin did not show significant protection against 
HOCl production. 
It appears the majority of reactive chlorine species target multiple bacterial components 
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exact targets, their mechanism of action and the bacterial repair systems that react in 
response to toxic chlorination events is an exciting area of research [48, 56, 71, 78].  
1.5 Mechanisms that sense and repair oxidative damage to 
proteins 
1.5.1 Repair mechanisms  
S. aureus maintains several repair systems to counter the effects of oxidation on protein thiol 
groups. The first is the well-characterized thioredoxin (Trx)/thioredoxin reductase (TrxR) 
system.  This system (Figure 1.11), which has been described in a number of extensive and 
pioneering studies by Holmgren and co-workers, is composed of a TrxR (designated as TrxB 
in S. aureus) and a thioredoxin-fold protein (Trx, designated as TrxA in S. aureus). TrxB is a 
flavoprotein disulfide reductase (FDR) enzyme that catalyzes the NADPH-dependent 
recycling of oxidized TrxA. In turn, TrxA is an oxidoreductase that reduces the disulfides that 
resulted from oxidation events in a variety of thiol-containing substrates [195-208].  TrxA is a 
member of the thioredoxin-fold superfamily that all have a thioredoxin (Trx) domain—four 
stranded beta sheets sandwiched between three alpha-helices—in common. So-called 
thioredoxin-fold proteins (TFPs) are found in all organisms and function in disulfide thiol 
interchange reactions, oxidative stress resistance, protein folding and removal of xenobiotics 
[199, 201, 207, 209, 210]. Thioredoxin proteins contain a characteristic CGPC motif that 
contains the two redox active cysteine residues that are involved in reducing disulfide-
containing substrates via disulfide exchange; this results in oxidation of its own Cys residues 
[199, 201, 211]. The importance of the Trx/TrxR system as a defense mechanism against 
oxidative stress has been shown in studies involving TrxR-null mutants which are 
subsequently lethal [208]. Furthermore, a number of bacteria including S. aureus are 
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Figure 1.11 Thiol disulfide interchange reactions of Trx/TrxR system. Trx (Step 2) can reduce disulfide 
substrates including LMW thiols or thiols on protein substrates (1). Oxidized Trx is recycled back to its 
reduced state via the NADPH-dependent TrxR reaction (Steps 3-5). 
 
Another important antioxidant enzyme involved in repairing damaged proteins is methionine 
sulfoxide reductase (Msr). Msr reverses the oxidation of methionine in proteins, i.e. it 
converts methionine sulfoxide residues back to methionine (Figure 1.5B) [80, 82, 224-227]. 
Methionine residues on protein surfaces have been hypothesized to act as oxidant 
scavengers; in such a scenario regeneration of these residues by Msr will allow for exposure 
to another round of oxidant [228, 229]. 
Another aspect of protein damage is the effect that oxidative stress has on protein folding. 
Specifically, RCS play a major role in protein denaturation when compared to ROS or RNS 
[45]. Jakob and co-workers, through a number of excellent studies and reviews, have 
described the effects of protein unfolding and aggregation due to RCS-mediated oxidative 
stress [71-73, 75, 230-234]. In regards to protein folding repair mechanisms in S. aureus,  a 
number of stress-related chaperones from the ClpB family have been indicated to be 
involved in refolding and repair of protein damage due to oxidative stress [235]. 
Lastly, some enzymes require metal cofactors for catalysis (Mn, Cu, Co, Fe-S), thus as 
expected the oxidation of metals via Fenton/Haber-Weiss chemistry would result in the 
decrease of amount of available metals and the accumulation of toxic radicals species. The 
only known repair mechanism of S. aureus that relates directly on metals is the repair of Fe-
S clusters. In S. aureus the suf system protects Fe-S cluster assembly during oxidative 
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1.5.2 Oxidative stress sensing and regulation mechanisms  
A number of the above-mentioned repair mechanisms are recruited largely due to sensing 
and regulatory mechanisms of S. aureus that respond very specifically to the type of oxidant 
encountered [240]. Overall, the metabolic profile of S. aureus would also need to adjust to 
respond to the oxidative damage of Fe-S clusters, and free cysteine and methionine. In a 
number of bacteria, including S. aureus, the pathways associated with transcriptional 
regulation and metabolism of cysteine and methionine are upregulated upon exposure to 
chlorine-based oxidative stresses [241-246]. These transcriptional regulators largely share a 
similar mechanism in response to ROS. Instead of inactivation or damage by ROS, these 
regulators are in fact activated. Activation occurs via redox sensitive cysteines that form 
intramolecular disulfide bonds which facilitates cooperative binding of RNA polymerase to 
activate transcription of the genes involved in ROS detoxification and repair mechanisms 
[247].  A number of transcriptional regulators are upregulated in response to ROS and RCS; 
these include Fur (KatA) [66, 248], PerR (KatA, AhpC/F, Trx/TrxR) [71, 173, 249], MgrA 
(capsule and membrane biosynthesis, coagulase, αtoxin, autolysis, multidrug efflux pumps, 
infection progression) [250-255], SarZ (metabolism of amino acids, fatty acids, nucleotides 
and sugars, pyrimidine synthesis and gluconate catabolism) [256, 257], SarA (Sod, TrxR, 
biotin formation, entertoxin C, collagen and fibronectin binding, proteases and virulence 
factors) [258-260], Spx (Trx/TrxR) [261, 262], QsrR (Quinone reductase, nitroreductase, 
glyoxalase, dioxygenase), HrcA (transcriptional repressor of heat shock genes), HypR2-
family (HOCl protection) and sigma B (infection progression and virulence) [263, 264].  
Regulators that have been show to specifically respond to HOCl-mediated stress include 
PerR, QsrR, HrcA, HypR2 and sigma B [263, 264].  
 
1.6 Oxidative stress resistance mediated by LMW Thiols and 
disulfide reductase enzymes  
1.6.1 LMW thiols 
In response to oxidative stress (ROS, RNS, RCS) and maintenance of redox balance, many 
organisms produce high concentrations of low molecular weight thiol compounds (Figure 
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Figure 1.12 Various LMW thiols implicated in oxidative stress responses. Glutatione (GSH, found in 
eukaryotes and Gram-negative bacteria), gamma-GlutamylCys (GGC, found in halobacteria, lactic acid 
bacteria), cysteine (Cys, found in all organisms), bacillithiol (BSH, found in Firmicutes), trypanothione 
(T(SH)2, found in Trypanosomes), mycothiol (MSH, found in Actinomycetes), coenzyme A (CoA, found in 
all organisms), ergothioneine (ESH, found in fungi and Mycobacteria), and ovothiol (OSH, found in 
Leishmania and marine invertebrates). 
S. aureus does not produce GSH, instead relying on coenzyme A (CoA) and bacillithiol 
(BSH) as its major LMW thiols [192, 268-274]. When redox-sensitive cysteines within active 
sites of proteins are oxidized they have the potential to form sulfonic acids, an oxidation 
state which cannot be reversed. This would be problematic to cells if not prevented. In this 
context LMW thiols act as a protective mechanism that organisms use in which oxidized 
proteins are S-thiolated by these molecules in a reversible manner to protect and regulate 
enzyme functions [55, 211, 267, 268, 271, 273-277]. 
CoA is a ubiquitous cofactor found in many organisms, and plays a central role in 
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oxidative stress resistance by acting as a redox buffer is also apparent. In such a role, CoA 
would be sacrificially oxidized by ROS and RCS to its disulfide. Importantly, S. aureus 
possesses a dedicated CoA disulfide reductase that maintains CoA in its reduced state, thus 
replenishing the pool of free CoA [268-270, 278]. In addition, S. aureus was found to 
produce CoA in millimolar quantities [279]. In light of these facts, it was therefore not 
surprising that a recent study demonstrated that proteins in S. aureus undergo S-thiolation 
by CoA upon challenge with high concentrations of H2O2 and the stressor diamide, as well 
as low concentrations of NaOCl (100 µM) [280]. However, the relative importance of CoA to 
the oxidative stress resistance mechanisms of S. aureus, and the manner by which it 
reverses CoA-thiolation, remains unexplored.    
Another major LMW thiol involved in oxidative stress of S. aureus is bacillithiol (BSH). It was 
discovered in 2009 and was found to be the α-glycoside of L-cysteinyl-D-glucosamine with 
L-malic acid [281]. It resembles the LMW thiol mycothiol (MSH) in that it contains the same 
cysteine moiety amide bonded to glucosamine [282]. However, MSH is linked to inositol, not 
malic acid, and mainly occurs in Actinomycetes. 
S. aureus BSH mutants show increased sensitivity towards oxidative stress, metals and 
fosfomycin [274, 283]. S. aureus strains that are unable to produce BSH showed decreased 
viability in mouse macrophage models, but appeared to be only slightly compromised under 
oxidative stress [284]. This suggests that BSH in S. aureus might fulfil a non-essential role 
during oxidative stress resistance, or one that can be complemented/replaced by a 
secondary LMW thiol.  Interestingly, the biosynthetic gene cluster for BSH production has 
been found upstream and co-directional to the panBCD operon responsible for pantothenate 
biosynthesis. However, the physiological relevance of this link is still to be uncovered [192]. 
Cysteine is unlikely to act as a redox buffer or play a role in redox homeostasis due to its 
toxicity at high concentrations. Furthermore it has been shown that cysteine undergoes Cu2+ 
catalyzed auto-oxidation to form cystine and H2O2 which would result in further oxidative 
damage [269, 285, 286] 
1.6.2 Disulfide reductase enzymes implicated in the recycling of LMW   
thiol disulfides in S. aureus. 
The reliance on LMW thiols as redox buffers necessitates the presence of disulfide 
reductase enzymes that can recycle these compounds once they have been oxidized to their 
disulfide forms. Since S. aureus does not produce GSH, it also does not have a glutathione 
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reductases: CoA disulfide reductase (CoADR) and lipoamide dehydrogenase (LipDH, LPD 
or LipA) (Figure 1.13). Importantly, no enzyme has been described that is able to reduce the 
disulfide of BSH (BSSB). However, S. aureus does have two functionally uncharacterized 
enzymes belonging to the same superfamily; they will be discussed in the next subsection.  
 
Figure 1.13 Thiol redox network of S. aureus. The top tier of enzymes are labeled FDRs which form part 
of the larger tDBDF superfamily. The three subgroups NADH peroxidase/oxidase and CoA-disulfide 
reductase (POR), disulfide reductase (DSR) and alkylhydroperoxide reductase (AHR) relevant to this 
study are shown. The unknown information is indicated by question marks [287]. 
 
Disulfide reductase enzymes are classified as FDRs, or more broadly belonging to the two 
dinucleotide binding domains flavoprotein (tDBDF) superfamily [166, 288].  As the name 
implies, tDBDFs contains two dinucleotide binding domains arranged in Rossman folds. Both 
domains are required for activity and bind the flavin cofactor, FAD (Flavin Adenosine 
Dinucleotide) and the second domain binds either NADH (Nicotinamide Adenine 
Dinucleotide, reduced) or NADPH (Nicotinamide Adenine Dinucleotide Phosphate, reduced).  
The tDBDFs can be broadly classified into two major groups (Figure 1.14) which are further 
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Figure 1.14 Two dinucleotide binding domains flavoprotein (tDBDF) superfamily showing nine subgroups 
based on structure-sequence alignment [288]. 
The first group include monooxygenases (MOX), 2,4-dienoyl CoA reductase (DCR), 
adrenodoxin reductase (ADR), glutamate synthase (GMS), and alkylhydroperoxide 
reductase (AHR). The second group includes disulfide reductase (DSR), NADH 
peroxidase/oxidase and CoA-disulfide reductase (POR), NADH ferredoxin reductase (NFR), 
and NADH dehydrogenase (NDH) [288]. In the context of disulfide reductase enzymes 
implicated in S. aureus redox homeostasis, only three subgroups—POR, DSR and AHR, 
representing CoADR, LipDH and two enzymes of unknown function—are relevant as shown 
in Figure 1.13.  
CoADR is classified as a POR subgroup member and represents the only known tDBDF in 
S. aureus capable of reducing the disulfide form of the LMW thiol CoA [269, 278]. It is a 
dimeric flavoprotein and shares up to 50% sequence identitiy with many other tDBDFs with 
the highest identity found over the pyridine-binding and FAD domains. While it also shares 
some similarity in the vicinity of the active site, it crucially lacks the disulfide motif CxxxxC 
that is characteristic of other disulfide reductases. Instead, it has a single Cys in the active 
site that ensures its activity through the formation of a  mixed disulfide with its substrate CoA 
[289]. Interestingly the single conserved Cys within CoADRs active site forms part of a 
SFxxC motif which is commonly seen in NADH peroxidase/oxidases and initially was thought 
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Cys43 which nucleophilically attacks one sulfur of the incoming CoA disulfide forming a 
mixed Cys43-CoA disulfide, whilst displacing one CoA molecule. The mixed disulfide state is 
the form in which it is usually isolated. The cycle continues with NADPH reducing the mixed 
disulfide via FAD, releasing another CoA molecule to regenerate the reduced form of the 























Figure 1.15 Catalytic mechanism of CoADR. The thiolate from Cys43 attacks one of the sulfur atoms on 
the incoming CoA disulfide (releasing one CoA) forming an enzyme mixed Cys-CoA disulfide. The 
enzyme is regenerated through NADPH reduction via FAD cofactor (releasing the second CoA) [269]. 
Since CoADR represents the only known enzyme with CoA disulfide reductase activity it has 
been targeted for the development of selective inhibitors to establish its relevance and 
importance to S. aureus growth and survival.  The first CoADR inhibitors were synthesized 
by Van der Westhuyzen and Strauss and were shown to be competitive mechanistic 
inhibitors [292]. However, these inhibitors did not have any effect on S. aureus growth, in 
agreement with the finding that under normal growth conditions CoADR-encoding gene cdr 
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Lipoamide dehydrogenase (LipDH, LPD or LipA) from S. aureus was first cloned and purified 
in 1991. LipDH, which catalyzes the NADP+-dependent oxidation of dihydrolipoamide, is 
classified as a DSR subgroup member and follows a similar mechanism (Figure 1.16) to that 
of other members of the DSR subgroup such as glutathione disulfide reductase.  
 
Figure 1.16 General mechanism observed for disulfide reductase (DSR) subgroup. The top tier shows the 
oxidative half reaction and the bottom the reductive half reaction [166].  
The general mechanism is initiated by the binding of NADPH which reduces the FAD 
cofactor to form a stable intermediate [FADH2●NAD(P)+]. Electrons are then transferred to 
the redox active disulfides via a covalent C4a-adduct whilst NAD(P)+ dissociates. The 
oxidative half reaction involves the N-terminal Cys forming a mixed disulfide intermediate. 
The final steps involve the C-terminal Cys thiolate attacking the sulfur of the mixed disulfide 
intermediate, releasing the reduced substrate and regenerating the oxidized enzyme for 
another round of catalysis [166, 294]. 
LipDH is found as a subunit of multi-enzyme systems of the pyruvate dehydrogenase (PDH) 
complex, 2-oxoglutarate dehydrogenase complex and branched chain 2-oxo acid 
dehydrogenase complex [295]. In S. aureus, it has been hypothesized as membrane bound 
subunit E3 of PDH. Experiments using LipDH in isolation proves to be unsuccessful owing to 
its association with other subunits of PDH, as well as the covalent attachment of its cofactor 
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suppression, by lipoylating E2 of the PDH (lipoyl-E2-PDH) which is shown to be secreted by 
S. aureus that then inactivates neutrophil toll like receptors 1/2 thus suppressing the immune 
response towards S. aureus [300]. Considering its very specialized role in metabolism, it is 
unlikely that LipDH has a functional role in oxidative stress resistance in this organism. 
 
1.6.3 Functionally uncharacterized tDBDF enzymes implicated in 
Oxidative Stress Resistance in S. aureus. 
Apart from the enzymes described in the previous subsections, S. aureus also produces two 
enzymes—MerA and YpdA—that appear to play an important role in oxidative defense 
mechanisms yet remain functionally uncharacterized.  
SaMerA, based upon bioinformatics analysis, can be classified as a tDBDF of the DSR 
subgroup containing a CxxxxC motif within the active site and two pyridine nucleotide 
binding sites. SaMerA shares highest sequence similarity to other DSR subgroup members 
such as mercuric ion reductases (MerA, from which it derives its name) and LipDHs. 
However, SaMerA lacks critical auxiliary cysteines that have been shown to be important in 
the catalytic mechanism of true mercuric ion reductases [166], and it does not contain a 
lipoic acid cofactor. It is therefore unlikely to have a function related to that of either of its 
fellow DSR sub group members.  
A study by Voyich et al showed that SaMerA was upregulated more than 80-fold) when S. 
aureus was challenged with neutrophils [301]. In a separate study, the HypR operon 
containing the gene that encodes SaMerA was found to be upregulated (~180-fold) under 
hypochlorite stress. The same study demonstrated that S. aureus in which the MerA-
encoding gene was knocked out is more sensitive than the wild-type to hypochlorite stress 
and has reduced survival in macrophage infection models [264]. Importantly, the homologue 
of SaMerA in E. coli, YkgC/RclA, is also significantly upregulated in response to hypochlorite 
stress [242]. In a separate study, the E. coli YkgC/RclA knockout mutant was shown to have 
increased sensitivity towards hypochlorite [76]. In light of these findings, the function of 
SaMerA seems to be related to its defense against host-generated oxidative stress. 
Uncovering this function of this enzyme constitutes the first aim of this study as discussed in 
Chapter 2. 
The other tDBDF of unknown function is YpdA, which shares closest homology to the TrxR 
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suggests that YpdA should have a TFP partner; however, it interestingly lacks the 
catalytically important CxxxxC motif found in all AHR enzymes and it is therefore unclear 
how this enzyme could act to reduce any disulfide without a disulfide motif. YpdA is found in 
all BSH producing bacteria and is proposed to play a role in bacillithiol dependent processes 
[211, 272, 281].  Using bioinformatics analysis as well as EMBL STRING, Gaballa et al 
showed that YpdA is associated with the biosynthesis of BSH [211]. These authors as well 
as a number of other authors have suggested that YpdA may function as a bacilliredoxin-like 
protein in reducing protein disulfides or may function in recycling bacillithiol disulfide (BSSB) 
analogous to CoADR [211, 246, 268, 272, 274, 281, 284, 302-304]. This enzyme and other 
select LMW thiols as a function of enzyme protection and regulation will be discussed further 
in Chapter 3. 
1.7 Aim and objectives of this study 
Oxidative stress is a crucially important component in the host-microbe interaction. 
Understanding the mechanisms by which pathogenic bacteria resist the oxidative attacks of 
the innate immune system can shed light onto the basic bacterial physiology as well as 
reveal new potential avenues by which the host’s natural defenses against infections can be 
rendered more effective. Discovering ways in which the oxidative stress response can be 
modulated—particularly in bacteria such as S. aureus where antimicrobial resistant strains 
are becoming all too common—may prove to be a critical step in improving our treatment of 
bacterial infections. 
In this context, this study set out to characterize enzymes putatively associated with 
oxidative stress resistance in S. aureus, as well as to clarify the respective roles of CoA and 
BSH in protecting enzyme activity in this organism under oxidative stress conditions. 
As such, the specific aims of this study were: 
(1) To characterize SaMerA, an S. aureus Flavin Disulfide Reductase (FDR) relevant to 
redox homeostasis.  
(2) To characterize the putative function of YpdA in the context of thiol/disulfide redox 
reactions involving bacillithiol (BSH). 
(3) To study the relative importance of CoA and BSH in the reversal of protein-based 
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Taken together, the aims of this study were formulated to increase our knowledge and 
understanding of the oxidative stress resistance mechanisms that are unique to S. aureus, 
but which could also be more widely relevant—particularly in the context of the host-
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Chapter 2 
CHARACTERIZATION OF S. AUREUS “MERA”
 
2.1 Introduction 
As described in Chapter 1, S. aureus produces a tDBDF of unknown molecular function in 
response to oxidative stress, currently named “MerA” (designated as SaMerA here on forth). 
SaMerA derives its name from its putative annotation as a mercuric reductase homologue 
(UniprotA0A224B076). This annotation is based on it showing sequence homology to known 
mercuric ion reductase (true “MerA”) proteins. There are a few studies published to date that 
make mention of SaMerA, yet the exact function of this protein remains unknown. 
The first study that highlighted the physiological relevance of SaMerA was done by Voyich et 
al, which showed that SaMerA is upregulated more than 80 fold in S. aureus strains MW2, 
MnCop, LAC, MRSA252 and COL following phagocytosis by neutrophils [2]. In a separate 
study, it was found that hypR-merA, which encodes for the Rrf2-family regulator HypR and 
SaMerA, were upregulated more than 180 fold under hypochlorite stress [3]. Finally, it was 
found that the hypR merA double mutant is also more sensitive to hypochlorite stress than 
the wild type [3]. 
Interestingly, the E. coli homologue of SaMerA (referred to as YkgC or RclA) has also been 
studied. Jakob and coworkers identified a new E. coli reactive chlorine-specific transcription 
factor, RclR. They found, amongst other important results, that RclR is responsible for the 
control of the expression of three genes (one of which is YkgC/RclA) which are essential for 
bacterial survival when confronted with chlorine stress [4]. In the same study E. coli mutants 
lacking RclA/YkgC are found to show increased sensitivity towards hypochlorite [4]. In a 
different study, Wang et al reported that the gene ykgC was significantly upregulated in E. 
coli O157:H7 human pathogen strains when exposed to hypochlorite [5]. 
Taken together, the results published to date all appear to point to the SaMerA enzyme and 
its homologues playing a very important role in oxidative stress resistance in bacteria; 
however the exact function or substrate/s upon which this enzyme acts remains elusive. The 
fact that oxidants such as H2O2 and HOCl also produce a large variety of secondary 
oxidants—any of which could be the target of SaMerA’s enzymatic action—further 
complicates analysis of the system.  
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The current chapter describes the results of a study focused on the characterization of 
SaMerA and identification of its most plausible physiological substrate, and as such the 
potential role it plays in S. aureus’ oxidative stress resistance. 
2.2 Results and discussion 
 Sequence analysis of SaMerA compared to other tDBDFs  
The tDBDF enzymes represent a diverse superfamily, with more than 1600 members [6]. 
Phylogenetic trees generated from structure-based alignments show that tDBDFs can be 
divided into two major groups consisting of nine subgroups in total (Table 2). Despite low 
pairwise sequence identity all members contain highly conserved domains including (from N- 
to C-terminal) an FAD binding domain, an ATG motif, a pyridine nucleotide binding domain, 
and GxxP and GD motifs. The active sites of the tDBDFs are found between the FAD 
binding domain and the ATG motif [6]. Despite the conservation amongst subgroups of 
tDBDFs, they have evolved to act on an extremely diverse range of substrates, including 
small molecules but also extending to larger protein partners [6-9]. The tDBDFs all share a 
common catalytic cycle, i.e. a reductive and oxidative half reaction. The reductive half 
reaction involves a hydride transfer from the pyridine nucleotide to FAD producing FADH2. 
The oxidative half reaction involves the passing of two electrons—one at a time or both 
simultaneously— to additional redoc centers in the same enzyme before being transferred to 
the final substrate acceptors. In the case of sequential single electron transfer, this usually 
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Table 2. Groups and subgroups of tDBDF superfamily [6]. 






Flavin containing monooxygenase 
N-hydroxylating monooxygenase 
Baeyer-Villiger monooxygenase 
2,4-dienoyl-CoA reductase (DCR) 2,4-dienoyl-CoA reductase 
Adrenodoxin reductase (ADR) Adrenodoxin reductase 
Glutamate synthase (GMS) Glutamate synthase 








Disulfide reductase (DSR) 




Mercuric ion reductase 
NADH ferredoxin reductase (NFR) 
NADH ferredoxin reductase 
NADH ferredoxin 
Nitrite Reductase 
NADH peroxidase/oxidase and 
disulfide CoA reductase (POR) 
NADH peroxidase/oxidase 




S. aureus MerA is annotated as a hypothetical mercuric ion reductase homologue and is 
classified as a member of the DSR subgroup, which includes glutathione reductase (Gor), 
dihydrolipoamide dehydrogenase (LipDH) and true mercuric ion reductases (MerA). The 
DSR subfamily contains additional highly conserved motifs, most important of which are the 
active site disulfide CxxxxC motif and a lysine residue that is shown to stabilize the reduced 
FAD intermediate. The sequence of SaMerA was therefore aligned to members of the DSR 
subgroup as well as its E.coli homologue RclA, for comparison purposes (Figure 2.1). 
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Overall the sequences show strong similarities as expected from their assignment to the 
same subgroup in the tDBDF enzyme family. Considering SaMerA is annotated as a 
mercuric ion reductase homologue it was also compared to a known mercuric ion reductase 
from Pseudomonas aeruginosa, PaMerA Tn501, which is by far the best studied mercuric 
ion reductase [10-25]. In addition to the active site motif CxxxxC, true mercuric ion 
reductases have a distinct pair of auxiliary Cys residues at their N-terminus (in the so-called 
NMerA domain) as well as an extended C-terminal region that also contains a Cys pair. The 
C-terminal Cys residues are critical for mercuric ion reductase activity [17]. Comparing the 
sequences of SaMerA to PaMerA Tn501, it becomes clear that both the N-terminal and C-
terminal Cys residues are absent in SaMerA. Consequently, SaMerA is not expected to have 
activity for Hg2+ reduction due to the absence of the critical auxiliary C-terminal Cys pair. 
SaMerA was also compared to other well-known members of the DSR subgroup, namely 
EcGor and EcLipDH; which reduce disulfide substrates GSSG and Lipoamide respectively. 
They both contain the CxxxxC motif which is involved in reducing their respective disulfide 
substrates. Based on alignment alone, SaMerA looks more like a Gor or LipDH than a true 
MerA. However, it is important to recall that in most cases LipDH, does not function in 
isolation, but rather forms part of a multi-enzyme complex. In addition, LipDH’s substrate, 
namely the lipoamide cofactor, is bound as an adduct to a Lys on the E2 domain of the multi-
enzyme complex [26]. It is therefore not likely that SaMerA has lipDH activity. It is also 
unlikely that it should show activity towards GSSG (i.e. act as a Gor) since S. aureus lacks 
the LMW thiol GSH [27, 28].  
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Figure 2.1 T-coffee multiple sequence alignment of S. aureus MerA (SaMerA), P. aeruginosa MerA Tn501 
(PaTn501MerA), E. coli Glutathione disulfide reductase (EcGor), E. coli Lipoamide dehydrogenase 
(EcLipDH) and the E.coli MerA homologue (EcRclA). Pink/Salmon highlighted regions show good 
sequence conservation. Section enclosed in the black box (SaMerA a.a 162-229) is the pyridine 
nucleotide binding domain. The box outlined in the thick grey line shows the conserved active site 
CxxxxC motif. All Cys residues are highlighted as blue dots. 
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 Cloning and plasmid constructs used 
This SaMerA wild-type (WT) plasmid was prepared by a previous member of the Strauss lab 
[1]. Briefly, the SaMerA gene (SAOUHSC_00581) was cloned from genomic DNA from the 
S. aureus RN4220 strain. The gene was inserted into a pET28a(+) expression vector for 
expression of a protein with a C-terminal 6×His-tag. The predicted active site of SaMerA 
contains the conserved CxxxxC motif; therefore, both single CysAla mutants as well as the 
double mutant were produced to aid in studying the enzyme’s catalytic mechanism. The 
SaMerA C48A mutant was generated by site-directed mutagenesis PCR using the pET28a-
MerA WT plasmid as template DNA, while the SaMerA pET28a-C43A and C43A C48A 
expression plasmids were kindly provided by Prof. Haike Antelmann (Institute of Biology - 
Microbiology. Freie Universität Berlin). The gene sequences contained in all plasmids were 
confirmed by sequencing prior to use.  
 Protein expression  
All plasmids were each separately transformed into E. coli BL21* (DE3) cells to be used in 
heterologous expression of the proteins. Optimum protein expression was obtained for 
SaMerA WT as well as the CysAla mutants by growing cultures in LB broth at 37oC 
overnight after induction with 0.5 mM IPTG at OD600nm = 0.5-0.6.  
 
Figure 2.2 10% SDS-PAGE analysis of SaMerA WT (1), SaMerA C43A (2), SaMerA C48A (3) and SaMerA 
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 Protein purification 
After growth and expression each pellet was lysed and proteins purified from the cell lysate 
using immobilized metal affinity chromatography (IMAC) on an ÄKTAPrime system. The 
purified fraction of each protein was then analysed by SDS-PAGE (Figure 2.2). The protein 
concentration was determined using the Bradford method as well as by measuring enzyme 
concentration using the FAD molar extinction coefficient. All of the proteins expressed well 
and yielded yellow/orange purified fractions characteristic of flavin-containing proteins. From 
an 500 mL LB broth culture an average of 21 mg of protein was obtained. The SaMerA 
C43AC48A mutant gave slightly lower yields, but overall the proteins expressed and purified 
very well. 
 Enzyme characterization  
2.2.5.1 General flavin spectral analysis 
In order to determine the cofactor requirement, SaMerA was anaerobically titrated with 
increasing amounts of either NADPH or NADH (Figure 2.3). This data was collected by a 










Like many of the DSRs, SaMerA showed a preference for NADPH over NADH in which the 









































Figure 2.3 Anaerobic titrations of SaMerA WT against NADPH (left spectrum) and NADH (right spectrum). 
The protein was titrated via sequential addition of NADPH/NADH (0.5mol) per flavin (1mol) up to an 
excess of 5mol. This data was previously collected [1]. 
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band), although it resisted full reduction despite the addition of excess NADPH. No reduction 
of the flavin cofactor was observed following the addition of NADH. 
2.2.5.2 Circular dichroism (CD) spectroscopy  
Wavelength (nM)


























Figure 2.4. CD spectroscopic analysis of SaMerA WT, SaMerA C43A, SaMerA C48A and SaMerA C43A 
C48A. 
 
The point mutations of the Cys residues of the CxxxxC motif in the SaMerA active site were 
done in order to aid in determining the catalytic mechanism of the enzyme with its potential 
substrate. CD spectroscopy was used to assess the effect these mutations may have on the 
overall folding of the enzyme. The CD spectra showed well folded proteins composed mainly 
of a mix of α-helixes and β-sheets as expected for tDBDF enzymes. Many of the tDBDFs are 
composed of approximately 50% α-helix and β-sheet. The SaMerA WT spectrum looked 
similar to the CD spectra of glutathione reductase and thioredoxin reductase [29, 30]. The 
mutants appear to have overall similar spectra to the wild type with positive increase in 
rotation values from 210 nm to 230nm and from 250 nm to 280 nm possibly due to a slight 
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2.2.5.3 X-ray crystal structure comparison 
The crystal structure of SaMerA WT was obtained at 1.9 Å resolution in conjunction with 
collaborators under direction of Professor Matthew Redinbo at the University of North 
Carolina at Chapel Hill, USA. The structure contained the bound FAD cofactor, but not 
NADPH or other molecules apart from solvent. 
The homodimeric structure of SaMerA (Figure 2.5) was solved with the FAD cofactor bound 
within the active site. As expected, the overall structure of SaMerA resembled that of other 
tDBDFs.  
 
Figure 2.5. X-ray crystal structure of homodimeric SaMerA WT at 1.9 Å resolution showing one FAD 
molecule per monomer. 
Stellenbosch University https://scholar.sun.ac.za
Chapter 2 
Characterization of S aureus “MerA” 
 
 
~ 55 ~ 
 
Figure 2.6 Model showing the surface of SaMerA, indicating the active site’s location and its size on one 
of the monomers. (A) Top view of the active site entrance of SaMerA with Cys43 of the active site motif 
highlighted in yellow. (B) Side view of the active site showing the disulfide formed between Cys43 and 
Cys48 (yellow stick structure), the FAD cofactor and the NAPDH binding site (labelled as NADPH). The 
active site is small and compact (~5Å) closest to the cysteine residues, but opens to a larger entrance 
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Figure 2.7 Schematic 2-dimensional diagram of the relative positions of the residues in the active site of 
SaMerA, as derived from the X-ray crystal structure. The active site’s entrance is at the bottom of the 
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Figure 2.8 Schematic 2-dimensional diagram of the relative positions of the residues in the active site of 
PaMerA Tn501 as derived from its X-ray crystal structure (PDB:1ZK7). The active site’s entrance is at the 
bottom of the schematic. The amino acid residue numbering relates to the corresponding residues in 
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In terms of the active site CxxxxC motif there is very little difference compared to other 
tDBDFs, as expected. The active site opening around the disulfides of SaMerA is small and 
compact, forming a 5Å wide channel closest to the disulfides but opening up to a larger 
entrance (Figure 2.6). Considering that tDBDFs act on their substrates that range from small 
molecules like peroxide and disulfides to fairly larger substrates such as small proteins 
(thioredoxins), the size and shape of the SaMerA active site suggests that it acts on a small 
molecule. The schematic diagram of SaMerA active site is shown in Figure 2.7. Compared to 
PaMerA Tn501 (shown in Figure 2.8) there are notable differences in the amino acids lining 
the active site. Specifically, the His427 residue in SaMerA is replaced by a Tyr in Tn501, and 
the polar and charged Thr301 and Lys13 is exchanged for Val and Gly. In addition, Miller 
and coworkers have shown that binding and transfer of Hg2+ in PaMerA Tn501 takes place 
by using an exogenous thiol and with the help of the critical N-terminal Cys pair. SaMerA 
lacks both auxiliary Cys pairs and is therefore unlikely to be able to bind Hg2+. However, the 
amino acids that line the active site (Lys13, Thr301, His427, Lys81, Arg368) are most likely 
involved in the binding of substrate. Considering the polar and positively charged nature of 
these residues, this suggests that the substrate likely contains groups that are negatively 
charged at physiological pH. 
 Assessing SaMerA’s activity as a mercuric ion reductase 
Considering SaMerA is annotated as a hypothetical mercuric ion (Hg2+) reductase 
homologue, it was therefore investigated if SaMerA shows any activity towards mercuric 
ions. True mercuric ion reductases such as PaMerA Tn501 make use of extra Cys pairs that 
play an important role in the catalytic mechanism of mercuric ion reductase as shown in 
Figure 2.9.The overall mechanism is essentially a ligand exchange or “passing on” of the 
Hg2+ between the Cys pairs. In Step 1 the enzyme encounters the exogenous thiol (Trx or 
GSH) which brings in the Hg2+ and passes this onto the first N-terminal Cys pair (C11/14) of 
MerA (Step 2). This results in the release of reduced Trx and the Hg2+ is subsequently 
passed onto the second C-terminal Cys residues (C558/559) (Step 4-5). Finally it is passed 
into the active site (Step 6-7) CxxxxC (Cys136/141 pair) where the mercuric ion is reduced 
(2 electron transfer from NADPH) to Hg0 and subsequently released, together with NADP+. 
The enzyme cycle restarts with the binding of a new NADPH and an incoming Trx/GSH-
Hg2+. It has also been shown in extensive work by Miller and co-workers that the N-terminal 
Cys (Cys 11/14) residues are dispensable and the catalytic cycle can still continue via the 
truncated pathway (Step 1 to 5 via step 8). The crystal structure and quantum mechanics 
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shows the energetically favorable transfer of the Hg2+ as well as the interplay between the 
competition of the Cys thiols/thiolates for Hg2+ versus protons [20, 21]. Miller and co-workers 
have also shown that the C-terminal Cys pair (Cys558/559) is critical for the full catalytic 
cycle [17, 23]. Single mutations of Cys558/559 drastically reduce catalytic activity, whilst a 
double CysAla mutant abolishes all activity. An additional feature of the mercuric ion 
reductase, like other enzymes associated with heavy metal binding, is that they have a 
heavy metal associated domain (HMA) in the extended N-terminal domain. It is hypothesized 
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Figure 2.9 Substrate exchange pathway of PaMerA Tn501. The outer reactions 1-7 show the full catalytic 
cycle of PaMerA Tn501 reducing Hg2+ to form Hg0. An exogenous thiol is required for substrate transfer 
to the auxiliary and active site disulfides. Exogenous thiol TrxA-Hg2+ is shown in the catalytic cycle. 
Truncated PaMerA Tn501, in which the auxiliary disulfides are proteolytically removed, can also reduce 
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Assay conditions for the putative mercuric ion reductase activity were based upon those 
reported by Miller and co-workers, using Hg(GSH)2 as the exogenous Hg2+-thiol  [17]. In 
Figure 2.10, it can be seen that under aerobic conditions SaMerA appears to have a low 
level activity in the presence of GSH (2.10.d), but then clearly increases when mercuric ion 
is included (2.10.f). This assessment is based on reactions lacking substrate (SaMerA WT + 
NADPH reactions Figure 2.10(b)). This was surprising considering SaMerA lacks the 
features of a true mercuric ion reductase. However, the Vmax rates reported for true mercuric 
ion reductases under similar enzyme concentrations are approximately 8-16 µM/Min 
(depending on the source of the enzyme). In comparison to these values, SaMerA average 
reaction rate of 1.0 µM/Min does not constitute meaningful activity towards mercury. In 
addition to using GSH as an exogenous thiol, β-mercaptoethanol was also tried in test 
reactions; however, this did not make a difference in activity. Furthermore under anaerobic 
conditions (Figure 2.10. c, e and g) SaMerA appears to have a low level activity in the 
presence of GSH (e) and does not appear to increase when mercuric ion is included (g). 
In light of the low mercuric ion reductase activity observed for SaMerA in our hands, we 
decided to express and purify PaMerA Tn501 to perform a direct comparison in their 
activities to exclude any potential error in the execution of the assay.  



















a - Buffer (No enzyme)
b - Aerobic SaMerA WT reaction
c - Anaerobic SaiMerA WT reaction
d - Aerobic SaMerA WT + GSH 
e - Anaerobic SaMerA WT + GSH 
f - Aerobic SaMerA WT + Hg(GSH)2 
 g- Anaerobic SaMerA WT + Hg(GSH)2
 
Figure 2.10 Assessment of SaMerA’s mercuric ion reductase activity by following the rate of oxidation of 
NADPH at 340 nm. (a) Reaction buffer (No enzyme), (b)Aerobic SaMerA WT, (c) Anaerobic SaMerA WT, (d) 
Aerobic SaMerA WT + GSH, (e) Anaerobic SaMerA WT  + GSH, (f) Aerobic SaMerA WT + Hg(GSH)2, (g) 
Anaerobic SaMerA WT + Hg(GSH)2. All reactions contained NADPH. Concentrations used: 100 µM 
NADPH, 100 µM Hg(GSH)2, 1 mM GSH, 25 nM enzyme. Data shown is the average rate obtained in four 
biological repeats SEM (n=4). 
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Figure 2.11 shows the activity of SaMerA WT (a-d) compared to that of PaMerA Tn501 (e-f). 
The data showed that PaMerA Tn501 indeed did require the exogenous thiol as previously 
described. In addition, the pretreatment step of the enzyme with DTT and refolding 
(described in literature and section 2.4.3) to ensure disulfides are reduced was 
indispensable when testing mercuric ion reductase activity. This data confirmed that SaMerA 
WT had no appreciable mercuric ion reductase activity. The SaMerA C43AC48A mutant also 
showed no activity (g-i) confirming that the low level activity observed for the wild-type does 
involve the active cysteine residues (d).  

















7 a - Buffer (No enzyme)
b - SaMerA WT
c - SaMerA WT + GSH
d - SaMerA WT + Hg(GSH)2 
e - PaMerA Tn501 + GSH
f  - PaMerA Tn501 + Hg(GSH)2
g - SaMerA C43AC48A
h - SaMerA C43AC48A + GSH
 i  - SaMerA C43AC48A + Hg(GSH)2
 
Figure 2.11 Assessment of SaMerA’s mercuric ion reductase activity against PaMerA Tn501 activity 
based on oxidation of the NADPH cofactor. (a) Reaction buffer (No enzyme), (b) SaMerA WT, (c) SaMerA 
WT + GSH, (d) SaMerA WT + Hg(GSH)2, (e) PaMerA Tn501 + GSH, (f) PaMerA Tn501 + Hg(GSH)2, (g) 
SaMerA C43AC48A, (h) SaMerA C43AC48A + GSH, (i) SaMerA C43AC48A + Hg(GSH)2. Concentrations 
used: 100 µM NADPH, 100µM Hg(GSH)2, 1mM GSH, 25nM Enzyme. All reactions contained NADPH. Data 
shown is the average rate obtained in four biological repeats SEM (n=4). 
 
We were also interested as to why there appeared to be some activity observed for SaMerA 
WT towards mercuric ion. We therefore investigated whether instead of direct reduction of 
the metal ion, the heavy metal might be potentiating the oxygen reducing activity of the 
flavoprotein [32, 33]. This was determined by assessing the SaMerA WT mercuric ion 
reductase activity in the presence of horse radish peroxidase (HRP) and substrate ABTS 
[34, 35]. ABTS is a chromogenic compound used as an indicator in a number of applications. 
ABTS is also used in the determination of H2O2 in the presence of an appropriate peroxidase 
(Figure 2.12). ABTS is colorless in solution but upon oxidation by HRP and H2O2 forms the 
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green ABTS radical which has an intense broad spectrum at 415 nm - 820 nm [35]. It can 










































Figure 2.12 Determination of H2O2 formation using ABTS and HRP. (A) ABTS is oxidized in the presence 
of H2O2 and HRP to form an ABTS radical which can be measured spectrophotometrically at 415-420 nm. 
(B) Hg2+ attenuates SaMerA’s formation of H2O2 from O2, as measured by coupling its production to 
formation of the ABTS radical as catalyzed by HRP. 
 
The results (Figure 2.13) show that SaMerA WT did indeed produce hydrogen peroxide in 
the presence of mercuric ion under aerobic conditions (Figure 2.13. column d), while very 
little formed under anaerobic conditions (Figure 2.13. column e). SaMerA C43A48A showed 
very little H2O2 - producing activity in the presence of mercuric ion under both aerobic and 
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35 a - Buffer (No HRP or SaMerA)
b - Aerobic HRP reference reaction
c - Anaerobic HRP reference reaction 
d - Aerobic SaMerA WT + Hg(GSH)2 
e - Anaerobic SaMerA WT + Hg(GSH)2 
f - Aerobic SaMerA C34AC48A + Hg(GSH)2 
 g- Anaerobic SaMerA C34AC48A 
      + Hg(GSH)2
  
Figure 2.13 Assessing the formation of H2O2 by SaMerA WT. The formation of H2O2 by SaMerA in the 
presence of Hg2+ was coupled to the formation of chromophore ABTS radical as catalyzed by horse 
radish peroxidase (HRP). Both aerobic and anaerobic conditions were evaluated. (a) Buffer (No HRP or 
SaMerA), (b) Aerobic reference reaction: HRP + ABTS + 100 µM H2O2, (c) Anaerobic reference reaction: 
HRP + ABTS + 100 µM H2O2, (d) Aerobic SaMerA WT + Hg(GSH)2, (e) Anaerobic SaMerA WT + Hg(GSH)2, 
(f) Aerobic SaMerA C43AC48A + Hg(GSH)2, (g) Anaerobic SaMerA C43C48A +  Hg(GSH)2. Concentrations 
used: 100 µM NADPH, 100 µM ABTS, 100 µM Hg(GSH)2, 25 nM enzyme. All reactions contained NADPH, 
HRP and ABTS. Only reference reactions contained exogenous H2O2. Data shown is the average rate 
obtained in one biological repeat performed in triplicate, with the errors showing the standard deviation. 
 
Taken together, this data suggests that the NAPDH oxidizing activity observed for SaMerA 
WT in the presence of mercuric ion is rather due to the low level of oxygen reduction being 
potentiated by the presence of the metal ion, rather than due to reduction of the metal ion 
itself. Moreover, the disulfide is clearly required for this oxygen reducing activity, further 
supporting the role of mercuric ion in potentiating this activity upon binding of the active site 
cysteine residues. It can be concluded that despite SaMerA WT having some apparent 
(albeit very little) activity towards mercuric ion, when compared to a true mercuric ion 
reductase like PaMerA Tn501 and when taking into account the results obtained in the 
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 Assessing SaMerA’s activity towards other metals 
After concluding that SaMerA has no appreciable activity as a mercuric ion reductase, we 
considered whether it acts on a different biological metal that is also relevant to oxidative 
stress such as iron (Fe3+), zinc (Zn2+) or copper (Cu2+) [36-42]. The metals iron, zinc and 
copper are important metal cofactors that are found in a number of redox active enzymes. 
The most well-known are Fe-S clusters that are particularly sensitive towards oxidation by 
ROS and RCS, forming toxic Fe3+. SaMerA was thus assessed for its ability to reduce Fe3+ 
thus repairing the effects of Fe2+ oxidation. For comparison, SaMerA was also assessed for 
its ability to reduce Zn2+ and Cu2+. 














2.0 a - Buffer (No substrate)
b - Buffer (No enzyme)
c - SaMerA WT  
d - SaMerA C43AC48A
e - Buffer (No enzyme)
f  - SaMerA WT
g - SaMerA C43AC48A
h - Buffer (No enzyme)




 j  - SaMerA C43AC48A 
 
Figure 2.14 SaMerA WT and SaMerA C43C48A activity for the reduction of iron, zinc and copper ions. (a) 
SaMerA WT (No metal substrate), (b) Buffer + FeCitrate, (c) SaMerA WT + FeCitrate, (d) SaMerA C43C48A 
+  FeCitrate, (e) Buffer + ZnCl2, (f) SaMerA WT + ZnCl2, (g) SaMerA C43AC48A + ZnCl2, (h) Buffer + CuCl2, 
(i) SaMerA WT + CuCl2, (j) SaMerA C43AC48A + CuCl2. Concentrations used: 100 µM NADPH, 100 µM 
metal substrate, 25 nM enzyme. All reactions contained NADPH. Data shown is the average rate obtained 
for one biological repeat (n=1) performed in triplicate; the error bars show standard deviation. 
 
The figure above (Figure 2.14) shows SaMerA activity towards reducing Fe3+ (FeCitrate) and 
other metals Zn2+ (ZnCl2) and Cu2+ (CuCl2). For SaMerA’s activity towards FeCitrate no 
difference is observed between the WT and the C43A C48A mutant (blue bars). Similarly, 
there is no difference between the WT and C43A C48 mutant against either Zn2+ or Cu2. In 
summary SaMerA does not appear to reduce Fe3+, Zn2+ or Cu2+. 
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 Assessing potential substrates for SaMerA 
With no appreciable activity towards mercury, iron, zinc or copper ions other potential 
substrates were explored. Considering SaMerA is classified in the DSR group, which 
includes glutathione reductase and thioredoxin reductase perhaps SaMerA WT is able to 
reduce the disulfides of a low molecular weight thiol or of a protein such as thioredoxin? Or 
does it act on such substrates only in context of the oxidants H2O2 or HOCl? We therefore 
set out to answer these questions by a conducting a variety of activity assays. 
2.2.8.1 Assessing potential protein partner/s 
Identifying suspected partners of a protein is an important aspect in an attempt to 
understand protein function or physiochemical properties of an unknown protein. Pull-down 
or “protein fishing” experiments using affinity tags have been widely used in determining 
potential protein binding partners [43-45]. A number of studies, including ones on thioredoxin 
and thioredoxin reductase, have been conducted using GST-fusion tagged proteins in 
identifying protein partners [46-48]. The same principle was used in evaluating the possibility 
that SaMerA might require a protein partner for its activity. Briefly the GST-fusion of SaMerA 
WT was expressed and purified (described in section 2.2.8) and used in a pull-down assay 
to identify any potential protein partners present in S. aureus JE2 lysates. S. aureus JE2 was 
cultured until exponential phase and thereafter oxidative stress was elicited by exposure to 
10 mM H2O2 during growth (see experimental section for details). This was done taking into 
consideration that SaMerA is overexpressed under conditions of oxidative stress. The lysate 
obtained from cells treated in this manner was subsequently used in a pull-down experiment 
with the GST-tagged SaMerA. The results, as determined by SDS-PAGE analysis, are 
shown in Figure 2.15. 
 
Figure 2.15 Pull-down assay for SaMerA WT against S. aureus JE2 lysate. Lanes (1) molecular weight 
ladder, (2) purified GST-tagged SaMerA WT, (3) S. aureus JE2 lysate wash 1, (4) S. aureus JE2 lysate 
wash 2, (5) S. aureus JE2 lysate wash 3, (6) S. aureus JE2 lysate wash 4, (7) S. aureus JE2 lysate wash 5, 
(8-10) GST-SaMerA WT elution fractions. 
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It can be seen that the only protein that eluted during the elution step was the GST-SaMerA. 
There are a few faint bands below the SaMerA bands (lane 8-10) but these faint bands were 
also present in the wash steps (lane 3-7). This confirms that GST-SaMerAWT was bound to 
the GSH resin, although no other protein appeared to bind to SaMerA. This result suggests 
that SaMerA WT does not require a protein partner. 
2.2.8.2 Assessing potential disulfide substrates 
Reactive oxygen species (ROS) as well as reactive chlorine species (RCS) are known to 
oxidize thiol groups. Cysteine thiols can undergo oxidation to sulfenic acids (via sulfenyl 
chlorides in the case of HOCl oxidation) which can react with another cysteine within close 
proximity forming disulfides [49-51]. The thioredoxin system (TrxA/TrB) is in place to reduce 
protein disulfides formed through ROS/RCS [52]. On the other hand, S. aureus also 
produces a number of LMW thiols (Cys, CoA, BSH, LipA) which can also form disulfides due 
to oxidative stress such as neutrophil derived H2O2 or HOCl. In order to recycle the disulfide 
form of the LMW thiol there are specific reductases (depending on the species) in place. 
Indeed, with the formation of LMW thiol disulfides S. aureus produces dedicated enzymes 
that are able to reduce the disulfide substrates.  For (CoAS)2, S. aureus has a dedicated 
CoA disulfide reductase that recycles the CoA disulfide back to the free CoA-SH [53-55]. In 
regards to lipoamide/dihydrolipoamide, S. aureus produces a dedicated lipoamide 
dehydrogenase [8, 56, 57]. Currently there is no direct evidence of a BSSB reductase being 
present in S. aureus, or any other organism. Another potential disulfide substrate is 
pantethine, the disulfide form of pantetheine, which is also a metabolic degradation product 
of CoA. 
In continuation for the search of potential substrates for SaMerA, selected disulfides were as 
assessed. In context to the neutrophil, LMW thiol disulfides were prepared via H2O2 
oxidation of LMW thiols (details described in 2.4.6). Known disulfide reductases Gor, LipDH 
and CoADR were used as positive control reactions towards disulfides (GSH)2, 
dihydrolipoamide (DHLA)2 and (CoAS)2 respectively. The same reaction conditions were 
used in assessing SaMerA’s activity towards the disulfide substrates. The results of these 
activity tests are shown in Figure 2.16 and Figure 2.17. 
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a - EcGor  + (GSH)2
b - EcLipDH + (DHLA)2
c - SaCoADR + (CoAS)2
 
Figure 2.16 EcGor, EcLipDH and SaCoADR activity towards disulfides respectively. (a) EcGor + (GSH)2, 
(b) EcLpDH +  dihydrolipoamide, (c) SaCoADR + (CoAS)2. Concentrations used: 100 µM NADPH, 100 µM 
disulfide substrate, 25 nM enzyme. All reactions contained NADPH except LipDH which contains NADH. 
Data shown is the average rate obtained for one biological repeat performed in triplicate; the error bars 
show standard deviation. 














2.0 a - SaMerA WT
b - SaMerA WT + (Cys)2
c - SaMerA WT + (GSH)2
d - SaMerA WT + (CoA)2
e - SaMerA WT + (DHLA)2
f  - SaMerA WT + (LipoA)
g - SaMerA WT + (BSH)2
h - SaMerA WT + (Pantotheine)2
 
Figure 2.17 Assessing SaMerA’s activity towards selected disulfides. (a) SaMerA, (b) SaMerA + (Cys)2, (c) 
SaMerA + (GSH)2, (d) SaMerA + (CoAS)2, (e) SaMerA + (DHLA)2, (f) SaMerA + lipoamide, (g) SaMerA + 
(BSH)2, (h) SaMerA + Pantethine. Concentrations used: 100 µM NADPH, 100 µM disulfide substrate, 25 nM 
enzyme. All reactions contained NADPH. Data shown is the average rate obtained for one biological 
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These results demonstrate that SaMerA did not show any substantial activity towards any of 
the selected disulfides tested. 
2.2.8.3 Hypochlorous acid and thiols 
Hypochlorous acid (HOCl) is an abundant myeloperoxidase-derived RCS found within the 
neutrophil environment [58-61]. Considering SaMerA did not show any appreciable activity 
towards H2O2- or H2O2 - derived disulfides it was therefore assessed if any activity would be 
shown towards HOCl or HOCl-derived thiol compounds. 
SaMerA’s activity towards HOCl was first attempted to be tested directly, but addition of 
NADPH to reaction mixtures containing HOCl caused immediate oxidation of the NADPH (as 
evidenced by disappearance of the absorbance at 340 nm). At higher HOCl concentrations, 
the NADPH was shown to be chlorinated (presumably on the amine of the adenine moiety) 
[62]. In the context of the neutrophil that produces HOCl, this suggests that it would most 
likely also react with molecules in the immediate vicinity of the neutrophil as soon as it is 
formed. Likely major primary and secondary targets for HOCl would be thiols and amines 
respectively. Consequently, the bulk of HOCl is expected to rather result in the formation of 
reactive or nonreactive chlorinated species within the neutrophil and engulfed pathogen, and 
that it is one or more of these compounds that would act as the substrate of SaMerA [58, 63-
66]. With this in mind, it was further investigated if SaMerA shows activity towards LMW 
disulfides derived from HOCl oxidation. Towards this end, each thiol was reacted with an 
equimolar amount of HOCl. The absence of residual HOCl was confirmed using the 
absorbance maximum for HOCl at 291 nm (ε=142 M-1.cm-1). Figure 2.18 shows SaMerA’s 
activity towards these HOCl-derived thiols. SaMerA showed very little activity towards any of 
the tested HOCl-derived compounds.  
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a - SaMerA WT
b - SaMerA WT + Cys:HOCl
c - SaMerA WT + GSH:HOCl
d - SaMerA WT + CoA:HOCl
e - SaMerA WT + DHLA:HOCl
f  - SaMerA WT + BSH:HOCl
g - SaMerA WT + 2,4-DNB-Cl
 
Figure 2.18 SaMerA’s activity towards HOCl-derived disulfides. (a) SaMerA WT, (b) SaMerA WT + 
Cys:HOCl, (c) SaMerA WT + GSH:HOCl, (d) SaMerA WT + CoA:HOCl, (e) SaMerA WT + DHLA:HOCl, (f) 
SaMerA WT + BSH:HOCl, (g) SaMerA WT + 2,4-dinitrobenzenesulfenyl chloride. Concentrations used: 
100µM NADPH, 100µM sulfenyl chloride substrate, 25nM enzyme. All reactions contained NADPH. Data 
shown is the average rate obtained in three biological repeats (n=3), each performed in triplicate. The 
error bars show the SEM. 
 
2.2.8.4 Hypochlorous acid and amino acids 
In the context of the neutrophil environment the secondary target of HOCl (after thiols) are 
amines. Considering that HOCl-treated LMW thiols showed no activity towards SaMerA, it 
was investigated whether HOCl-derived chloramine compounds would act as substrates of 
SaMerA as a means to rendering them harmless. A number of chloramines were tested as 
shown in Figure 2.19. The various amino acid chloramines were prepared using HOCl and 
amino acid mixed in a 1:1 ratio, following which their concentrations were confirmed using 
the chloramine absorbance maximum at 252 nm (ε = 429 M-1.cm-1) [66]. 
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a - SaMerA WT (No chloramine)




f  - GlycineHOCl
g - GlutamicAcidHOCl
h - AsparticAcidHOCl
 i  - MethionineHOCl








 r  - SerineHOCl
 s  - ThreonineHOCl




 x  - LysineHOCl
 y  - HistidineHOCl
 
Figure 2.19 SaMerA’s activity towards various chloramines. All reactions contain NADPH and enzyme. 
Concentrations used: 100 µM NADPH, 100 µM chloramine substrate, 25 nM enzyme. Data shown is the 
average rate obtained in two biological repeats (n=2), each performed in triplicate. The error bars show 
the range/2. 
 
SaMerA showed varied activity towards the range of chloramines tested, with greatest 
activity towards N-chlorotaurine and N-chloro-β-alanine. In addition to the amino acid 
chloramines, the chloramine of the taurine variant hypotaurine was also tested (j). 
Hypotaurine is involved in the biosynthesis of taurine, but also shows structural similarities to 
both taurine and β-alanine. We were interested if the enzyme can distinguish between these 
compounds. The chloramine of hypotaurine showed much lower activity than N-chlorotaurine 
which can be in part due to the binding of the sulfinic acid (hypotaurine) compared to the 
sulfonic acid (taurine) in SaMerA’s active site. The reaction product of HOCl with cysteamine 
was also assessed (l), although in its case it is unclear if the HOCl reacts with thiol first, 
following transfer to form the more stable chloroamine. Regardless, there have been some 
reports of the role cysteamine plays in antimicrobial mechanisms of a number of pathogens 
[67-72]. SaMerA showed low activity towards the cysteamine/HOCl mixture.  
Taurine is probably the most prominent amino acid in the neutrophil environment [73]. It is 
an abundant non-proteogenic sulfonated β-amino acid that is found in all cell types, with 
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particularly high concentrations (up to 50 mM) found in neutrophils [58, 60, 61, 66, 73-81]. It 
is well established that most of the HOCl that is formed by myeloperoxidases reacts with 
taurine to form N-chlorotaurine (NCT) [82-89]. NCT is a proven antimicrobial with activity in 
the micromolar range as demonstrated in a number of studies [82, 83, 90-135]. The activity 
of SaMerA for N-chloro-β-alanine was not surprising, considering β-alanine is structurally 
similar to taurine. The high activity of SaMerA towards NCT was an exciting finding that 
potentially links the enzyme directly to a key neutrophil-derived compound.  
Considering that SaMerA showed activity towards chloramines, the activity of the E. coli 
homologue YkgC/RclA was also assessed under similar conditions. 



















a -  YkgC/RclA (No chloramine)




f  - GlycineHOCl
g - GlutamicAcidHOCl
h - AsparticAcidHOCl
 i  - MethionineHOCl








 r  - SerineHOCl
 s  - ThreonineHOCl




 x  - LysineHOCl
 y  - HistidineHOCl
 
Figure 2.20 YkgC’s activity towards various chloramines. All reactions contain NADPH and enzyme. 
Concentrations used: 100 µM NADPH, 100 µM chloramine substrate, 25 nM enzyme. Data shown is the 
average rate obtained for one biological repeat (n=1) performed in triplicate. The error bars show the 
standard deviation. 
YkgC/RclA indeed showed activity towards the various chloramines. Gratifyingly, the highest 
activity was also seen for NCT and chloro-β-alanine, although YkgC seemed to show a 
preference for the latter substrate, in contrast to SaMerA that clearly prefers to act on NCT. 
The chloramines of other physiologically relevant amino acids such as γ-aminobutyric acid 
(GABA), ε-caproic acid, 1-aminopropanoic acid and 2-aminoethylphosphonic acid were also 
tested as substrates of SaMerA and YkgC; however, their activity (data not shown) was not 
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found to be considerably different to the activity seen for chloramines of the amino acids 
(excluding NCT and chloro-β-alanine) as shown in Figure 2.19 and Figure 2.20. 
 N-chlorotaurine (NCT) 
Both SaMerA and YkgC/RclA showed good activity towards NCT when prepared by mixing 
HOCl and taurine in a 1:1 ratio, followed by confirmation of its concentration using its 
absorbance maximum at 252 nm (ε =429 M-1.cm-1) [66]. NCT can also be prepared in a pure 
form by using an ethanolic mixture of taurine sodium salt and chloramine T (see 
experimental methods for details) [97, 136]. The NCT produced via both these methods was 
analysed by proton NMR to confirm the formation of the chloramine. Since the synthetic NCT 
can be prepared directly at a specific concentration, all further experiments enzyme activity 
assays were performed using this form of the compound. 
Initially the enzyme concentration was set to 25 nM and the concentration of NCT 
incrementally increased to establish if the enzyme adhered to the Michaelis-Menten model of 
kinetic behavior. However, this proved to be problematic as various studies have shown that 
NCT reacts with nucleotides [66, 85, 137-144], thus giving a basal background oxidation rate 
in reactions that contain NADPH/NADH. To address this problem all activity results are 
therefore reported as the catalysed vs uncatalysed (cat/uncat) ratio, i.e. the ratio of the rate 
of NADPH oxidation seen in the presence of enzyme compared to the rate when enzyme is 
absent. In the first set of experiments two concentrations of NCT were used to assess the 
activity of SaMerA WT and its mutants.  
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Figure 2.21 Cat/uncat ratio of NADPH oxidation by 50 µM or 100 µM NCT as mediated by SaMerA. NADPH 
was 100 µM in all reactions. Data represents the result of one biological repeat (n=1) performed in 































Figure 2.22 Cat/uncat ratio of NADPH oxidation by 50 µM or 100 µM NCT as mediated by 100 nM or 200 
nM SaMerA. NADPH was 100 µM in all reactions. Data represents the result of one biological repeat (n=1) 
performed in triplicate. The error bars show the standard deviation. 
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The cat/uncat ratio at 50 µM NCT using 25 nM SaMerA WT was more than 2.0 the cat/uncat 
ratio for that seen using SaMerA C43AC48A (Figure 2.21). In regards to the single mutants 
SaMerA C43A showed some residual activity, which could be due to the fact that the Cys48, 
which is in close proximity to the FAD (Figure 2.7), may perform a modified monothiol-based 
reaction. In the case of the C48A mutant, the remaining Cys43 is still intact but since it is 
further away from the FAD it may not able to be regenerated after one round of catalysis. 
Increasing the NCT concentration showed a decrease in the cat/uncat ratio which is due to a 
higher background rate of the chlorination of nucleotide. Importantly, increasing the enzyme 
concentration showed an increase in cat/uncat ratio, confirming the involvement of the 
enzyme in catalysis (Figure 2.22). Considering the background rate due chlorination of 
nucleotide, as well as the cat/uncat data at 50 µM NCT (Figure 2.21), the approach to 
confirm enzyme activity towards NCT was then altered such that the substrates NCT and 
NADPH were kept constant at 50 µM and 100 µM respectively while the enzyme 
concentration was increased incrementally. 
[Enzyme] (nM)


















y = 0.0607x (+- 0.0126)
R² = 0.8533
YkgC/RclA
y = 0.0896x (+- 0.0088)
R² = 0.9778
SaMerA C43A 
y = 0.0036x (+- 0.0039)
R² = 0.2366
SaMerA C48A 
y = 0.0022x (+- 0.0053) 
R² = 0.0295
SaMerA C43AC48A 
y = 0.0607x (+-0.0126)
R² = 0.8533
 
Figure 2.23 Activity (as determined from initial rates) of SaMerA WT, its single and double mutants and 
YkgC/RclA acting on 50 µM NCT (prepared synthetically).  Data represents the result of one biological 
repeat (n=1) performed in triplicate. The error bars show the standard deviation. The solid lines represent 
the best fit straight line through the data points. The slopes of the fitted lines (the specific activity in 
µM/min/nM enzyme) are given in the legend. 
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The result in Figure 2.23 gratifyingly showed a linear relationship of SaMerA and 
YkgC/RclA’s activity towards NCT as the enzymes’ concentration increased. This result 
further confirmed the enzymatic activity of SaMerA and YkgC/RclA towards NCT. All three 
the SaMerA mutants showed very low specific activities for NCT under these conditions, 
indicating the requirement of the active site CxxxxC motif for catalysis. 
With these positive results obtained using NCT synthesized directly, we decided to repeat 
the experiment using NCT made by mixing HOCl and taurine. This was based on the 
consideration that the HOCl produced by MPO in the neutrophil would most likely form NCT 
in a similar manner by reaction with taurine. Using the same reaction conditions used to 
obtain the data in Figure 2.23, we tested NCT and N-chloro-β-alanine made by mixing HOCl 
and the amino acid in a 1:1 ratio.  
The first attempt at this experiment using SaMerA acting on either 50 µM NCT or N-chloro-β-
alanine worked well (Figure 2.24). The specific activities obtained in this manner agreed 
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[Enzyme] (nM)

















SaMerA WT + NCT
y = 0.0653x (+- 0.0069) 
R² = 0.8461
SaMerA WT + Beta-AlaCl
y = 0.0926x (+- 0.0014)
R² = 0.9459
SaMerA C43A + NCT
y = 0.0036x (+- 0.0039)
R² = 0.2366
SaMerA C48A  + NCT
y = 0.0022x (+- 0.0053)
R² = 0.0295
SaMerA C43AC48A  + NCT
y = 0.0067x (+- 0.0071)
R² = 0.3165
 
Figure 2.24 Activity (as determined from initial rates) of SaMerA WT and its mutants acting on 50 µM NCT 
(prepared by mixing HOCl and taurine) and 50 µM N-chloro-β-alanine (prepared by mixing HOCl and β-
Ala). Activity of SaMerA WT against NCT shown as black data points whilst SaMerA WT against N-chloro-
β-alanine shown in bue.  Data represents the result of one biological repeat (n=1) performed in triplicate. 
The error bars show the standard deviation. The solid lines represent the best fit straight line through the 
data points. The slopes of the fitted lines (the specific activity in µM/min/nM enzyme) are given in the 
legend. 
 
Experiments conducted with YkgC/RclA under similar reaction conditions showed that the 
reaction had already reached completion before analysis commenced (data not shown). 
That is, all the NADPH substrate had been consumed before the first reading could be taken 
on the spectrophotometer. To address this, the YkgC/RclA concentration was decreased 
below 25 nM while maintaining the substrate concentrations as in the previous experiment 
(Figure 2.25). The resulting specific activities towards NCT and N-chloro-β-alanine were very 
similar, and ~4-fold higher than the values obtained with SaMerA.  
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y = 0.2943x (+- 0.0179)
R² = 0.9854
YkgC/RclA + Beta-AlaCl 













Figure 2.25 Activity (as determined from initial rates) of YkgC/RclA towards 50 µM NCT (prepared by 
mixing HOCl and taurine) and 50 µM N-chloro-β-alanine (prepared by mixing HOCl and β-Ala). Data 
represents the result of one biological repeat (n=1) performed in triplicate. The error bars show the 
standard deviation. The solid lines represent the best fit straight line through the data points. The slopes 
of the fitted lines (the specific activity in µM/min/nM enzyme) are given in the legend. 
 
Taken together, these results indicate that both SaMerA and YkgC/RclA show a linear 
enzyme concentration-dependent increase in activity towards HOCl-derived NCT and N-
chloro-β-alanine. This data further supports the hypothesis that SaMerA and YkgC/RclA 
detoxifies chloramines that form from neutrophil-produced HOCl that reacts with abundant 
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2.2.9.1 Proposed catalytic mechanism of SaMerA  
A search of the protein database (PDB) shows a number of X-ray crystal structures with the 
ligand taurine bound. These include the taurine/alpha-ketoglutarate dioxygenase from E. coli 
(1GQW, 1GY9), iron-free TauD from E. coli (1OTJ, 1OS7), bile acid hydrolase from 
Clostridium perfringens (2BJF), E. coli GTP cyclohydrolase II (2BZ1), peptidoglycan 
endopeptidase from Bdellovibrio bacteriovorus (3V39), NanB sialidase from Streptococcus 
pneumoniae (4FOQ), Ternary complex of DNA polymerase epsilon (4M8O) and the ligand 
binding domain Vibrio cholerae chemoreceptor Mlp37 (5AVF). These enzymes are unrelated 
to SaMerA or YkgC/RclA; however, some are involved in the biosynthesis of hypotaurine 
and finally taurine (1GQW, 1GY9, 1OTJ). Mapping the ligand interactions of the active site 
residues of these enzymes with taurine shows hydrogen bonding and ionic interactions with 
the sulfonic acid moiety mediated by arginine, valine, lysine or histidine. The amino portion 
of taurine is usually bound to aspartic acid, asparagine or tyrosine. Examples of ligand 
binding plots with taurine in various proteins are shown in Figure 2.26. 
SaMerA has similar amino acids arranged around the entrance of the active site, and 
therefore the schematic diagram of its active site layout was drawn showing the potential 
interactions with NCT (Figure 2.27). The 3-dimensional model of the active site shown in 
Figure 2.28 gives one a sense of the relative size of the active site, and how taurine/NCT 
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Figure 2.27 Schematic diagram showing potential binding interactions between residues in SaMerA’s 
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Figure 2.28 Vacuum electrostatics (protein contact potential) of the SaMerA active site showing the 
potential binding mode of taurine from two different views (A) and (B). Taurine was manually placed into 
SaMerA’s active site using the manual mode in Pymol. The taurine molecule was obtained from the PDB. 
Amino acids potentially involved in taurine binding Thr301, Lys13 and Lys81 are colored in blue and 
labelled accordingly. Arg368 (above the plane of view and not showed) can also form a hydrogen bond to 
taurine.  
 
The proposed mechanism of SaMerA (Eox) with NCT is shown in Figure 2.29 A and B. The 
proposed mechanism follows that of other DSRs involving a reductive and oxidative half 
reaction, and the known mechanism of thiols reacting with chloramines. The reductive half 
reaction involves the transfer of electrons from the incoming NADPH to the FAD, which 
subsequently reduces the resting disulfide of Eox. Cys48 would be able to form a charge 
transfer complex with the FAD at this stage (EH2.NADP+). The oxidative half reaction 
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involves the deprotonation of Cys43 (most likely by His427) to give a thiolate that can attack 
the chloramine of the incoming NCT. This would result in formation of a sulfenyl chloride 
enzyme intermediate, and release of taurine following the protonation of its amine (most 
likely by His427). Thereafter the thiolate of Cys48 attacks the Cys43-Cl, releasing Cl- and 
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Figure 2.29 Proposed mechanism of SaMerA with NCT. (A) Briefly SaMerA (Eox) with resting disulfide 
(top right-hand side) is reduced by the incoming NADPH via FAD. Cys48 forms a charge transfer complex 
with FAD and a proton is abstracted by His427 from Cys43 which attacks the chloramine of NCT, forming 
a sulfenyl chloride intermediate and releasing taurine. The Cys48 thiolate attacks the Cys43-Cl, resulting 
in the release of Cl- and NADP+ to regenerate Eox for another round of catalysis. (B) shows a short-hand 
scheme of NCT reacting with thiol. Redrawn from [66]. 
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 Synthesis of potential inhibitors of SaMerA 
To further strengthen our mechanistic hypothesis for SaMerA, we set out to synthesize small 
molecule mechanism-based inhibitors of the enzyme. As a proof of principle, we investigated 
the use of small molecule “warhead” type inhibitors, namely the acivicin derivatives 
(isoxazolines) [145-148]. These inhibitors form irreversible covalent modifications (via 
addition-elimination) with the nucleophilic cysteine residue/s in enzyme active sites (Scheme 
1). Isoxazoline inhibitors have been used to inhibit plasmodium glyceraldehyde-3-phopshate 




Scheme 1. Bromoisoxazole reacting with active site Cys to form irreversible enzyme-inhibitor complex. 
 
The following section is based upon the synthesis and in vitro testing of 3-bromo-4,5-
dihydro-isoxazole-5-carboxylic acid (compound 6k), 3-bromo-5-tert-butyl-4,5-dihydro-
isoxazole (compound 6l), 3-bromo-5-cyclohexyl-4,5-dihydro-isoxazole (compound 6b), 3-

























Figure 2.30 Putative SaMerA inhibitors 3-bromo-4,5-dihydro-isoxazole-5-carboxylic acid (compound 6k), 
3-bromo-5-tert-butyl-4,5-dihydro-isoxazole (compound 6l), 3-bromo-5-cyclohexyl-4,5-dihydro-isoxazole 
(compound 6b), 3-bromo-4,5-dihydro-isoxazole-5-sulfonic acid (compound 6s), N-chlorotaurine (NCT) is 
shown for comparison. 
The only differences to the four compounds are the entities attached to the bromoisoxazole 
group. SaMerA and YkgC/RclA showed considerable activity towards N-chloro-β-alanine 
and NCT, therefore the four compounds were chosen to mimic the structures of these 
substrates. Compound 6k contains the free carboxylic group which shares close similarity to 
β-alanine, whereas compound 6s has a sulfonic group which resembles taurine. 
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Compounds 6l and 6b contain large and more hydrophobic groups, which we predicted may 
affect them gaining access to the active site Cys residue/s, and could therefore be used to 
demonstrate selectivity. However, compounds 6l and 6b are more likely to be able to cross 
the bacterial cell membrane compared to 6s or 6k. With these considerations in mind, we set 
out to synthesise and test these compounds. 
2.2.10.1 Synthesis of compounds 6k, 6l, 6b, 6s 
The synthesis of compound 6k, 6a and 6b was based upon an established method by 
Girardin et al [151]. Although compound 6s was not part of the small library published by 
Girardin et al, the same procedure was used in its synthesis. The reactions proceed via 













Figure 2. 31 Cycloaddition reaction of dibromoformaldoxime and acrylic acid forming compound 6k. 
 
All compounds were UV active and hence product formation could easily be tracked via TLC 
analysis. For details of the reaction conditions, see the experimental section. 
 
2.2.10.2 1H NMR analysis of purified compounds 
The structures of compounds 6k, 6l and 6b were successfully confirmed by 1H NMR. 
Difficulties were encountered with the synthesis of the sulphonate-containing compound 6s. 
NMR analysis of potential products revealed that it was mainly unreacted vinysulfonic 
acid/acrylate species. Synthesis of compound 6s was thus abandoned and the study was 
continued with compounds 6k, 6l and 6b. 
 Assessment of enzyme inhibition of SaMerA and YkgC/RclA 
Compounds 6k, 6l and 6b were made up in DMSO to a stock concentration of 100 mM, and 
were used as such in subsequent experiments. Each compound was separately incubated 
on ice for 30 mins with either SaMerA or YkgC/RclA respectively (that had previously been 
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treated with DTT) at a 1:10 ratio of enzyme:inhibitor. Thereafter, excess compound was 
removed using a membrane spin concentrator with MW cutoff of 3,000 Da. The treated 
enzymes were then assayed for activity on 50 µM NCT using the same experimental 
approach as described previous for the data obtained and shown in Figure 2.23. In addition 
to enzymes treated with inhibitor, enzymes were also treated with DMSO (i.e. without 
inhibitor) as control. In addition, iodoacetamide and N-methylmaleimide, which are known 
cysteine-alkylating agents, were used as positive controls [152]. 






SaMerA + NCT 
y = 0.0607x (± 0.0126)
R² = 0.8533
SaMerA + DMSO 
y = 0.0417x  (± 0.0062)
R² = 0.9182
SaMerA + 6k 
y = 0.0163x (± 0.0037)
R² = 0.8256
SaMerA + 6l 
y = 0.015x (± 0.0021)
R² = 0.7947
SaMerA + 6b 
y = 0.0273x (± 0.0049)
R² = 0.9644
SaMerA + IOA 
y = 0.0201x (± 0.0085)
R² = 0.9622
SaMerA + NEM 













Figure 2.32 Activity of inhibitor treated SaMerA WT (1:10 Enz: Inhibitor) acting on 50 µM NCT. Control 
reactions with DMSO, iodacetamide (IOM) and N-methylmaleimide (NEM)-treated SaMerA WT are also 
shown for comparison. Data represents the result of one biological repeat (n=1) performed in triplicate. 
The error bars show the standard deviation. The solid lines represent the best fit straight line through the 
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YkgC/RclA + NCT 
y = 0.0896x (± 0.0068)
R² = 0.9778
YkgC/RclA + 6k 
y = 0.0049x (± 0.0029)
R² = 0.4205
YkgC/RclA + 6l 
y = 0.0045x (± 0.0047)
R² = 0.4907
YkgC/RclA + 6b 
y = 0.0041x (± 0.0031)
R² = 0.4458
YkgC/RclA + IOA 
y = 0.0084x (± 0.0066)
R² = 0.5132
YkgC/RclA + NEM 













Figure 2.33 Activity of inhibitor treated YkgC/RclA (1:10 Enz: Inhibitor) acting in 50 µM NCT. Shown for 
comparisons are YkgC/RclA untreated (DMSO control) as well as control reactions using iodacetamide- 
and N-methylmaleimide-treated YkgC/RclA. Data represents the result of one biological repeat (n=1) 
performed in triplicate. The error bars show the standard deviation. The solid lines represent the best fit 
straight line through the data points. The slopes of the fitted lines (the specific activity in µM/min/nM 
enzyme) are given in the legend. 
 
All the tested compounds were able to inhibit SaMerA (Figure 2.32). The compounds 
inhibited the activity of SaMerA by reducing its specific activity approximately 4-fold 
compared to the untreated SaMerA.  Likewise, the tested compounds were also able to 
inhibit YkgC/RclA (Figure 2.33). When comparing the specific activities of SaMerA treated 
with 6k, 6l and 6b (Figure 2.32) to those of YkgC/RclA treated with the same compounds, 
YkgC/RclA showed a greater inhibition. The positive controls, SaMerA and YkgC/RclA 
treated with iodacetamide and N-methylmaleimide, also showed substantial inhibition 
compared to the untreated enzymes. Overall, the compounds and controls showed a greater 
inhibition of YkgC/RclA.  
To rule out the possibility that the compounds are denaturing or unfolding upon treatment 
(i.e. that observed inhibition is unrelated to the mechanism), the treated enzymes’ structures 
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were analysed by CD spectroscopy (see Additonal Experimetal data section for data). The 
CD spectra showed that the compounds did not cause any severe unfolding or change to the 
overall structure of the enzymes. On the contrary, there was some notable difference in the 
β-sheet turns (24-260 nm) and an increase (at 210 nm) of the dichroism for the enzyme 
treated with 6k, 6l and 6b. These differences suggest a tighter folding (rigidification) of the 
enzyme. The more compact/tighter folding relates to the β-sheet turns which are found 
between the interface of the two monomers. Directly behind these β-sheet turns are four 
helixes in which the active site is located. Thus it does appear that the active site forms a 
more compact or stabilized state upon binding the inhibitor compounds, and hence the 
observed differences in the CD spectra. 
2.2.11.1 Time-dependent enzyme inhibition 
After determining that the compounds do not unfold the enzyme, it was investigated whether 
the compounds inhibit the enzymes in a time-dependent manner. One of the characteristics 
of mechanism-based inhibition is the time-dependent loss of enzyme activity [153]. To 
assess time-dependent inhibition SaMerA and YkgC/RclA were separately incubated with 
10-fold excess compound. Aliquots were then taken out at time 0, 5, 10, 20 and 30 minutes 
and the sample tested for activity using 50 µM NCT as substrate. Initial rates were then 
plotted against time. Control reactions of untreated enzyme as well as enzyme without NCT 
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Figure 2.34 Time-dependent inhibition of SaMerA activity towards 50 µM NCT by compounds 6k, 6l and 
6b. 25 nM SaMerA : 250 nM inhibitor compound was used in each experiment. Data represents the result 
of one biological repeat (n=1) performed in triplicate. The error bars show the standard deviation. The 
solid lines represent the best fit straight line through the data points. Linear regression used for SaMerA 
WT DMSO, No Substrate. Exponential decay used for SaMerA WT + inhibitors 6k,6l, and 6b. 
 
Figure 2.35 Time-dependent inhibition of YkgC/RclA activity towards 50 µM NCT by compounds 6k, 6l and 
6b. 25 nM YkgC : 250 nM inhibitor compound was used in each experiment. Data represents the result of 
one biological repeat (n=1) performed in triplicate. The error bars show the standard deviation. The solid 
lines represent the best fit straight line through the data points. Linear regression used for YkgC/RclA 
DMSO, No Substrate. Exponential decay used for SaMerA WT + inhibitors 6k,6l, and 6b. 
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All the tested compounds show time-dependent inhibition of SaMerA (Figure 2.34) and 
YkgC/RclA (Figure 2.35) respectively, supporting the analysis that the compounds are 
indeed mechanism-based inhibitors. Interestingly compounds 6k and 6l showed similar 
trends in the rate of inactivation of the enzymes, while compound 6b showed an increased 
rate of inhibition. 
The three inhibitors were chosen to mimic the structures of the substrates N-chloro-β-
alanine and NCT. Compound 6k contains the free carboxylic group whereas compounds 6l 
and 6b contain more hydrophobic groups. Based on the amino acids around the active site 
as well as the reactivity of SaMerA and YkgC/RclA towards N-chloro-β-alanine and NCT, it 
was expected that the carboxylate-containing compound 6k would show inhibition. However, 
we did not expect compounds 6l and 6b to show inhibition comparable to 6k considering the 
presence of the hydrophobic and sterically bulky tert-butyl (6l) and cyclohexane (6b) groups 
that we predicted would affect binding to SaMerA or YkgC/RclA. Nonetheless, the data 
shows that the active site of SaMerA and YkgC/RclA is sensitive to covalent modification by 
compounds acting as nucleophile traps.  
2.2.11.2 Mass spectrometry  
Variants of compound 6k and 6l have both been used in inhibition studies targeting the 
enzyme MurE, which is involved in murein biosynthesis [154]. These studies showed that the 
compounds inhibited the MurE enzyme by forming a covalent adduct to a lysine residue 
(Lys391) in the enzyme, preventing catalysis [154]. For the present study we assumed that 
compounds 6k, 6l and 6b would attach to SaMerA’s active site Cys residue/s based upon 
the proposed reaction mechanism and the reactivity of bromoisoxazoles towards thiols. 
However, there is also a lysine residue (Lys13) within the active site of SaMerA, thus it was 
also possible that the compound might attach to this lysine. To determine which amino acid 
residue was modified by the bromoisoxazolines, the treated enzymes were digested with 
trypsin, followed by mass spectrometry analysis of the resulting fragments. The MS analysis 
was performed by Dr M Vlok (Stellenbosch Central Analytical Facility). For these 
experiments compound 6k was used for demonstration of the proof of principle. The result is 
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Table 3. Mass spectrometry results for SaMerA treated with 6k. 
Protein identified: Mercuric reductase homologue OS=Staphylococcus aureus OX=1280 




Figure 2.36 SaMerA protein sequence showing fragment identifying modified cys43 residue. 
The mass spectrometry data (Table 3)  showed that indeed compound 6k was attached to 
an active site cysteine. The modification (i.e. following reaction with 6k) was identified on 
several peptide fragments, including that shown in Table 3. The specific modification was 
localized to Cys43 by subsequent fragmentation in the MS. Interestingly, the peptide 
fragments obtained from the treated enzyme were much larger and fewer in number than 
those obtained from a SaMerA DMSO-treated sample. This finding could also further support 
the analysis that binding of the compound leads to the establishment of a tighter, more 
stable protein complex. This is in agreement with the CD spectroscopy data for enzymes 
treated with the inhibitor compounds.  
In regards to the bromoisoxazole warhead, there are a few structures in the PDB of 
unrelated enzymes that have isoxozale-derived inhibitors (e.g. glutamate receptor 1M5D, 
1M5C, T-cell PTPase 1XBO,  farnesoid X receptor (FXR) agonist 3P88) that share a number 
of common interacting amino acids, namely Pro, Thr, Tyr, Phe and His. These amino acids 
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are also found around the active site of SaMerA (Phe10, Thr17, Thr301, Pro367, Phe434, 
Phe438, Phe440). In addition to crystal structures containing isoxazole derivatives, there are 
a few structures that contain acivicin (2Z8K, 3WHS) and they also share similar amino acid 
coordination to the inhibitor. It is therefore plausible that all compounds would be able to 
coordinate to any of the above mentioned amino acids lining the entrance of the active site 
of SaMerA. However, in the SaMerA structure many of these amino acids are far apart (3-
6Å) or point towards the inside of the entrance leading towards the active site. Thus 
presumably upon binding to inhibitor these amino acids would coordinate closer together. 
This proposed ligand binding interactions would have to be confirmed by a co-crystal 
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 In vitro assessment of NCT against S. aureus and E. coli wild 
type and SaMerA mutant 
Voyich et al have shown that the expression of SaMerA is upregulated more than 80-fold in 
S. aureus strains MW2, MnCop, LAC, MRSA252, COL following phagocytosis by neutrophils 
[2]. In addition, a separate study showed that both hypR and the merA gene were 
upregulated 180-fold under hypochlorite stress in S. aureus [3]. The hypR-merA mutant was 
more sensitive to hypochlorite than the wild type [3].  In a study by Jakob and co-workers, 
YkgC/RclA-lacking mutants had increased sensitivity towards 2.5 mM hypochlorite [4]. Thus 
these studies indicate that SaMerA (and YkgC/RclA) responds to the HOCl produced in the 
neutrophil environment, which we previously suggested likely forms NCT that itself has 
known antimicrobial properties. 
In the present study, we demonstrated that SaMerA (and its E. coli homologue) have 
substantial activity towards NCT. We therefore used genetic knockout strains of S. aureus 
and E. coli that do not express SaMerA or YkgC/RclA to investigate if these strains show an 
increased sensitivity specifically towards NCT when compared to the wild type strains. 
The antimicrobial activity of NCT against S. aureus JE2 and S. aureus NE785 (∆merA) was 
assessed every hour for 8 hours. Several studies have shown that NCT has antimicrobial 
activity against various bacterial species [83, 90, 92, 93, 95, 99, 105, 106, 111, 112, 120, 
121, 123, 125]. In addition, these studies have shown that the concentration of NCT required 
to kill bacteria are strain-dependent. In the present study concentrations ranging from 25-100 
µM NCT were initially used, based on similar ranges used by Nagl et al against S. aureus 
ATCC 25923 [83]. These concentration ranges did not result in a decrease in cell viability for 
either the wild-type (S. aureus JE2) or mutant (S. aureus NE785) strains after 6 hours 
exposure (data not shown). The concentration of NCT was thus increased to 1 mM and 2 
mM. At 2 mM, S. aureus JE2 was killed within 1 hour (data not shown), and at 1 mM killing 
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Figure 2.37 S. aureus JE2 and NE785 (∆merA) susceptibility to 1 mM NCT. The data represents the 
average of one biological experiment performed in triplicate. Error bars indicate standard deviation. 
 
The results of Figure 2.37 confirm that the S. aureus ∆merA mutant (NE785) is more 
sensitive to NCT than the wild-type (JE2). The NE785 strain starts decreasing in number 
more than 2 fold log CFU/ml after 3 hours. At 4 hours the NE785 strain has decreased more 
than 3 fold log CFU/ml compared to the wild-type strain. 
With this positive result, we then assessed whether the same effect is observed with E.coli 
K12 and JW5040 (∆ykgC) (Figure 2.38). 
 
Figure 2.38 E. coli K12 and JW5040 (∆ykgC) susceptibility to 1 mM NCT. The data represents the average 
of one biological experiment performed in triplicate. Error bars indicate standard deviation. 
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Both E.coli strains were sensitive to NCT with complete cell death after 3 hours exposure. 
There was no significant difference between the wild type (K12) and the YkgC/RclA-lacking 
mutant (JW5040). The E. coli cells appear to be more sensitive to NCT under these 
conditions when compared to S. aureus, which only showed complete cell death after 5.5-6 
hours exposure. We were unsure as to the reason why the E.coli wild type and mutant 
showed very little difference in NCT sensitivity. Other conditions, such as using shorter time 
periods as well as increasing the NCT concentration to 2 mM, were also explored for E.coli 
strains however there still appeared to be no differences between the wild type and JW5040 
strain. Nonetheless, Jakob and co-workers have shown that the E. coli YkgC/RclA-lacking 
mutant is more sensitive to 2 mM HOCl compared to the wild type [4]. The present study 
made use of a different growth media, a different wild-type strain and the use of NCT (not 
HOCl) which could account for different outcomes observed. 
2.2.12.1 In vitro assessment of compound 6k against S. aureus JE2. 
To complement the result obtained with the genetic knockout of S. aureus (NE785), the wild 
type S. aureus JE2 was also treated with compound 6k in an attempt to chemically knockout 
SaMerA. As a proof of principle, the chemical knockout of SaMerA in wild-type JE2, should 
also show sensitivity to NCT compared to the untreated wild-type. 
Initially an excess of compound 6k (1 mM) was incubated with S. aureus JE2 for 2 hours, 
and thereafter assayed for susceptibility to NCT (Figure 2.39). A high concentration of 6k 
was used in hopes of abolishing SaMerA, making it more susceptible to NCT. However, 
there were no noteworthy differences observed in comparing the controls and treated 
samples. The approach was then altered to pretreatment of S. aureus JE2 with low doses of 
NCT (50 µM) in order to allow S. aureus to overexpress MerA due to the oxidative stress 
conditions induced by NCT. Thereafter, the cells were incubated with 1 mM compound 6k 
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Figure 2.39 S. aureus JE2 and NE785 pre-incubated with compound 6k for 2 hours before performing the 
susceptibility test using 1 mM NCT. The data represents the average of one biological experiment 
performed in triplicate. Error bars indicate standard deviation. 
 
 
Figure 2.40 S. aureus JE2 and NE785 pre-incubated with 50 µM NCT for 18 hours, following by treatment 
with 1 mM compound 6k for 3 hours before performing the susceptibility test using 1 mM NCT. The data 
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The data shows that neither strategy was successful in demonstrating an effect following 
treatment with 6k. Nonetheless, the positive outcome from these experiments is the 
confirmation that the NE785 strain (SaMerA-lacking knockout) is more sensitive to NCT than 
the wildtype JE2. It is unknown as to why compound 6k is not affecting JE2. The most likely 
reasons are that compound 6k is not entering the cell, it is being effluxed out of the cell or 
that it binds to another target (such as the cell wall synthesizing proteins). 
2.3 Conclusion 
When S. aureus is challenged by neutrophils or HOCl, the expression of SaMerA is 
significantly upregulated [2, 3]. Furthermore, SaMerA-lacking mutants have been shown to 
be more sensitive to HOCl than the wild-type S. aureus [3]. SaMerA has previously 
putatively been assigned as a mercuric ion reductase homologue. The question arose as to 
the physiological relevance a mercuric ion reductase-like enzyme would have under 
oxidative stress conditions.  
This study set out to characterize and identify SaMerA’s potential substrate and its role in 
oxidative stress resistance. The first crystal structure obtained of SaMerA, shows that it 
indeed it looks very similar to many tDBDFs. SaMerA is classified in the DSR subgroup of 
the tDBDF superfamily. This subgroup includes glutathione reductase, dihydrolipoamide 
dehydrogenase, mercuric ion reductase and high molecular weight thioredoxin reductase. 
Considering that SaMerA has been annotated as a mercuric ion reductase it was initially 
investigated if SaMerA was able to reduce Hg2+. Based on a sequence analysis alone, 
SaMerA was already shown to lack the critical Cys residues that are required for true 
mercuric ion reductase catalysis as previously described for PaMerA Tn501. SaMerA was 
unable to show any mercuric ion reductase activity but did show potentiated hydrogen 
peroxide formation in the presence of NADPH and Hg2+ (i.e. the ability of the NADPH-treated 
flavoprotein to reduce oxygen was augmented in the presence of Hg2+). SaMerA was also 
found to be unable to reduce other biologically relevant metals. 
Other members of the DSR subgroup such as thioredoxin reductase require a cognate 
protein partner, which is involved in the catalytic cycle (Trx/TrR). Thus it was assessed if 
SaMerA required a protein partner through pull-down experiments. SaMerA did not show 
any protein partners in the pull-down experiments. 
Glutathione reductase is well characterized in its’ involvement reducing GSSG. Since S. 
aureus does not produce the LMW thiol GSH, other disulfides of LMW thiols were tested for 
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activity against SaMerA. SaMerA showed little to no activity for low molecular weight 
disulfides. 
In context to other biological relevant reactive species produced by the neutrophil, HOCl and 
HOCl-derived reactive species were tested.  HOCl alone was shown to abolish all activity, 
presumably through oxidation as well as chlorination of NADPH. SaMerA showed 
particularly high activity towards chlorinated amino acids with highest activity for found for N-
chlorotaurine, followed by N-chloro-β-alanine.   
This finding was particularly interesting considering the high concentrations of taurine (up to 
50 mM) produced by the neutrophil [58, 60, 61, 66, 73-81]. In addition, it is known that HOCl 
is heterogeneously produced in the phagolysosomes [88]. The product of the reaction of 
HOCl and taurine is N-chlorotaurine (NCT), which is a key component of the human defense 
system with proven antimicrobial properties [82, 83, 90-92, 94, 95, 99, 102, 106, 120-122]. In 
addition to SaMerA showing activity towards NCT, its E. coli homologue YkgC/RclA also 
showed highest activity towards NCT and N-chloro-β-alanine. YkgC/RclA has previously 
been implicated in the defense against reactive chlorine species [4]. YkgC mutants are also 
much more sensitive to HOCl stress when compared to the E. coli wild-type [4, 5]. In 
addition, the YkgC/RclA-encoding gene was significantly up regulated in the human 
pathogenic bacterial E. coli strain O157:H7 when exposed to HOCl [5].  
Having established that SaMerA and YkgC/RclA have considerable activity towards NCT, 
three inhibitors containing bromoisoxazole-type “warheads” that also mimic the structure of 
the substrate NCT were synthesized.  The three compounds 6k, 6l and 6b were chemically 
different from one another in hopes of seeing a selective inhibition of SaMerA and 
YkgC/RclA. We were pleased to find that the compounds inhibited SaMerA and YkgC/RclA, 
although no clear selectivity was observed. To further support the hypothesis of mechanism-
based inhibition the compounds were found to inhibit both SaMerA and YkgC/RclA in a time-
dependent manner. It was also shown that the compound 6k formed a covalent adduct 
toward the active site Cys43 of SaMerA.  Using structures from the PDB that have bound 
ligands such as taurine and isoxazole derivatives, plausible binding modes for the substrate 
NCT as well as the inhibitor were proposed.  
The antimicrobial activity of NCT against S. aureus JE2 and S. aureus NE785 (∆merA) was 
also assessed. S. aureus NE785 showed an increased sensitivity towards NCT compared to 
the wild-type JE2. Under the conditions using in these tests, there was no significant 
difference observed between the E. coli wildtype and its YkgC-lacking mutant. However, a 
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study done by Jakob et al revealed that the YkgC/RclA mutant is more sensitive to HOCl 
than the wild-type [4]. 
To complement the genetic knock out data, compound 6k was used against S. aureus wild 
type in attempts of creating a chemical knockout of SaMerA. Under various approaches, 
there was no phenotypic change observed between the treated (with 6k) or untreated S. 
aureus strains. This was proposed to be due to the compound 6k not entering the cells, or it 
is in fact targeting an alternative target (murein/peptidoglycan synthesis (MurE)). Other 
possibilities could be that compound 6k is effluxed out of the cell or rendered inactive by 
other bacterial defense mechanisms. 
These results described in this chapter revealed for the first time a link between a key 
compound of the human immune system (NCT) and a microbial enzyme (SaMerA and 
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Figure 2.41 A section of the neutrophil showing engulfed bacterium within phagolysosome. Shown in 
blue are the key compounds that lead to the formation of NCT, and the proposed role of SaMerA.  
Overall, we were pleased to find that SaMerA and YkgC/RclA show considerable activity 
towards NCT, a major component of the human immune system. We are therefore 
proposing that the enzyme should be more appropriately renamed as a taurine 
chloraminase. This enzyme is also conserved in a number of other pathogenic bacteria. 
These results provide insight into how S. aureus (and E. coli) responds to oxidative stress, 
specifically the reactive chlorine species NCT and how the bacteria protects itself against its 
antimicrobial effects. 
This study also sets a basis upon which a larger/more diverse library of compounds can be 
tested against a novel bacterial target such as SaMerA or YkgC/RclA, which play an 
important role in defense against the reactive chlorine species NCT. In this manner it sets 
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2.4 Materials and methods 
Unless otherwise stated, the majority of all chemicals and compounds were purchased from 
Sigma-Aldrich. All reactions were done in triplicate unless otherwise stated or indicated in 
text or figures. All enzyme assays were done at 25oC, unless otherwise stated. All 
compounds or substrates were made up in reaction buffer as used in each section, unless 
otherwise stated. 
2.4.1 Cloning and plasmids used 
SaMerA WT - merA gene (SAOUHSC_00581/ JP02758_0526) was amplified from genomic 
S. aureus DNA strain RN4220 (isolated using a genomic DNA extraction kit from Novagen) 
using the primers, forward: 5’-GCA GTC ACT GTC ACC ATG GTC GTA ATA TTG -3’ (NcoI 
site underlined) and reverse: 5’-CAC CAG GTT TTT ATG TTT CTC GAG GAA ATT 
AAATAA -3’ (XhoI site underlined).  The PCR reaction of merA involved 1 µL Pfu buffer, 0.4 
mM dNTP mix, 1 mM forward primer, 1 mM reverse primer, 1 ng genomic DNA, 1.25 U Pfu 
DNA polymerase and the final volume made up to 25 µl with distilled, deionized water. The 
PCR program involved a 2 minute initial step at 94°C followed by 30 cycles of denaturation 
at 94°C for 15 seconds. Thereafter the annealing cycle was done at 55°C for 30 seconds 
and a final extension cycle for 1 min at 70°C. The reaction mixtures were subjected to gel 
electrophoresis on a 1% agarose gel and subsequently visualized through gel staining with 
SYBR™ gold (Invitrogen) and viewed on a UV gel reader. The band for merA gene 
(~1400bps) was excised and purified using a Novagen gel clean-up kit. The merA gene was 
then subsequently used to generate the pET28a-SaMerA WT plasmid. Briefly the pET28a 
plasmid as well as the merA gene were digested separately with NcoI and XhoI (New 
England Biolabs) for 1 hour at 37°C without shaking. The restriction digestion of pET28a and 
merA gene were then subjected to gel electrophoresis on a 1% agarose gel and 
subsequently visualized through gel staining with SYBR™ gold (Invitrogen) and viewed on a 
UV gel reader. The NcoI/XhoI cut plasmid band and merA band were then excised and 
purified using a Novagen gel clean-up kit. Approximately 10 ng of NcoI/XhoI cut pET28a and 
merA were incubated with 10 U of T4 DNA ligase and ligase buffer for 1 Hour at 37°C 
without shaking. Thereafter 1 µL of the plasmid-insert construct was added to 80 µL of 
chemically-competent Mach 1 cells, and incubated on ice for 30 mins. The cell mixture was 
heat-shocked at 42⁰C for 45 seconds, and then cooled on ice for 5 mins. Approximately 900 
µL or prewarmed LB broth was added to the transformation mixture and incubated at 37⁰C 
and shaking for 1 hour. The sample was then centrifuged at 4500 rpm for 10 mins. Half of 
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the supernatant was discarded, with the cell pellet being re-suspended in the remaining 
supernatant. The resuspended cells were then plated onto LB plates containing 30 mg/L 
kanamycin and incubated overnight at 37°C. Colonies were then selected and restriction 
digestion checks were done by loading the digestion mixture onto 1% agarose gels to 
assess which colony liberated the merA gene of correct size. The positive colonies were 
then sent for sequencing for confirmation. The correctly sequenced colonies were grown up 
overnight at 37°C in 5 ml LB containing 30 mg/L kanamycin. Thereafter the pET28a-SaMerA 
plasmid was isolated and purified using a Zyppy Plasmid Miniprep I Kit (Zymo Research). 
The plasmid was then used for transformation into respective cloning/expression cells for 
further use. 
SaMerA C43A – Using site directed mutagenesis, the pET28a-SaMerA WT plasmid was 
used as a template and the following primers were used. Forward primer: 5’- GGA GGC 
ACT GCT ATA AAC ATA GGA TGT ATA CCT TCG -3’, reverse primer: 5’-CGA AGG TAT 
ACA TCC TAT GTT TAT AGC AGT GCC TCC -3’. The PCR reaction involved 5 µL of KAPA 
hotstart buffer, 1 µL PolIII hotstart mixture, 1 ng of pET28a-SaMerA template, 10 ng of 
forward primer, 10 ng of reverse primer and the final volume made up to 50 µl with distilled, 
deionized water. The PCR program involved an initial 1 minute step at 95°C. This was 
followed by 45 cycles of denaturation at 95°C for 30 seconds, annealing cycle at 52°C for 3 
min 30 seconds and a final extension cycle for 3 min at 65°C. After the 45 cycles a final 
extension step of 1 minute was done at 65°C, thereafter the heating block was set to 4°C.  
The reaction mixtures were subjected to gel electrophoresis on a 1% agarose gel and 
subsequently visualized through gel staining with NANCY™-520 gel electrophoresis stain 
and viewed on a UV gel reader. The band for pET28a-SaMerA C43A (~5500bps) was 
excised and purified using a Thermo Scientific DNA gel extraction kit. The purified plasmid 
was then subjected to digestion by 1 µL DpnI (New England Biolabs) for 1 hour at 37°C 
without shaking. The sample was then cooled on ice for 5 minutes and used directly for 
transformation into respective cloning/expression cells. 
SaMerA C48A and C43AC48A  – These pET28a-SaMerA C48A and C43C48A plasmids 
were kindly provided by Prof. Haike Antelmann (Institute of Biology - Microbiology. Freie 
Universität Berlin). The SaMerA mutants were produced by site-directed mutagenesis and 
inserted into the pET28a plasmid with NheI and HindIII restriction sites. The plasmids were 
sequenced and then used for transformation into respective cloning/expression cells. 
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GST-SaMerA- SaMerA was cloned into pGEX-6P-1 using BamHI and XhoI restriction sites 
by Dr A Schenkmayerova, a previous member in the Strauss Lab. The plasmid was then 
used directly for transformation into respective cloning/expression cells. 
EcGor, EcLpd(LipDH) and EcYkgC  – Over expressing clones were purchased from the 
ASKA collection (National BioResource Project) [155]. These clones were used directly in 
overexpression and enzyme purification. 
SaTrxA – The S. aureus Thioredoxin pET28a plasmid was synthesized by GenScript®, 
USA. The gene was flanked by NdeI and XhoI restriction sites. The plasmid was codon 
optimized for overexpression in E.coli. The plasmid was then used directly for transformation 
into respective cloning/expression cells. 
SaCoADR – The pET28a-CoADR plasmid was already available in the Strauss lab. The 
gene was flanked by NdeI and XhoI restriction sites. This plasmid was subsequently used 
directly for transformation into respective cloning/expression cells. 
PaMerA Tn501 –The PaMerA Tn501 pET28a plasmid was synthesized by GenScript®, 
USA. The gene was flanked by NdeI and XhoI restriction sites. The plasmid was codon 
optimized for overexpression in E.coli. The plasmid was then used directly for transformation 
into respective cloning/expression cells. 
2.4.2 Protein purification 
All purified and sequenced plasmids were then transformed into E. coli BL21(Star)DE3 for 
protein overexpression. Overexpression was performed in LB broth supplemented with 30 
mg/L kanamycin (except GST-SaMerA, Ampicillin 100 mg/L) and grown at 37°C whilst 
shaking in non-baffled flasks. Once an OD600nm = 0.5-0.6 was reached the cultures were then 
induced with IPTG at a final concentration of 0.5 mM. Cultures were then continued 
overnight (except SaCoADR: 3h growth) at 37 °C.  Thereafter the cells were harvested by 
centrifugation at 8000 rpm. Each cell pellet (except GST-SaMerA) was resuspended in 
approximately 10 mL of sonication buffer (5 mM imidazole, 500 mM NaCl and 20 mM Tris–
HCl, pH 7.9; 10 mL/1 g cell paste) and subsequently sonicated to elicit cell lysis. After 
centrifugation at 15 000×g for 30 min, the crude extract (supernatant) was applied to a 0.45 
µm syringe filter (AMICON) to remove any further debris. The clarified lysate was then 
applied to a previously prepared (Ni2+) 1 mL HisTrapFF metal affinity purification column 
using an ÅKTAprime purification system. After an initial wash step of 5-10% elution buffer to 
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remove unbound protein, the protein of interest was then eluted by increasing the imidazole 
concentration to 500 mM. Protein elution was monitored by UV at 280 nm on the 
ÄKTAPrime. Residual imidazole was then removed from the purified protein fractions and 
buffer exchanged using a 5ml HiTrap Desalting columns (50 mM potassium phosphate, 5 
mM MgCl2, pH 8.0). Thereafter a 10% SDS-PAGE gel was run for each protein purified. 
Protein concentration of non-flavin proteins was determined using Bradford reagent (BIO-
RAD). However for all flavoproteins the concentrations were determined using their FAD 
molar extinction coefficients at 450 nm. Molar extinction coefficients of each were 
determined using literature and EXPASY Protpram.  Glycerol was added to the pure protein 
solution to a final concentration of 5%, after which the protein was aliquoted and stored at -
80 °C. 
In addition to the above mentioned general purification protocol, PaMerA Tn501 was purified 
using adapted method from Ledwidge et al [17] and S. aureus coenzyme A disulfide 
reductase was purified using an established protocol [156]. Images of SDS-PAGE gels of 
purified proteins EcGor, EcLipDH and EcYkgC are shown in the Appendix. All proteins 
yielded yellow fractions and concentrations were measuring using their FAD molar extinction 
coefficients.  
2.4.3 Enzyme characterization 
2.4.3.1 General flavin spectra of SaMerA 
SaMerA was separately titrated with NADPH and NADH (0.5 – 5.0 mol NADPH per mol 
FAD) under anaerobic conditions at 25⁰C in 50 mM Tris-HCl (pH 7.5), and 150 mM NaCl. 
The titration was conducted in an anaerobic cuvette, sealed with a gas-tight rubber septum 
and repeatedly flushed with nitrogen gas. All reactants were flushed with nitrogen gas prior 
to titration. The reduction of the enzyme flavin by NADPH was monitored by collecting 
spectra from 800 nm to 240 nm on a Cary 60 UV-Vis Spectrometer (Agilent Technologies). 
2.4.3.2 General flavin spectra of other enzymes used in this chapter. 
All enzymes (EcGor, EcRclA/YkgC, EcLipDH, SaCoADR) were separately made up in 50mM 
potassium phosphate pH 8 to a final concentration of 2.5 µM and placed in a 1 mL 1cm 
quartz cuvette. Absorbance scans were done on a Cary 60 UV-Vis Spectrometer (Agilent 
Technologies). The flavin spectra of EcGor, EcRclA/YkgC, EcLipDH, SaCoADR can be 
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2.4.3.3 Circular Dichroism (CD) spectroscopy 
All measurements were done on a Chirascan plus (Applied Photophysics) and data 
processed with Pro-data Viewer 4.2.6 (Applied Photophysics). An air blank (cell holder only) 
as well as a buffer/solvent blank of 10 mM potassium phosphate pH 8 in cell was done. Each 
protein sample was made up in 10 mM potassium phosphate pH 8 to a final concentration of 
1µM in a total volume of 180 µl and placed in a 0.5 mm quartz suprasil cell with demountable 
window and cell holder 013.000 (Hellma Analytics). The captured data represents an 
average of three independent spectra combined. 
2.4.4 Assessing SaMerA as a mercuric-ion reductase  
All assays were based upon Miller et al using 25 nM PaMerA Tn501, 50 mM potassium 
phosphate, pH 7.3, 100 µM NADPH and 100 µM Hg-substrate [17]. Prior to each reaction, 
PaMerA Tn501 was purified and treated with DTT (5 mM for each 30 µM of enzyme) 
thereafter ammonium precipitated and refolded as described. Two exceptions were done in 
the present study, the first being that an IMAC column was used instead of an anion-
exchange, and secondly a 5ml HiTrap Desalting column was used instead of a gel filtration 
column. The concentration of the enzyme was determined using the molar extinction 
coefficient of FAD [17]. Similarly, SaMerA was also purified, pretreated with DTT, refolded 
and purified as described. Hg(GSH)2 was prepared and used as a substrate for both 
PaMerA Tn501 and SaMerA [17]. Considering that the assays worked with Hg(GSH)2, 
Hg(Trx)2 was not tested as done in literature [17]. In all reactions the substrate (Hg(GSH)2) 
was placed in the wells and the enzyme mixture (25 nM enzyme, 100 µM NADPH in buffer) 
added thereafter to initiate the reaction. Reactions were done at 25oC in clear flat-bottom 96 
well plates (Griener Bio-one) and absorbance at 340 nm read using a Thermo Scientific 
Varioskan microplate spectrophotometer.  
For peroxidase assays:  initially a peroxidase kit was used (Pierce peroxidase detection kit), 
however after numerous attempts in optimizing, this kit was abandoned due to inconsistent 
results. The strategy was then changed to the use of horseradish peroxidase, HRP 
(Sigma#9003-99-0) and ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)). 
For aerobic reactions: Assay conditions used were 25 nM SaMerA, 50 nM HRP, 50 mM 
potassium phosphate, pH 7.4, 100 µM NADPH, 100 µM Hg-substrate and 100 µM ABTS. 
The substrate ABTS was made up to a concentration of 10 mM in 50 mM potassium 
phosphate, pH 7.4. This was made fresh prior to use. Control reactions made use of 30% 
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w/v H2O2 solution as is. Each reaction contained 25 nM SaMerA enzyme, 100 µM NADPH in 
buffer with 50 nM HRP incubated at room temperature for 2 minutes. This reaction mixture 
was then added to the wells of a clear flat-bottom 96 well plate (Griener Bio-one) already 
containing the substrates (100 µM Hg(GSH)2 and 100 µM ABTS) and initial rates obtained 
from increase in absorbance at 420 nm. All absorbance readings were done using a Thermo 
Scientific Varioskan microplate spectrophotometer.  
For anaerobic reactions: The same reactions conditions and buffer was used. However all 
reagents (except enzymes) were made anaerobic prior to use using a tonometer and 
anaerobic cuvette which were all repeatedly flushed with nitrogen. The substrates (100 µM 
Hg(GSH)2 and 100 µM ABTS) were first placed into the cuvette and the reaction initiated 
upon addition of reaction mixture (SaMerA, HRP, 100 µM NADPH) and initial rates obtained 
from an increase in absorbance at 420 nm.  All absorbance readings were done on a Cary 
60 UV-Vis Spectrometer using the 1 cm anaerobic cuvette.  
2.4.5 Assessing potential protein partners of SaMerA  
GST-SaMerA was expressed and purified as described in protein expression and purification 
section. 
S. aureus JE2 (USA300) was grown in a large batch culture (2 litres) in LB broth. After 
reaching an OD600 = 0.5, the cells were challenged with 10 mM H2O2 every 20 minutes over 
an hour. After a further 2 hours growth the cells were then spun down and the pellet stored 
until use for pull down experiments.  
The pellet of S. aureus JE2 culture was freeze thawed and sonicated immediately in 10ml of 
binding buffer (140 mM NaCl, 2.7 mM KCl, 10 mM NaHPO4, 1.8 mM KH2PO4, pH 7.3). The 
lysates were used in pull down experiments. Batch purification was done using glutathione 
sepharose 4B (GE Healthcare) and supplied product instructions. Briefly, GST-SaMerA was 
bound to the GSH resin using binding buffer, followed by incubation of resin bound SaMerA-
GST with S. aureus JE2 lysate. The resin was washed several times with binding buffer to 
remove unbound proteins and finally GST-SaMerA was eluted with elution buffer (50 mM 
Tris-HCl, 10 mM reduced glutathione, pH 8). All eluted fractions were run on a 10% SDS-
PAGE gel.  
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2.4.6 Assessing potential disulfide substrates 
Enzymes used included SaCoADR, EcGor, EcLipDH, and SaMerA. Prior to use, all purified 
enzymes were treated with 10-fold DTT to ensure reduction of disulfides. Excess DTT was 
removed using Amicon centrifugal concentrators with MW 3,000 Da cutoff. Reaction 
conditions involved 25 nM enzyme, 50 mM potassium phosphate, pH 7.4, 100 µM NADPH, 
100 µM substrate.  
Substrate (CoAS)2 was prepared using an established method [157]. A solution of 10 mL of 
CoA (final concentration of 2 mM) in 50 mM Tris pH 7.6 was prepared followed by the 
addition of powdered diamide (final concentration of 1 mM). The solution was gently shaken 
for 30 mins at room temperature. Thereafter the diamide was removed using DCM extraction 
(4×4 ml). The absorbance maximum at 260 nm of the resulting (CoAS)2  solution was then 
used to calculate the concentration of the stock solution. The formation of (CoAS)2 was also 
assessed through incubating CoA with10 fold HOCl or H2O2 for 1 hour at room temperature. 
The disulfide (CoAS)2  did not form with HOCl but did indeed form with H2O2 treatment.  
Disulfides ((Cys)2, (GSH)2, (BSH)2, (DHLA)2) were formed by incubating thiols with 10-fold  
H2O2 at room temperature for 1 hour. The concentration of each was determined at an 
absorbance maximum of 261 nm. Interestingly the disulfides ((Cys)2, (GSH)2, (BSH)2, 
(DHLA)2) did not appear to form (lack of disulfide peak) when treated with HOCl. 
Enzyme reactions were carried out as follows: a solution containing 25 nM SaMerA,100 µM 
NADPH in reaction buffer was added to a clear flat-bottom 96well plate already containing 
the disulfide substrates (100 µM). Similarly control reactions were performed using 25 nM 
SaCoADR + ((CoAS)2), EcGor + ((GSH)2), EcLipDH + dihydrolipoamide respectively. Initial 
rates were determined following the decrease in absorbance at 340 nm. All absorbance 
readings were done using a Thermo Scientific Varioskan microplate spectrophotometer. 
2.4.7 Assessing various reactive chlorine species 
All assays involved the following reaction conditions, 25 nM enzyme, 50 mM potassium 
phosphate, pH 7.4, 100 µM NADPH, 100 µM “chlorinated” compound. Substrates were first 
added to wells of a clear flat-bottom 96well plate and the enzyme mixture (enzyme, NADPH, 
buffer) was then added to initiate the reaction. Initial rates were determined following the 
decrease in absorbance at 340 nm. All absorbance readings were done using a Thermo 
Scientific Varioskan microplate spectrophotometer. 
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For amino acid chloramines: Various ratios of HOCl:amino acid were tried. Ratios of 1:1 
(HOCl:amino acid) gave the best results (i.e. no residual HOCl left unreacted as confirmed 
by UV spectroscopy 291 nm). All amino acids showed the typical chloramine UV maximum 
at 252 nm (ε = 429 M-1. cm-1). However methionine, tyrosine, tryptophan did show broader 
peaks as well as additional peaks, owing to the possibility that chlorination can occur on 
other functional groups of these amino acids. 
2.4.8 Enzyme assays involving NCT 
All assays involved the following reaction conditions, 25 nM enzyme, 50 mM potassium 
phosphate, pH 7.4, 100 µM NADPH, 100 µM NCT. Substrates were first added to wells of a 
clear flat-bottom 96-well plate and the enzyme mixture (enzyme, NADPH, buffer) was then 
added to initiate the reaction. Initial rates were determined following the decrease in 
absorbance at 340 nm. All absorbance readings were done using a Thermo Scientific 
Varioskan microplate spectrophotometer. 
NCT was prepared via two methods. HOCl mixing with taurine involving 1:2 (HOCl: taurine). 
The solution was allowed to stand for 10 minutes at room temperature before use. NCT was 
also prepared by mixing 5 g of powdered taurine (sodium salt) in 100 mL absolute ethanol. 
To this 12 g of chloramine-T was added and the solution stirred for 5 hours at room 
temperature. The resulting sodium salt of NCT was filtered off and washed with 2×20 mL of 
absolute ethanol. The NCT powder was further dried overnight by high vac. The NCT 
prepared from both methods were confirmed by UV spectroscopy and 1HNMR. Unless 
otherwise stated, the NCT prepared using chloramine-T was used in subsequent assays. 
2.4.9 In vitro assessment of NCT against S. aureus and E.coli wildtype 
and SaMerA mutant 
S. aureus susceptibility to NCT 
Bacterial strains S. aureus JE2 and S. aureus NE785 (obtained from the NARSA repository) 
were streaked out on LB agar and grown at 37°C for 24 hours.  A single colony was selected 
and inoculated into LB broth and incubated aerobically at 37°C for 18 hours.  N-
Chlorotaurine (NCT) was dissolved to 1 mM in 0.01 M phosphate-buffer (pH 7.1).  An 
overnight culture was inoculated into the 1 mM NCT solution to 6 log CFU/mL, and 
subsequently incubated at room temperature.  The survivability of strains was followed every 
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hour for 6 hours by serially diluting cells and plating on agar.  To inactivate the antimicrobial 
action of NCT, cells were initially diluted (10-1) in 0.6 % (m/v) sodium thiosulphate in PBS 
(pH 7), and thereafter serially diluted in PBS (10-2 and subsequent dilutions).  Colony 
forming units were determined by plating the serially diluted cells on LB agar and incubating 
at 37°C for 24 hours.  After incubation cells were counted and expressed as log CFU/mL. 
Escherichia coli susceptibility to NCT  
Bacterial strains E. coli K12 and E. coli JW5040 (obtained from the Keio collection) were 
streaked out on LB agar and grown at 37°C for 24 hours.  A single colony was selected and 
inoculated into LB broth and incubated aerobically at 37°C for 18 hours.  N-Chlorotaurine 
(NCT) was dissolved to 1 mM in 0.01 M phosphate-buffer (pH 7.1).  An overnight culture was 
inoculated into the 2 mM NCT solution to 6 log CFU/mL, and subsequently incubated at 
room temperature. The survivability of strains was followed every hour for 6 hours by serially 
diluting cells and plating on agar.  The survivability of strains was also followed over shorter 
time points (0, 5, 10, 20, 30, 45 and 60 min) by serially diluting cells and plating on agar.  To 
inactivate the antimicrobial action of NCT, cells were initially diluted (10-1) in 0.6 % (m/v) 
sodium thiosulphate in PBS (pH 7), and thereafter serially diluted in PBS (10-2 and 
subsequent dilutions).  Colony forming units were determined by plating the serially diluted 
cells on LB agar and incubating at 37 °C for 24 hours.  After incubation cells were counted 
and expressed as log CFU/mL. 
2.4.10 Potential inhibitors of SaMerA 
2.4.10.1 Synthesis and purification 
The general procedure was followed: To a solution of 1,1,-dibromoformaldoxmine (1 eq.) in 
DMF (5 mL/g) at -10oC was added to the alkene (1.2 eq.) whilst stirring. Thereafter a solution 
of KHCO3 (2.5 eq.) in water (6 mL/g) was added over a period of 1 hour. The reaction 
mixture was then warmed to room temperature over 1 hour. 1N HCl was added and the 
mixture extracted with MTBE (3×). The combined organic layers were washed with water 
and brine and dried over MgSO4 and concentrated under reduced pressure using a rotary 
evaporator. The crude product was purified by column chromatography (Merck silica gel 60 
(particle size 0.040-0.063 mm)) and progress visualized by TLC (aluminium-backed Merck 
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2.4.10.2 Purification and analysis 
Column solvent conditions used for compounds: Compound 6k (Ethyl acetate: Methanol: 
H2O (7:2:1)). Compound 6l (Hexane: Ethyl Acetate (9.5:0.5)). Compound 6b (Hexane: Ethyl 
Acetate (9.5:0.5)). All 1H NMR spectra were collected using a 300 MHz Varian VNMRS 
instrument at the Central Analytical Facility (CAF) of the University of Stellenbosch. 
Chemical shifts (δ), reported in ppm were recorded using the residual solvent peak as 
reference. Proton spectral data are reported as: chemical shift, multiplicity (ovlp = 
overlapping, s = singlet, d = doublet, t = triplet, q = quartet, p =pentet, m = multiplet, br = 
broad), coupling constant (J) in Hz, and proton integration. TLC analysis and 1HNMR of 
compounds are shown in section 2.5 (Additional Experimental Data). 
Compound 6k (980mg of a clear odorless oil was obtained, 61% yield) 1HNMR (300MHz, 
DMSO-d6) δ 4.8 (dd, J=11.7, 6.9Hz, 1H), δ 2.9 (dd, J=17.6, 11.7Hz, 1H), δ 2.7 (dd, J=17.6, 
7Hz, 1H). Compound 6l (1310mg of a white powder was obtained, 86% yield) 1HNMR 
(300MHz, DMSO-d6) δ 5.08 (dd, J=10.7, 7Hz, 1H), δ 3.68 (d, J=11.7Hz, 1H), δ 3.62 (dd, 
J=11.7Hz, 1H), δ 1.43 (s, 9H). Compound 6b (1903mg of a clear oil with a pungent 
peppermint odor was obtained, 53% yield) 1HNMR (300MHz, chloroform-d) δ 4.52-4.27 (m, 
1H), δ 3.16 (dd, J=17.3Hz, 1H), δ 2.93 (dd, J=17.3Hz, 1H), δ 1.9-1.4 (m, 6H), δ 1.39-1.1 (m, 
3H), δ 0.97 (m, 2H). 
 
2.4.10.3 Enzyme inhibition studies 
All assays involved the following buffer conditions, 50 mM potassium phosphate, pH 7.4. 
Each enzyme was pretreated with DTT as previously described, to ensure all disulfides were 
reduced. Excess DTT was removed using an Amicon centrifugal concentrator with 3,000 Da 
MW cutoff. Enzyme concentration was calculated using an FAD molar extinction coefficient 
of 11.3 mM-1cm-1 [17]. There after each enzyme was incubated on ice with 10 fold excess 
compound for 30 minutes. Excess compound was removed using an Amicon centrifugal 
concentrator with 3,000 Da MW cutoff.  There after the pre-treated enzymes were then 
placed on ice for further use.  Control reactions of enzyme with DMSO (no compound), 
iodoacetamide and N-methylmaleimide were treated in the same fashion. Using these pre-
treated enzymes, reactions were setup and tested against 50 µM NCT as described in 
results section. Substrate (NCT) was first added to wells of a clear flat-bottom 96 well plate 
and the enzyme mixture (pre-treated enzyme, NADPH, buffer) was then added to initiate the 
reaction. Initial rates were determined following the decrease in absorbance at 340 nm. All 
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absorbance readings were done using a Thermo Scientific Varioskan microplate 
spectrophotometer. 
2.4.10.4 Circular Dichroism (CD) spectroscopy 
All measurements were done at 25oC on a Chirascan plus (Applied Photophysics) and data 
processed with Pro-data Viewer 4.2.6 (Applied Photophysics). An air blank (cell holder only) 
as well as a buffer/solvent blank of 10 mM potassium phosphate pH 8 in cell was done. Each 
pre-treated protein sample (compound treated) was made up in 10 mM potassium 
phosphate pH 8 to a final concentration of 10 µM in a total volume of 180 µL and placed in a 
0.5 mm quartz suprasil cell with demountable window and cell holder 013.000 (Hellma 
Analytics). The captured data represents an average of three independent spectra 
combined. 
2.4.10.5 Time-dependent enzyme inhibition studies 
All assays involved the following buffer conditions, 50 mM potassium phosphate, pH 7.4. A 
clear flat-bottom 96 well plate was prepared with appropriate wells containing 50 µM NCT. 
Each enzyme was pre-treated with DTT and excess removed as previously described. 
However instead of leaving the compound to incubate for 30 minutes, appropriate aliquots 
were taken out at time zero (immediately after adding compound), 5 minutes, 10 minutes, 20 
minutes and 30 minutes. Control reactions were done using enzyme and DMSO (No 
compound) as well as enzyme with no substrate NCT. Final reaction conditions were 25 nM 
pre-treated enzyme (250 nM compound), 50 mM potassium phosphate, pH 7.4, 100 µM 
NADPH and 50 µM NCT. Initial rates were determined following the decrease in absorbance 
at 340 nm. All absorbance readings were done using a Thermo Scientific Varioskan 
microplate spectrophotometer. 
2.4.10.6 Mass spectrometry analysis 
In-gel Digest 
All reagents are analytical grade or equivalent. Gel slices supplied were destained in an 
Eppendorf 1.5 mL tube with 200 mM NH4HCO3: Acetonitrile 50:50 (Sigma) until clear. 
Samples were dehydrated and desiccated before reduction with 2 mM triscarboxyethyl 
phosphine (TCEP; Fluka) in 25 mM NH4HCO3 for 15 minutes at room temperature with 
agitation. Excess TCEP were removed and the gel pieces again dehydrated. Cysteine 
residues were thiomethylated with 20 mM S-methyl methanethiosulfonate (Sigma) in 25 mM 
NH4HCO3 for 30 minutes at room temperature. After thiomethylation the gel pieces were 
dehydrated and washed with 25 mM NH4HCO3 followed by another dehydration step. 
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Proteins were digested by rehydrating the gel pieces in trypsin (Pierce) solution (20ng/µl) 
and incubating at 37°C overnight. Peptides were extracted from the gel pieces once with 50 
µL water and once with 50% acetonitrile. The samples were dried down and resuspended in 
30 µL 2% acetonitrile: water; 0.1% FA. 
Residual digest reagents were removed using an in-house manufactured C18 stage tip 
(Empore Octadecyl C18 extraction discs; Supelco). The samples were loaded onto the stage 
tip after activating the C18 membrane with 30 µL methanol (Sigma) and equilibration with 30 
µL 2% acetonitrile: water; 0.05% TFA. The bound sample was washed with 30 µL 2% 
acetonitrile: water; 0.1% TFA before elution with 30 µL 50% acetonitrile: water 0.05% TFA. 
The eluate was evaporated to dryness. The dried peptides were dissolved in 2% acetonitrile: 
water; 0.1% FA for LC-MS analysis. 
Liquid chromatography - Dionex nano-RSLC 
Liquid chromatography was performed on a Thermo Scientific Ultimate 3000 RSLC 
equipped with a 2 cm×100 µm C18 trap column and a 35cmx75µm in-house manufactured 
C18 column (Luna C18, 5 µm; Phenomenex) analytical column. The solvent system 
employed was loading: 2% acetonitrile: water; 0.1% Formic acid (FA); Solvent A: 2% 
acetonitrile: water; 0.1% FA and Solvent B: 100% acetonitrile: water. The samples were 
loaded onto the trap column using loading solvent at a flow rate of 15 µL/min from a 
temperature controlled autosampler set at 7°C. Loading was performed for 5 min before the 
sample was eluted onto the analytical column. Flow rate was set to 500 nL/minute and the 
gradient generated as follows: 2.0% -10%B over 5 min; 5% -25% B from 5 -50 minutes using 
Chromeleon non-linear gradient 6, 25%-45% from 50-65 minutes, using Chromeleon non-
linear gradient 6. Chromatography was performed at 50°C and the outflow delivered to the 
mass spectrometer through a stainless steel nano-bore emitter.  
Mass spectrometry 
Mass spectrometry was performed using a Thermo Scientific Fusion mass spectrometer 
equipped with a Nanospray Flex ionization source. The sample was introduced through a 
stainless steel emitter. Data was collected in positive mode with spray voltage set to 2.2 kV 
and ion transfer capillary set to 280°C. Spectra were internally calibrated using polysiloxane 
ions at m/z = 445.12003 and 371.10024. MS1 scans were performed using the orbitrap 
detector set at 120 000 resolution over the scan range 350-1650 with AGC target at 3 E5 
and maximum injection time of 40 ms. Data was acquired in profile mode. 
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MS2 acquisitions were performed using monoisotopic precursor selection for ion with 
charges +2±6 with error tolerance set to +/- 0.02 ppm. Precursor ions were excluded from 
fragmentation once for a period of 30s. Precursor ions were selected for fragmentation in 
HCD mode using the quadrupole mass analyzer with HCD energy set to 32.5%. Fragment 
ions were detected in the orbitrap mass analyzer set to 15 000 resolution. The AGC target 
was set to 1E4 and the maximum injection time to 45 milliseconds. The data was acquired in 
centroid mode. 
Data Analysis 
The raw files generated by the mass spectrometers were imported into Proteome Discoverer 
v1.4 (Thermo Scientific) and processed using both Sequest and Mascot algorithms. 
Database interrogation was performed against a concatenated database created by using 
the Uniprot Staphylococcucea and E. coli databases. Sequences of common contaminants 
were also added to the database. Semi-tryptic cleavage allowing for 2 missed cleavages 
was used and precursor mass tolerance was set to 10 ppm and fragment mass tolerance set 
to 0.5 Da. Protein deamidation (NQ) and oxidation (M) was allowed as dynamic 
modifications and thiomethyl of C as static modification. Peptide validation was performed 
using the peptide validator node set to search against a decoy database with strict FDR 1%. 
 
2.4.10.7 In vitro assessment of compound 6k against S. aureus JE2 wildtype and 
SaMerA mutant 
Pretreatment of S. aureus with 1 mM compound 6k then exposure to 1 mM NCT 
Bacterial strains S. aureus JE2 and S. aureus NE785 (obtained from the NARSA repository) 
were streaked out on LB agar and grown at 37°C for 24 hours.  A single colony was selected 
and inoculated into LB broth and incubated aerobically at 37 °C for 18 hours.  After 
incubation, cultures were inoculated at 1 % (v/v) in LB broth supplemented with 1 mM 6k 
and incubated aerobically at 37 °C for 2 hours. After exposure to 6k, bacterial cells were 
inoculated in 1 mM NCT in 0.01 M phosphate-buffer (pH 7.1) solution to 6 log CFU/ml, and 
subsequently incubated at room temperature.  The survivability of strains was followed every 
hour for 6 hours by serially diluting cells and plating on agar.  To inactivate the antimicrobial 
action of NCT, cells were initially diluted (10-1) in 0.6 % (m/v) sodium thiosulphate in PBS 
(pH 7), and thereafter serially diluted in PBS (10-2 and subsequent dilutions).  Colony 
forming units were determined by plating the serially diluted cells on LB agar and incubating 
at 37 °C for 24 hours.  After incubation cells were counted and expressed as log CFU/mL. 
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Pretreatment of S. aureus with 50 µM NCT overnight then exposure to compound 6k 
followed by 1 mM NCT 
Bacterial strains S. aureus JE2 and S. aureus NE785 (obtained from the NARSA repository) 
were streaked out on LB agar and grown at 37 °C for 24 hours.  A single colony was 
selected and inoculated into LB broth and incubated aerobically at 37 °C for 18 hours.  After 
incubation, cultures were inoculated at 1 % (v/v) in LB broth supplemented with 50 µM NCT 
and incubated aerobically at 37 °C for 18 hours.  After incubation, bacterial cells (9 log 
CFU/ml) were exposed to 1 mM 6k at room temperature for 3 hours. After exposure to 6k, 
bacterial cells were inoculated in 1 mM NCT in 0.01 M phosphate-buffer (pH 7.1) solution to 
6 log CFU/ml, and subsequently incubated at room temperature.  The survivability of strains 
was followed every hour for 5 hours by serially diluting cells and plating on agar.  To 
inactivate the antimicrobial action of NCT, cells were initially diluted (10-1) in 0.6 % (m/v) 
sodium thiosulphate in PBS (pH 7), and thereafter serially diluted in PBS (10-2 and 
subsequent dilutions).  Colony forming units were determined by plating the serially diluted 
cells on LB agar and incubating at 37 °C for 24 hours.  After incubation cells were counted 
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2.5 Additional experimental data 
 
Figure 2.42 1HNMR of Compound 6k. 
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Figure 2.43 1HNMR of Compound 6l. 
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Figure 2.44 1HNMR of Compound 6b. 
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Figure 2.45 1HNMR of Compound NCT. Spectrum (1) NCT made via mixing HOCl:Taurine 1:2, (2) Taurine 
sodium salt, (3) NCT made via ethanolic mixture of Chloramine-T and Taurine sodium salt. 
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Figure 2.46 TLC of compounds synthesized and silica column purified. Compound 6K crude product (3), 
15- 20 pooled fractions from column and sent for NMR (15-20). Compound 6l crude product (3), change of 
solvents (4), fractions 18-20 combined from column and sent for NMR (18-20). Compound 6b crude 
product (5), fractions 8-10 combined from column and put on a second column, purified compound from 
second column fractions 10-11 combined and sent for NMR. Compound 6s crude product (3), very faint 
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Figure 2.47 CD spectroscopy of treated SaMerA WT with DMSO, IOA (iodacetamide), NEM (n-
methylmaleimide), compounds 6k, 6l and 6b. 
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Figure 2.48 CD spectroscopy of treated YkgC/RclA WT with IOA (iodacetamide), NEM (n-




Figure 2.49 10% SDS-PAGE of (A) PaMerA Tn501, (B) EcGor, (C) EcLipDH, (D) EcYkgC/RclA, (E) SaTrA. 
Far fight lanes of each gel were the final purified samples used for assays. 
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INVESTIGATION OF THE LMW THIOL-BASED 
REDOX SYSTEMS OF S. AUREUS 
 
3.1 Introduction 
For many organisms, living in an oxygen-rich environment can be a challenge. Over time, 
organisms have developed mechanisms for surviving in the presence of a range of oxygen 
levels, giving rise to obligate anaerobes, microaerophiles, and aerobes. However, the main 
challenge remains: overexposure to oxygen can result in stress and even death in any 
organism. The first hypothesis that proposed some form/entity of oxygen reactive species as 
the cause of stress in and the death of organisms was postulated in 1954 [1, 2]. It is now 
well known that oxygen can pass through cell membranes very easily and cause a wide 
range of damaging effects. Many studies have been conducted on understanding the 
mechanisms relating to the generation of the reactive species that cause oxidative stress in 
organisms. A number of studies have also shown that oxidative stress causes redox 
imbalance within cells which is one of the key underlying mechanisms to cell proliferation, 
signaling, aging and even cell death [3].  
There are a number of ways in which organisms respond to oxidative stress. By far the best 
studied system is that of the bacterium E. coli [4]. This bacterium’s defense mechanisms 
include oxidant scavenging enzymes (superoxide dismutase, catalase, alkyl 
hydroperoxidase or dedicated peroxidases), reactive oxygen sensors (regulators such as 
OxyR, SoxRS) and dedicated repair mechanisms for the damage caused by oxidative 
species. These include reactive oxygen species (ROS), reactive nitrogen species (RNS) and 
reactive chlorine species (RCS), which together target bacterial membranes, proteins that 
rely on metal cofactors, DNA and lipids.  
Of these, proteins are by far the most abundantly targeted biomolecule and therefore 
account for the bulk of the damage caused by oxidative stress [5]. The most common 
consequence is the oxidation of protein cofactors (especially metals) and amino acid residue 
side chains. Sulfur-containing amino acids are particularly vulnerable and reactive towards 
ROS, RNS and RCS. Despite such amino acids having a low abundance within proteins, 
their location/s in protein sequences is often conserved due to their important roles in 
catalysis and/or the maintenance of structure [6] 
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In response to oxidative stress many organisms significantly increase the concentration of 
cysteine-based metabolites [7]. These compounds, collectively referred to as low molecular 
weight (LMW) thiols, are found in all living systems and primarily play a role in redox 
balance/homeostasis [7-9]. A number of LMW thiols have been discovered and are shown in 
Figure 3.2. The best studied of these is the tripeptide L-γ-glutamyl-L-cysteinylglycine, 
otherwise known as glutathione (GSH). GSH plays many roles in eukaryotes and Gram-
negative bacteria, including acting as a redox buffer (by being sacrificially oxidized to its 
disulfide, GSSG), in the detoxification of reactive species, in the reduction of ribonucleotides 
and S-thiolation to name a few (Figure 3.1) [7, 10-23]. Glutathione peroxidase (Gpx) is 
oxidized by peroxide and reduced by GSH also forming GSSG. In turn GSSG is reduced by 
glutathione disulfide reductase (Gor). Harmful xenobiotics are removed by the action of 
glutathione-S-transferases (GSTs) through GSH conjugation. Ribonucleotide reductase 
(RNR) relies on a reducing system such as Grx/GSSG that recycles the RNR active site 





























Figure 3.1 Roles of GSH in redox-related functions in E. coli. The many roles of GSH include the 
maintenance of redox homeostasis, removal of toxic compounds, maintaining the ribonucleotide 
reductase catalytic cycle and acting as a cofactor. Grx (Glutaredoxin), Gpx (Glutathione peroxidase), GST 
(Glutahtione-S-Transferase). Redrawn and adapted from [20].  
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Figure 3.2 Various LMW thiols implicated in oxidative stress responses. Glutatione (GSH, found in 
eukaryotes and Gram-negative bacteria), gamma-GlutamylCys (GGC, found in halobacteria, lactic acid 
bacteria), cysteine (Cys, found in all organisms), bacillithiol (BSH, found in Firmicutes), trypanothione 
(T(SH)2, found in Trypanosomes), mycothiol (MSH, found in Actinomycetes), coenzyme A (CoA, found in 
all organisms), ergothioneine (ESH, found in fungi and Mycobacteria), and ovothiol (OSH, found in 
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Another major function of GSH is in protein protection and regulation. Many important 
enzymes contain redox sensitive active site thiols and exposure to oxidants would result in a 
number of thiol species. As a protective mechanism, sulfenic acids and other labile thiol 
species are able to react with LMW thiols via S-thiolation. In the absence of such a 
protective mechanism, the cysteine residues would be susceptible to irreversible over-
oxidation. The process of S-thiolation is a reversible process that returns the proteins to their 
native form. The best studied example of such a process is the GSSG/glutaredoxin-based 
system that is schematically shown in Figure 3.3 [6, 7, 24-40]. In this model system, 
glutaredoxin (Grx) enzymes harness the reducing power of GSH to maintain the cellular 
redox state as well as GSH-dependent reactions. Grxs belong to the Thioredoxin-fold protein 
(TFP) family and are classified into two groups based on the mechanism used to reduce 
protein disulfides (Figure 3.3) [37]. In the dithiol mechanism, Grx reduces a protein disulfide 
to form a mixed disulfide with the target protein (Figure 3.3; Step 1). The second thiol of Grx 
then reduces the mixed disulfide to release the target protein in a reduced state (Step 2). 
The Grx monothiol mechanism is primarily involved in the process of de-glutathionylation.  In 
this mechanism one of the Cys residues of Grx attacks a S-glutathionylated protein complex 
to release the free protein while forming Grx-SSG by disulfide exchange (Figure 3.3; Step 6). 
This mixed disulfide, in turn, is exchanged with free GSH to recycle the Grx back to its 
reduced form, while producing glutathione disulfide (GSSG) (Figure 3.3; Step 4). The GSSG 
is recycled by Glutathione reductase (Gor), which reduces GSSG back to free GSH (Figure 
3.3; Step 5) [11, 40-46].  
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Figure 3.3 The Glutaredoxin/GSSG redox system. The most well studied system of S-thiolation is S-
Glutathionylation. The process of S-glutathionylation is a reversible process involving small proteins 
called glutaredoxins (Grxs). Glutaredoxins function via two mechanisms namely a mono- and – dithiol 
mechanism. In the dithiol mechanism, Grxs reduce protein disulfides using both of their active site thiols 
(Step 1-4). The monothiol mechanism is utilized in reversing S-glutathionylation. Both mechanisms of 
Grx utilize GSH and subsequently form glutathione disulfide (GSSG). GSSG is recycled by NADPH 
dependent glutathione disulfide reductase (Gor). Adapted from [37] 
 
S. aureus lacks GSH and therefore has to use alternative LMW thiol(s) to establish a redox 
system capable of resisting oxidative damage. Possible candidates include cysteine (Cys), 
lipoic acid/lipoamide, coenzyme A (CoA) and bacillithiol (BSH) [7, 30, 31, 47-49]. However, 
since high concentrations of Cys are particularly toxic to cells, it is therefore not usually 
directly involved in the maintenance of redox homeostasis [7, 49]. Similarly, lipoamide is also 
an unlikely candidate as it has not been directly implicated in maintaining redox homeostasis 
in any organism. Instead, it is usually found covalently attached to a Lys residue of lipoamide 
dehydrogenase, which itself forms part of multienzyme complexes such as those of keto acid 
dehydrogenase, pyruvate dehydrogenase (PDH) and ketoglutarate dehydrogenase (KDH) 
[50-52]. Consequently, BSH and CoA have been considered to be the major LMW thiols 
implicated in maintaining redox homeostasis in S. aureus and protecting it against oxidative 
stress [7, 30, 31, 47-49].  
BSH is a LMW thiol that is found in members of the Firmicutes phylum. The structure and 
distribution of BSH was confirmed in 2009 through a large collaborative effort which has 
ultimately allowed for further studies on the biosynthetic pathway of BSH [32, 53-55]. Using 
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similarities to the MSH biosynthetic pathway and EMBL STRING, candidate genes for the 
first steps of BSH biosynthesis were identified in Bacilli [32]. Along with these candidate 
genes other genes were identified involving pantothenate biosynthesis (panE and coaX) as 
well as genes of unassigned function (Figure 3.4). The finding of CoA-associated genes 
linked to BSH biosynthesis might suggest that the biosynthesis of these two LMW thiols are 
linked in some manner [24, 56]. 
 
Figure 3.4 EMBL STRING analysis of known BSH- and CoA-related genes and their association with 
genes of unknown function in B. subtilis. Some of the genes identified interacting with BSH biosynthesis 
include panE (encoding 2-dehydropantoate 2-reductase), coaX (encoding Type III pantothenate kinase), 
mgsA (encoding methylglyoxal synthase), yphP (encoding bacilliredoxin BrxA) and yqiW (encoding 
bacilliredoxin BrxB) as well as a number of uncharacterized genes. 
 
In addition to the known biosynthetic genes, others that are likely associated with BSH-
dependent enzymology have also been identified. Two TFP-like proteins, YqiW and YphP, 
resemble Grx and have been shown to play a role in de-thiolation of bacillithiolated OhrR 
and MetE in B. subtilis [57]. YpjG is predicted to function as an ABC transporter protein 
although no experimental data shows this. Conserved DUF881-domain containing protein 
YlxX is yet to be characterized. Another protein of unknown function is YpdA, which shares 
close sequence identity to thioredoxin reductase and has been hypothesized as a protein 
with potential BSSB reductase activity. A similar analysis in S. aureus shows that it contains 
many of the homologues of the Bacillus spp. BSH biosynthetic genes, as well as 
homologues of YpdA, YphP, YqiW and YtxJ. 
Since the identification of the BSH biosynthetic genes, BSH has been shown to have many 
diverse roles, including the reduction of thionitrosylated (-SNO) compounds, detoxification of 
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xenobiotics, maintaining metal homeostasis and also in virulence [24, 54, 56, 58, 59]. The 
many known functions of BSH are summarized in Figure 3.5. BSH is shown to regulate the 
peroxide sensor OhrR via S-thiolation under oxidative stress conditions [60]. BSH is also 
involved in the detoxification of RNS and electrophiles via aldehyde dehydrogenase and 
bacillithiol-S-conjugate amidase respectively [54]. It has also been shown that fosfomycin, 
methylglyoxal (MG) and formaldehyde (FA) are rendered harmless via BSH dependent-S-
transferase [32]. Analogous to GSH, BSH has also been proposed to be involved in the 
chelation of zinc and copper as well as detoxification of selenite and thus potentially playing 
a role in metal homeostasis [32, 53, 54]. BSH has been shown to play a role in infection and 
virulence of clinical isolates of S. aureus with BSH-deficient strains showing decreased 








































Figure 3.5 Roles of BSH in redox-related and detoxification functions in Firmicutes. Clockwise from the 
top: Under oxidative stress BSH regulates the peroxide sensor OhrR through S-thiolation. BSH is also 
involved in the detoxification of reactive nitrogen species via BSH conjugation (BSNO). The removal of 
reactive electrophiles (RX) is also carried out via BSH conjugation (BS-R) using bacillithiol-S-conjugate 
amidase (Bca). Other harmful compounds such as fosfomycin, methylglyoxal (MG) and formaldehyde 
(FA) are rendered harmless by BSH dependent-S-transferase (BST). BSH has also been shown to play a 
role in zinc and copper chelation potentially affecting metal homeostasis. BSH reacts avidly with 
thiophilic metals and metalloids such as selenite which is removed by BSH conjugation. Adapted and 
redrawn from [32, 54]. 
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There is also evidence that many Firmicutes—including S. aureus—utilize BSH in S-
thiolation of key enzymes as both a protection and regulatory mechanism [7, 24, 27, 29-31, 
54, 56, 58, 59]. The manner in which bacillithiolation and debacillithiolation occurs is well 
established and shows similarities to that of the monothiol mechanism of S-
glutathionylation/de-glutathionylation model system. Briefly, BSH-protected enzymes are de-
bacillithiolated by bacilliredoxin proteins BrxA (YphP) or BrxB (YqiW) to form Brx-SSB mixed 
disulfides which are proposed to subsequently be reduced by BSH resulting in the formation 
of BSSB (Figure 3.6) [7, 24, 29, 54, 56, 57, 63]. However, this step remains to be 
experimentally confirmed. The Brx proteins are members of the TFP superfamily, although 
they have a shorter disulfide motif (CxC) rather than the CxxC motif seen in Grxs. Evidence 
shows that BrxA is able to reduce protein disulfides, albeit inefficiently with low kcat/KM values 
(2.6–4.7 ± 0.2×103 M−1.s−1) when compared to thioredoxin or protein disulfide isomerase 
(11.2 ± 0.8 and 170 ± 50×103 M−1.s−1 respectively) [64]. There is no evidence that BrxB is 















Figure 3.6 Reversal of S-bacillithiolation by bacilliredoxin (Brx). The bacillithiolated protein is de-
bacillithiolated by Brx, resulting in a Brx-SSB. This mixed disulfide is proposed to be reduced by BSH 
leading to the formation of BSSB, but this remains to be experimentally proven. It is unknown how BSSB 
is recycled back to BSH. All unconfirmed reactions are indicated in red. Adapted and redrawn from [29]. 
 
As stated above, the mechanism whereby Brx-SSB is recycled back to its reduced form 
remains to be confirmed. Considering BSH is predominantly found in the free thiol (reduced) 
form, with a high BSH/BSSB ratio, suggests the presence of a BSSB reductase [53, 65]. The 
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current consensus candidate protein for having BSSB (bacillithiol disulfide) reductase activity 
is YpdA.  A recent paper by Cheung and co-workers discussed the potential role of YpdA in 
maintaining intracellular redox homeostasis [66]. This study showed that the ypdA mutant 
caused an increase in levels of BSSB and a lower bacillithiol redox ratio compared to the 
isogenic parent. In addition, the YpdA over-expressing strain showed increased levels of 
BSH and decreasing amounts of BSSB. The YpdA protein was also purified and it was found 
that YpdA was able to consume NADPH and NADH in the absence of BSSB—presumably 
due to oxidation by O2. Importantly, the authors were unable to direct demonstrate any 
BSSB reductase activity [66]. The potential role of YpdA in the mechanism of S-
bacillithiolation/de-bacillithiolation therefore remains unclear, and its elucidation forms a 
central focus of the studies described in this chapter. 
The other LMW thiol that is proposed to be involved in redox homeostasis in S. aureus, CoA, 
already plays an important role in central metabolism. However, the identification of a 
designated CoA disulfide reductase (CoADR) enzyme in a number of bacteria supports the 
analysis that CoA has role in redox homeostasis [7, 48, 49, 67-74].  Interestingly, CoA has 
been shown to S-thiolate proteins under conditions of oxidative stress to form mixed disulfide 
conjugated proteins [74-77]. However, it is unknown how proteins that are thiolated by CoA 
in this manner are returned to the free thiol form, as no CoA-specific redoxins have been 
identified to date (Figure 3.7 Panel A). While it may be possible that such “CoAlated” 
proteins (the term was coined by Gout and co-workers) could be de-thiolated by CoA itself to 
from CoA disulfide and the reduced protein (Figure 3.7 Panel B), this has not been 
demonstrated to occur experimentally. It therefore remains unclear to what extent CoA plays 
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Figure 3.7 The process of S-CoAlation/de-CoAlation. While the evidence of S-thiolated enzymes by CoA 
is clear, the mechanism of de-CoAlation is unknown (A). Since there are no CoA specific redoxins, it is 
possible that CoA itself is able to rescue CoAlated enzymes with the formation of (CoAS)2 which would 
then be reduced by CoADR (B). An alternative hypothesis might be that CoADR is able to react directly 
with CoAlated proteins to form CoA and the free protein(C). 
 
In this chapter, we describe our studies that investigated the potential role of YpdA as the 
putative BSSB reductase in the bacillithiol/Brx pathway. We also report on a comparative 
analysis of the relative roles of BSH and CoA in the protection and regulation of a key 
metabolic enzyme in S. aureus. Together, these studies improve our understanding of the 
mechanisms that S. aureus uses to protect its proteins against the damage of oxidative 
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3.2 Results and discussion 
3.2.1 Sequence analysis of SaYpdA to other tDBDFs 
YpdA was first identified by Helmann and co-workers. It is conserved among BSH-producing 
bacteria, including S. aureus, and has been proposed to function as a BSSB disulfide 
reductase [7, 24, 27, 31, 32, 53, 54, 56, 58, 62, 78-81]. S. aureus YpdA (SaYpdA) shares 
highest sequence identity (~25-29%) to bacterial thioredoxin reductases (TrxR’s) which form 
part of the alkylhydroperoxide reductase (AHR) subgroup of the tDBDFs [32, 54]. Two 
members of the AHR subgroup were previously described in chapter 1 namely, TrxR and 
AhpF.  Members of this subgroup contain a characteristic CxxC motif that contains the two 
redox active cysteine residues that are critical for the catalytic mechanism in reducing the 
disulfide of their cognate thioredoxin-fold protein (TFP) partners via disulfide exchange. This 
results in oxidation of its own Cys residues, forming a disulfide which is reduced by NADPH 
via the flavin cofactor [13, 82-86]. 
A BLAST sequence homology search of SaYpdA against the PDB database indeed reveals 
closest homology to TrxRs from a number of bacterial species, as well as to some ferredoxin 
NADP+ oxidoreductase. Using the top hits a sequence alignment was generated using 
MUSCLE and ESPript with secondary elements shown based on the structure of the TrxR-
like protein from T. acidophilum (PDB: 3CTY) (Figure 3.8).  While a number of the regions 
are conserved for two dinucleotide binding, SaYpdA lacks the conserved CxxC motif that 
has been shown to be essential for catalysis by AHR subgroup enzymes [13, 83, 86-88]. 
While SaYpdA does have three Cys residues (Cys14, Cys118 and Cys287), none of these 
are in the location of the expected CxxC motif. Instead, a seemingly arbitrary HYFK 
sequence is found in its place. This indicates that SaYpdA should not show any typical 
disulfide reductase activity. Moreover, the top hit in the PDB based on sequence homology 
to SaYpdA is the TrxR-like enzyme from T. acidophilum. This protein has proven thioredoxin 
reductase activity, yet it is unable to use NAD(P)H as a reductant [89]. The amino acids 
important for NAD(P)H binding in TrxRs are found in a HRRxxxR/K motif, indicated in a 
green box in Figure 3.8. The TrxR-like enzyme from T. acidophilum lacks all the important 
residues of this motif, confirming that it does not use a nucleotide as reductant. However, the 
other TrxRs and one of the two ferredoxin NADP+ oxidoreductase to which YpdA shows 
homology (PDB: 5YGQ) does contain the full motif, with the second ferredoxin NADP+ 
oxidoreductase containing two of the key residues of the motif. In contrast, SaYpdA has a 
YRGGDYS sequence where the motif is expected to be found, suggesting that like the T. 
acidophilum TrxR-like protein it too has a unique reductant. 
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Figure 3.8 ESPript sequence alignment of S. aureus YpdA (SAOUHSC_01499) against the top hits of 
sequence homology search against proteins in the PDB. These are TrxR proteins (3CTY, 5UTH, 4ZN0) 
and two ferredoxin reductases (3AB1, 5YGQ). Numbering and secondary elements shown are based on 
the 3CTY structure (the TrxR-like protein from T. acidophilum). Important structural elements are the FAD 
binding region that spans from residues ~20-150, the NAD(P)H binding region that spans from residues 
~160-240 (residues 184-191 that are critical for NADPH binding is shown in a green box) and the CxxC 
motif found in many members of the AHR subgroup (residues 145-148 shown in the black box. Cys 
residues of the CxxC motif as well as Cys residues of SaYpdA are highlighted as blue dots.  
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Mechanistically, it is possible that SaYpdA could bind a TFP-like protein partner like other 
members of the AHR subgroup, and that its flavin cofactor could reduce the TFP-based 
disulfide directly (i.e. without involving the usual CxxC motif as intermediary). Alternatively, 
one of the other Cys residues could act as an intermediary. To assess the likelihood that any 
of the Cys residues of SaYpdA could come in close contact or are otherwise catalytically 
relevant, a structural model was built based on the TrxR from S. aureus (PDB id 4GCM). 
The resulting model is shown in Figure 3.9. It shows the typical Rossman folds where the 
FAD and NADPH (shown in blue) are expected to be bound. In the active site, the catalytic 
disulfides of TrxR (shown in red) are situated at the top of a helix in close proximity to the 
FAD cofactor (Figure 3.10). However, the corresponding sequence of SaYpdA is not 
structurally defined. In addition, all three of its Cys resides are very far apart from one 
another, as well as from the FAD cofactor. Therefore, based on this model a considerable 
conformational change would need to occur in order for any of the Cys residues to be 
catalytically relevant.   
 
Figure 3.9 Model_YpdA_SaTrxR (Cyan) using SaTrxR (4GCM) as template (overlayed in Green). 
Model_YpdA_SaTrxR was built using Expasy SWISS-MODEL using SaTrxR (4GCM) as template. Root-
mean-square-deviation of model compared to template mean 2.11Å. Both NADPH and FAD shown in both 
monomers as dark blue stick structures. 
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Figure 3.10 Active site view of the one monomer of Model_YpdA_SaTrxR (Cyan) using SaTrxR (4GCM) as 
template (Green). Both NADPH and FAD are shown in navy blue to highlight relative distance of each 
cofactor. The active site disulfide of SaTrxR (4GCM) is shown in red. The Cys residues of SaYpdA are 
shown in magenta.  
 
Importantly, it has been shown that a large conformational change does occur in bacterial 
TrxR protein upon Trx binding, involving a rotation of more than 67 degrees [90]. This 
rotation brings the NADPH within 1.4Å of the FAD cofactor. The large conformational change 
can be seen by comparing the structures shown Figure 3.11 and Figure 3.12. Before Trx 
binds NADPH is positioned approximately 16Å from the FAD, with the disulfides also buried 
within the protein (Figure 3.11). Upon binding of Trx, a large conformational change occurs 
via a rotation of the NADPH binding domain, including α-helixes 1, 2, 3) and β-sheet 1 
(Figure 3.12). The α-helix 3 and β-sheet 1 twist while the disulfide swings out to interact with 
Trx. α-helix 1 and 2 rotate further behind the NADPH. The disordered region does not 
appear to undergo any significant conformational changes before and after binding of Trx.  
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Figure 3.11 X-ray crystal structure of E. coli TrxR (PDB id 1C10) showing the active site before substrate 
(Trx) binding. FAD and NADPH are shown in blue to highlight the large distance between the two 
cofactors. The disulfide CxxC motif is shown in red. α-helixes (1,2,3), β-sheet (1) and disordered region 
are labelled accordingly for comparison to the EcTrxR after binding to substrate. 
 
Figure 3.12 X-ray crystal structure of E. coli TrxR (1F6M) showing the active site after substrate (Trx) 
binding. FAD and NADPH are shown in blue to highlight the distance between the two cofactors. The 
disulfide CxxC motif is shown in red. α-helixes (1,2,3), β-sheet (1) and disordered region are labelled 
accordingly for comparison to the EcTrxR before binding to substrate. Trx, which would be bound to the 
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In the SaYpdA model (Figure 3.10), two of the Cys residues are found in the disordered 
region which does not undergo any significant changes in the EcTrxR. Therefore, based on 
our current knowledge, and taking all the structural evidence together, it remains difficult to 
propose any reasonable mechanism whereby SaYpdA could act as a protein or small 
molecule disulfide reductase. To investigate the protein biochemically, we set out to express 
and purify the enzyme, as well as other proteins pertinent to the study.  
3.2.2 Protein expression and purification 
Expression plasmids for SaYpdA, SaCoADR, SaBrxB and SaGAPDH were available in our 
laboratory or were obtained from collaborators. All plasmids were each separately 
transformed into E. coli BL21* (DE3) cells for heterologous expression of the target proteins. 
All proteins expressed well and were purified on an ÄKTAPrime using immobilized metal 
affinity chromatography (IMAC). The purified proteins were subsequently analysed by SDS-
PAGE (Figure 3.13). The protein concentration was determined using the Bradford assay for 
GAPDH and BrxB. The enzyme concentration for SaCoADR and SaYpdA was determined 
using the FAD molar extinction coefficient (11.3 mM−1.cm−1). 
 
Figure 3.13 10% SDS-PAGE gel analysis of proteins purified in this study. Gel (A) SaBrxB, (B) SaGAPDH 
and SaCoADR, (C) SaYpdA. Molecular weight marker shown with respective kDa increments. Lanes 
pertaining to other proteins not relevant to this section were omitted from each gel. 
 
3.2.3 Enzyme characterization 
In light of SaYpdA lacking the NADPH binding motif, an investigation into the cofactor 
requirement was carried out. SaYpdA was titrated with either NADPH or NADH under 
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anaerobic conditions to exclude background effects due to reoxidation of the flavin by 
oxygen (Figure 3.14). This data was collected by a previous Strauss lab member [91]. 
      
Figure 3.14 Anaerobic titrations of SaYpdA against NADPH (left spectrum) and NADH (right spectrum). 
The protein was titrated via sequential addition of NADPH/NADH (0.5mol) per flavin (1mol) up to an 
excess of 5mol. This data was previously collected [91]. 
SaYpdA showed a preference for NADPH over NADH with the flavin being readily reduced 
by NADPH (decrease of 450 nm). The recent report by Cheung and co-workers also showed 
that SaYpdA consumed NADPH in the absence of any other substrates; however, 
considering that these experiments were done aerobically it is cannot be excluded that this 
was due to oxidation by oxygen. This is supported by their finding that SaYpdA was also 
able to consume NADH, in contrast to our findings. These results indicate that in spite of 
conataining only part (GGGxxA) of the NADPH binding motif, SaYpdA is still able to bind the 
nucleotide in a manner that leads to reduction of the flavin cofactor.   
3.2.4 Evaluating potential protein partner/s of SaYpdA 
SaYpdA shares highest level of sequence identity to the TrxRs from the AHR subgroup. It 
has been well documented that this subgroup of enzymes mainly act in conjunction with TFP 
partners to reduce oxidized protein disulfides. In light of this, it was evaluated whether 
SaYpdA might require a protein partner for catalysis. Many biophysical studies, including 
that of TrxR and Trx, have been carried out using Glutathione-S-Transferase- (GST-) fusion 
tagged proteins in identifying potential protein partners via pull-down assays [92-94]. In 
these assays, the protein of interest is immobilized to a GSH affinity column via a GST-
fusion tag and any potential protein partners will bind to the protein of interest. This assay is 
also referred to as “protein-fishing” in which potential protein partners are thus “fished” out of 
a complex lysate solution by passing it over the “bait” of immobilized target protein. 
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Pull-down experiments involved the use of purified SaYpdA-GST that was used as the 
protein of interest or “bait” to be immobilized to GSH affinity column. Lysate was prepared by 
culturing S. aureus JE2 to exponential phase (OD600 of 0.5), at which point the cultures were 
challenged with 1 mM H2O2 to elicit oxidative stress response.  When bacteria are exposed 
to hydrogen peroxide the OxyR peroxide regulator is known to induce expression of a 
number of defense systems involved in counteracting oxidative stress, including AhpF, AhpC 
and TrxR/Trx [16, 95-97]. The lysate obtained after such treatment should therefore be 
enriched in proteins involved in oxidative stress resistance. After immobilizing GST-SaYpdA 
to a GSH column, the S. aureus JE2 lysate was allowed to incubate with the immobilized 
GST-SaYpdA. Thereafter any unbound protein and lysate was washed off the column, 
followed by elution of GST-SaYpdA (and any proteins bound to it) by increasing the GSH 
concentration in the elution buffer. The resulting eluate was subsequently analysed by SDS-
PAGE.  The results of the pull-down experiments are shown in Figure 3.15. There were two 
other prominent bands below the GST-SaYpdA (61 kDa). The lower band (26 kDa) in lane 6 
and 7 is known to be GST cleaved from the tagged protein (GST-SaYpdA) as cautioned in 
the manufacturer’s guidelines. An extra band (indicated by the arrow) was observed 
between the GST-SaYpdA and GST cleaved band in lane 6 and 7 with approximate size of 
30 kDa. This band was isolated and sent for mass spectrometry (MS) identification. The MS 
results showed a positive identification for a fragment of SaYpdA. Thus it appears that 
SaYpdA underwent some degradation during the experiment. Nonetheless, the results 
provide no evidence for SaYpdA having any possible protein partners (such as TFPs) other 
than itself under the test conditions. Furthermore, unpublished data obtained from a previous 
Strauss lab member showed that SaYpdA was unable to reduce the S. aureus TFP 
thioredoxin A (TrxA, the cognate partner of S. aureus TrxR) [91]. This further indicates that 
SaYpdA does not appear to require a protein partner for catalysis. 
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Figure 3.15 Pull-down assay for SaYpdA-GST using S. aureus JE2 lysate following exposure to H2O2. 
Lanes (1) molecular weight marker, (2) S. aureus JE2 lysate, (3) S. aureus JE2 lysate wash step 2 to 
remove any unbound proteins on column, (4) S. aureus JE2 lysate wash step 1 to remove any unbound 
protein, (5) S. aureus JE2 lysate wash step 3 to remove any unbound protein, (6-7) SaYpdA-GST and any 
potentially bound protein partners were eluted using GSH elution buffer. 
 
 
3.2.5 Assessing the activity of SaYpdA as BSSB reductase 
As explained above, SaYpdA has been hypothesized to function as a BSSB reductase by 
several groups [32, 54]. We therefore set out to directly determine if SaYpdA could reduce 
BSSB. A number of different concentrations of enzyme and BSSB were used in the activity 
tests, which used the rate of reduction of NADPH as proxy for BBSB reductase activity. 
Some low levels of initial activity was observed but only at high BSSB concentrations (at 400 
µM and above). Lower concentrations of BSSB showed no differences compared to the 
blank reaction without BSSB (Figure 3.16).  However, the progress shown in panel A shows 
that there is in fact very little absorbance decrease (~0.06 AU, corresponding to ~ 10-15 µM 
NADPH) considering 400 µM BSSB was used. The initial rates of the first 15 seconds of the 
reaction of SaYpdA acting on 400 µM BSSB, compared to several controls, are shown in 
panel B in triplicate. Based on these results the activity of SaYpdA seems to be too low to be 
physiologically significant.   
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Figure 3.16 Assessing 25 nM SaYpdA’s activity with BSSB as substrate. Panel A: SaYpdA progress 
curves using BSSB at the indicated concentrations. Panel B: Average rate of SaYpdA against 400 µM 
BSSB. (a) control reaction with 100 µM NADPH only, (b) control 25nM SaYpdA+100 µM NADPH, (c) control 
25nM SaYpdA + 100 µM NADPH + 1mM H2O2 , (d) Reaction 25nM SaYpdA + 100 µM NADPH + 400uM 
BSSB. Each bar graph represents one experiment performed in triplicate. The error bars show the 
standard deviation.  
 
As mentioned in a previous section, Cheung and co-workers reported SaYpdA’s role as a 
potential BSSB reductase using a combination of genetic and biochemical experiments. [66]. 
While the study shows some interesting results relating to cellular/global changes in 
BSH/BSSB levels upon oxidative stress, the authors note that they were unable to show 
direct BSSB reductase activity from purified enzyme. In light of this finding, as well as the 
results of the current study, any evidence that SaYpdA is a BSSB disulfide reductase 
remains elusive. We therefore set out determine if the protein could have another role within 
the context of BSH-based redox biology. 
  
3.2.6 Establishing a model protein system for studying protein S-
thiolation: GAPDH and BSH 
A number of proteins have been shown to undergo S-thiolation in the cell in response to 
oxidative stress [24, 27, 29, 34, 35, 57, 77, 81, 98-136]. To date, a number of S-thiolated 
proteins have been identified in Firmicutes – these include OhrR, MetE, GuaB, Brx, GAPDH 
and AldA [24, 27]. 
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Glyceraldehyde-3-phosphate (G3P) dehydrogenase (GAPDH) is a key glycolytic enzyme 
that catalyzes the reversible phosphorylation of G3P to 1,3-bisphosphoglycerate (1,3-BPG) 
in the presence of inorganic phosphate and NAD+ [63]. GADPH contains a conserved redox-
sensitive Cys within its active site. In in vivo studies GAPDH has been shown to be the most 
prominent target of S-thiolation by a number of low molecular weight thiols [34, 63, 108, 121, 
122, 137-140]. Furthermore, S-thiolation of GAPDH by LMW thiols causes inactivation of the 
protein, which is only reversed upon de-thiolation. In this context, S-thiolation not only 
regulates enzyme activity, but also protects the vulnerable active site Cys from over-
oxidation. GAPDH has also been found to be S-bacillithiolated in S. aureus [27, 29, 56, 63].  
Antelmann and co-workers have established an in vitro method to study S-thiolation that 
occurs in response to oxidative stress by using GAPDH and bacilliredoxin (BrxB) as a model 
system [63]. Figure 3.17 shows the overall approach and experimental setup.  GAPDH is 
first treated with excess DTT to ensure that the active site thiol is in a reduced state (1). 
Thereafter excess DTT is removed using a centrifugal concentrator with a membrane with 
MW cutoff of 3,000 Da (2). This desalted GAPDH sample is then S-bacillithiolated with 10-
fold BSH in the presence of excess oxidant (H2O2 or HOCl). Subsequently, residual oxidant 
and unreacted LMW thiol is removed by again using a centrifugal concentrator as described 
above. S-bacillithiolated GAPDH is then assayed for residual GAPDH activity, or further 



































Figure 3.17 Model system for studying S-thiolation based on GAPDH’s thiolation by BSH.  Active GAPDH 
is reduced with excess DTT (1), whereafter excess DTT is removed (2-3). Oxidation of GAPDH in absence 
of any LMW thiol results in inactive sulfonic acids (4). In the presence of BSH GAPDH is protected from 
over oxidation by S-thiolation, forming GAPDH-SSB (5). GAPDH-SSB has been shown to be de-
bacillithiolated by the Brx system to regenerate active GAPDH (1). 
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Using the above described method and approach (Figure 3.17), each reaction was assessed 
for GAPDH activity in the forward direction using excess G3P and NAD+ in the presence 
sodium arsenate (Na₃AsO₄). Sodium arsenate was used as a co-substrate to form unstable 
1-arseno-3-phosphoglycerate, which subsequently degrades forcing the GAPDH reaction in 
the forward direction [63]. 
The results of the experiment are shown in Figure 3.18. The reference reaction containing 
GAPDH pretreated with DTT showed full activity; as in the studies by Antelmann and co-
workers was set as 100% activity [63]. DTT-pretreated GAPDH was then S-bacillithiolated in 
the presence of the two major types of biologically relevant oxidants, i.e. H2O2 and HOCl. S-
bacillithiolated GAPDH (GAPDH-SSB, No DTT) showed no activity following treatment with 
either oxidant, confirming that S-bacillithiolation, like S-thiolation by many other LMW thiols, 
causes enzyme inactivation. The reversibility of the S-bacillithiolation of GAPDH was 
assessed using excess DTT (10 mM) as well as a previously demonstrated enzymatic 
mechanism that relies on bacilliredoxin (BrxB) [63]. S-bacillithiolated GAPDH was de-
bacillithiolated by DTT (GAPDH-SSB + DTT) with GAPDH activity being restored to 
approximately 65%. Likewise, S-bacillithiolated GAPDH was de-bacillithiolated by BrxB 
(GAPDH-SSB + BrxB) and GAPDH activity was restored to levels similar as those following 
treatment with DTT. The lack of full restoration of activity (i.e. the failure to obtain 100% 
activity following de-bacillithiolation) after treatment with DTT and BrxB was also observed in 
studies by Antelmann and co-workers [63]. This suggests that under these experimental 
conditions some of the GAPDH enzyme is irreversibly inactivated via over-oxidation of the 
active site Cys to sulfonic acid.   
The de-bacillithiolation of GAPDH-SSB was also evaluated using excess BSH (10 mM). BSH 
alone was only about half as efficient in restoring the activity of bacillithiolated GADPH 
(GAPDH-SSB + BSH). Finally, the ability of SaYpdA to function as a bacilliredoxin was also 
evaluated (GAPDH-SSB + SaYpdA). Interestingly, the results were similar to those obtained 
with BSH, with low but meaningful levels of activity restoration. This might suggest that 
SaYpdA rather acts on mixed disulfides of BSH, rather than on BSSB.  
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Figure 3.18 The reversible S-bacilithiolation of GAPDH by BSH. GAPDH-SSB denotes S-bacillithiolated 
protein. All data is compared to the activity of untreated GAPDH as reference. GAPDH-SSB was 
generated in vitro by treatment of 40 μM GADPH with 2.5 mM H2O2 or HOCl in the presence of 400 μM 
BSH. For non-enzymatic de-bacillithiolation, 2.5 μM GAPDH-SSB was incubated with either 10 mM DTT or 
BSH for 30 min. For enzymatic de-bacillithiolation, 2.5 μM GAPDH-SSB was incubated with 12.5 μM Brx or 
SaYpdA proteins for 30 min. GAPDH activity was measured after addition of G3P and NAD+ by 
spectrophotometric monitoring of NADH generation at 340 nm [63]. Each bar graph represents one 
biological repeat (n=1) performed in triplicate, with the error bars denoting standard deviation. 
 
The results of these experiments support literature findings that S-bacillithiolation of GAPDH 
protects the enzyme from harmful over-oxidation, as well as regulating the enzyme’s activity. 
BrxB was able to de-bacillithiolate GAPDH-SSB in line with previous literature reports [63]. 
The current experiments also show that excess BSH (10 mM) was able to de-bacillithiolate 
GADPH-SSB sufficiently to give low levels of GAPDH activity (~30%). Interestingly, SaYpdA 
was also able to restore activity to levels similar to that seen following de-bacillithiolation by 
BSH. Both of these findings are new, and have not previously been reported. Importantly, 
the current studies still provide little insight in how Brx-SSB is recycled. Based on SaYpdA’s 
low level activity towards GAPDH-SSB, it is possible that it actually acts on Brx-SSB. 
Alternatively, Brx-SSB could be recycled to Brx by reaction with BSH to form BSSB, the 
more classically accepted route for redoxin reduction. Further studies will be needed to 
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3.2.7 S-thiolation by CoA:  GAPDH and the recycling of CoA 
CoA is an important cofactor that is found in all living systems and plays an important role in 
central metabolism [30, 47, 141-143]. There are a few documented studies that show S-
thiolation of proteins by CoA; however the biological significance of this phenomenon still 
remains to be fully uncovered [74-77, 144]. Moreover, the mechanism by which proteins that 
are thiolated by CoA (so-called CoAlated proteins) is de-thiolated is also unclear. 
To assess the role of CoA in protecting and regulating enzyme activity, the same GADPH-
based model system described in the previous section was used. Briefly, GAPDH was first 
pretreated with DTT to ensure the active site thiol was in its reduced form. Thereafter, 
excess DTT was removed using a centrifugal concentrator with a membrane with a MW 
cutoff of 3,000 Da. S-CoAlation of GAPDH was achieved using 10-fold CoA in the presence 
of excess oxidant (H2O2 or HOCl). Thereafter, residual oxidant and unreacted LMW thiol was 
removed using a centrifugal concentrator as described above. Since there are no known 
CoA-redoxins, a number of strategies were evaluated for the de-thiolation of CoA from 
GAPDH-SCoA. These include the use of excess DTT, BSH and CoA. It was also 
investigated if BrxB could function in removing CoA from GADPH-SCoA. The results of this 
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Figure 3.19 The reversible S-CoAlation of GAPDH by CoA. GAPDH-SCoA denotes S-CoAlated protein. All 
activity results are compared to the activity of untreated GAPDH, which was set at 100%. GAPDH-SCoA 
was generated in vitro by treatment of 40 μM GAPDH with 2.5 mM H2O2 or HOCl in the presence of 400 μM 
CoA. Excess oxidant and CoA was removed using a centrifugal concentrator. For non-enzymatic de-
thiolation, 2.5 μM GAPDH-SCoA was incubated with either 10 mM DTT, 10 mM BSH or 10 mM CoA for 
30 min. For enzymatic de-thiolation, 2.5 μM GAPDH-SCoA was incubated with 12.5 μM Brx protein for 
30 min. GAPDH activity was measured after addition of G3P and NAD+ by spectrophotometric monitoring 
of NADH generation at 340 nm [63]. Each bar graph represents one biological repeat performed in 
triplicate, with the error bars denoting standard deviation. 
 
First and most importantly, GAPDH-SCoA was shown to be inactive, confirming the 
protective role that CoA may play under oxidative stress conditions. The activity of GAPDH-
SCoA was restored upon non-enzymatic de-thiolation by DTT to approximately 60%, similar 
to what was previously seen in the BSH-based experiments. This failure to restore full 
activity (100%) again suggests that some GAPDH was irreversibly inactivated by the 
oxidants. We also examined whether the S-CoAlation of GAPDH can be reversed by excess 
CoA or BSH. Non-enzymatic de-thiolation of GAPDH-SCoA was found to be successful 
using both CoA and BSH, although twice as much so in the case of GAPDH-SCoA formed 
by pretreatment with H2O2 compared to the enzyme pretreated with HOCl. While this 
appears to indicate that less GAPDH-SCoA is de-thiolated when it was formed following 
HOCl treatment, the result could also be interpreted to show that more GAPDH is irreversibly 
inactivated by HOCl compared to H2O2. Indeed, it has been shown that thiol oxidation by 
HOCl occurs much faster than using other oxidants such as H2O2 [145, 146]. Nonetheless, 
the ability of CoA and BSH to act in de-thiolation reactions in vivo would depend on their free 
thiol-disulfide ratios within the cell. These findings also suggest that in the absence of an 
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enzymatic redoxin system, LMW thiols can provide a substitute reducing system for the de-
thiolatation of protein mixed disulfides. Interestingly, the activity of GAPDH-SCoA was 
restored by BSH to much higher levels than observed in the previous experiment with 
GAPDH-SSB. This suggests that the formation of BS-SCoA mixed disulfides (the likely 
product of such a non-enzymatic de-thiolation reaction) is more likely than the formation of 
BSSB. Moreover, GAPDH-SCoA’s activity was also restored using BrxB. These findings 
implicate a possible mechanism of de-thiolation of CoA from a protein as well as showing the 
non-specificity or multifaceted functions of BrxB in maintaining redox homeostasis. 
Considering the lack of a specific CoA redoxin, further investigation was performed to 
identifying an alternative enzymatic mechanism of de-thiolation of CoA. In this regard, the 
CoADR enzyme has been implicated in fulfilling the role of reducing CoA disulfides [7, 48, 
49, 67-72, 74, 147]. SaCoADR forms part of the NADH peroxidase/oxidase and CoA-
disulfide reductase (POR) subgroup of tDBDF’s [48, 69, 82]. SaCoADR has a unique 
mechanism that relies on a single Cys (Cys43) within a conserved SFXXXC motif for 
catalysis. This Cys thiolate attacks a single sulphur atom of the CoA-disulfide substrate, 
thereby displacing a molecule of CoA while forming a mixed disulfide (SaCoADR-CoA). 
Subsequently, NADPH binds to the oxidized enzyme and reduces the mixed disulfide via the 
flavin cofactor, thereby regenerating the reduced enzyme as well as releasing the second 
CoA molecule. Interestingly, when SaCoADR binds the CoA-disulfide substrate only one 
CoA molecule enters into the active site [48, 69, 82]. SaCoADR could therefore play a role in 
removing CoA from CoA-thiolated proteins as the CoA portion of the SaCoADR-SCoA mixed 
disulfide should be able to enter the enzyme’s active site to form the enzyme-bound CoA 
mixed disulfide that is subsequently reduced by flavin. We set out to investigate such a 
proposal experimentally. 
Using the same model system as described above, GAPDH-SCoA was generated in vitro 
using with 2.5 mM H2O2 in the presence of 400 μM CoA. Excess CoA and oxidant were 
removed using a centrifugal concentrator with a membrane with a 3,000 Da MW cutoff. 
GAPDH-SCoA was then used directly as a substrate for CoADR. The results, which indicate 
that GAPDH-SCoA can function as an alternate substrate of CoADR, are shown in Figure 
3.20. This suggests a novel function for SaCoADR in being able to reduce CoA that is 
attached to a protein, i.e. by acting on a CoAlated protein. 
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Figure 3.20 Activity of SaCoADR towards GAPDH-SCoA. (A) 25nM SaCoADR + 100 μM (CoAS)2 shown as 
100% activity. (b) 25nM SaCoADR + 100 μM GAPDH (c) 25nM SaCoADR + 100 μM GAPDH-SCoA activity. 




SaYpdA has been hypothesized to be a BSSB reductase [7, 24, 27, 31, 32, 53, 54, 56, 58, 
62, 78-81]. Despite SaYpdA sharing highest sequence identity to members of the AHR 
subgroup, it lacks the important CxxC motif critical for disulfide reductase activity. Pull-down 
experiments as well as direct enzymatic activity assays performed in this study did not 
support the hypothesis that SaYpdA functions as a BSSB reductase. Recent published data 
on SaYpdA showed interesting results relating to the change in levels of BSH/BSSB in S. 
aureus YpdA mutants; however, the authors of the study were unable to show direct 
biochemical evidence for BSSB reductase activity [66].  
In light of these findings it was further investigated if SaYpdA might play a role in the BSH 
system by mediating de-thiolation. This study revealed that SaYpdA was able to directly act 
on S-bacillithiolated GAPDH at low activity levels. We speculate that SaYpdA might also be 
involved in binding directly to Brx-SSB and de-thiolating Brx to recycle it in this manner. 
Further experiments are needed to investigate this hypothesis. 
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Protein S-thiolation by cellular LMW thiols is an important post-translational modification 
particularly in light of enzyme protection and regulation under oxidative stress. Using a 
model system based on S. aureus GAPDH—which is known to be regulated by S-
thiolation— we assessed the relative importance of BSH and CoA in protecting proteins 
against oxidative damage by reversible S-thiolation. The results show that BSH indeed 
protects GAPDH from the adverse effects of oxidative stress in line with previous findings 
described in the literature [24, 32, 53, 56, 58, 62, 80, 81]. Furthermore, both DTT and 
SaBrxB were able to reverse S-thiolation by BSH under conditions of oxidative stress. 
CoA was also able to protect GAPDH from the effects of oxidative stress. There were clear 
differences in H2O2 and HOCl treatments. The S-thiolation of GAPDH by CoA showed 
similar reversibility with DTT, CoA, BSH and BrxB when it followed H2O2 treatment, but was 
lower following treatment with HOCl. These differences were not seen in the experiments 
using BSH, despite using the same experimental conditions and approach. Both BSH and 
CoA have similar redox potentials, i.e. -225 and -230mV respectively, while their pKas  are 
7.9 and 9.8 respectively. It could therefore be that under the experimental conditions CoA is 
less nucleophilic compared to BSH, showing less reactivity towards to thiol oxidation 
products formed under HOCl conditions compared to H2O2. This would lead to more GAPDH 
being irreversibly oxidized under the HOCl conditions when CoA is present. Literature 
reports also suggest that there are differences in S-thiolation/de-thiolation depending on the 
organism, enzyme isoforms and experimental conditions used [63]. 
Nevertheless, the S-thiolation of GAPDH, a key metabolic enzyme, further highlights the 
rationale of protein regulation and thiol protection against over oxidation. Without a 
protective thiol mechanism the cell would expend unnecessary energy to synthesize new 
protein. Furthermore, under oxidative stress, the cell would regulate GAPDH by S-thiolation 
therefore shuttling the energy requirements into the pentose phosphate pathway to supply 
the extra need for NADPH to reverse the imbalance in redox potential caused from such 
stress. 
An exciting discovery of this study is the finding that SaCoADR was able to de-thiolate 
GAPDH-SCoA.  This suggests that SaCoADR could act on any mixed disulfide of CoA. 
Further studies will need to be done in order to confirm this hypothesis. Taken together, the 
results of this study have provided several new and important insights regarding the LMW 
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3.4 Materials and methods 
Unless otherwise stated, the majority of all chemicals and compounds were purchased from 
Sigma-Aldrich. A small amount of BSSB was kindly provided from Prof. Haike Antelmann 
(Institute of Biology - Microbiology. Freie Universität Berlin). Larger amounts of BSH were 
purchased from JEMA Biosciences, San Diego, USA.  All reactions were done in triplicate 
unless otherwise stated or indicated in text or figures. 
3.4.1 Cloning and plasmids used 
SaYpdA - S. aureus ypdA gene (SAOUHSC_01499) was amplified from strain RN4220 
using the following forward primer: 5’-GAG GCC GAA CAT ATG CAA AAA GTT GAA AGT-3 
(NdeI site underlined) and reverse primer: 5’-GTA CAT AGA CCT CTCGAG TTA TGA TTC 
TAA GGG-3’ (XhoI site underlined). The PCR reaction mixture included 1 µL Pfu buffer, 0.4 
mM dNTP mix, 1 mM forward primer, 1 mM reverse primer, 1 ng genomic DNA, 1.25 U Pfu 
DNA polymerase and the final volume made up to 25 µL with distilled, deionized water. The 
PCR program involved a 2 minute initial step at 94°C followed by 30 cycles of denaturation 
at 94°C for 15 seconds. Thereafter the annealing cycle was done at 55°C for 30 seconds 
and a final extension cycle for 1 min at 70°C. The reaction mixtures were subjected to gel 
electrophoresis on a 1% agarose gel and subsequently visualized through gel staining with 
SYBR™ gold (Invitrogen) and viewed on a UV gel reader. The band corresponding to the 
expected size of the ypdA gene (~1200 bp) was excised and purified using a Novagen gel 
clean-up kit. The amplified ypdA gene was subsequently used to generate the pET28a-YpdA 
expression plasmid. Briefly, the pET28a plasmid as well as the amplified ypdA gene was 
digested separately with NdeI and XhoI (New England Biolabs) for 1 hour at 37°C without 
shaking. The restriction digestion mixtures of pET28a and ypdA gene were then subjected to 
gel electrophoresis on a 1% agarose gel and subsequently visualized through gel staining 
with SYBR™ gold (Invitrogen) and viewed on a UV gel reader. The NdeI/XhoI cut plasmid 
band and ypdA band were then excised and purified using a Novagen gel clean-up kit. 
Approximately 10 ng of NdeI/XhoI cut pET28a and ypdA were incubated with 10U of T4 DNA 
ligase and ligase buffer for 1 hour at 37°C without shaking. Thereafter 1 µL of the plasmid-
insert construct was added to 80 µL of chemically-competent Mach 1 cells, and incubated on 
ice for 30 mins. The cell mixture was heat-shocked at 42°C for 45 seconds, and then cooled 
on ice for 5 mins. Approximately 900 µL of pre-warmed LB broth was added to the 
transformation mixture and incubated at 37°C and shaking for 1 hour. The sample was then 
centrifuged at 4500 RPM for 10 mins. Half of the supernatant was discarded, with the cell 
pellet being re-suspended in the remaining supernatant. The resuspended cells were then 
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plated onto LB plates containing 30 mg/L kanamycin and incubated overnight at 37°C. 
Colonies were then selected and restriction digestion checks were done by loading the 
digestion mixture onto 1% agarose gels to assess which colonies contained a plasmid that 
liberated a gene insert corresponding to the expected size of the ypdA gene. The colonies 
positively identified to contain inserts were then sent for sequencing to verify the identity of 
the insert. The correctly sequenced colonies were grown up overnight at 37°C in 5 ml LB 
containing 30 mg/L kanamycin. Thereafter the pET28a-SaYpdA expression plasmid was 
isolated and purified using a Zyppy Plasmid Miniprep I Kit (Zymo Research). The plasmid 
was then used for transformation into respective cloning/expression cells for further use. 
SaYpdA-GST - S. aureus ypdA was cloned into pGEX-6P-1 using BamHI and XhoI 
restriction sites by a previous member in the Strauss Lab. The plasmid was then used 
directly for transformation into respective cloning/expression cells. 
SaGAPDH – The SaGAPDH expression plasmid was kindly provided by Prof. Haike 
Antelmann (Institute of Biology - Microbiology. Freie Universität Berlin). Briefly, the S. aureus 
gap gene (SAUSA300_0756) was cloned from genomic DNA from the S. aureus USA300 
strain into a pET11b plasmid vector with N-terminal NdeI and C-terminal BamHI sites. 
SaBrxB – The SaBrxB expression plasmid was kindly provided by Prof. Haike Antelmann 
(Institute of Biology - Microbiology. Freie Universität Berlin).  The S. aureus brxB gene 
(SAUSA300_1321) was cloned from genomic DNA from S. aureus USA300 strain into a 
pET11b plasmid vector with N-terminal NdeI and C-terminal BamHI sites. 
SaCoADR - A pET28a(+)-based SaCoADR expression vector was available in our 
laboratory [147]. The cdr gene was cloned from genomic DNA from S. aureus ATCC 35556 
strain and inserted into pET28a(+) flanked by N-terminal NdeI and C-terminal XhoI sites. 
All plasmids were confirmed by sequencing and yielded His tag proteins. 
3.4.1 Protein expression and purification 
Each plasmid was separately transformed into E. coli BL21*(DE3) for protein 
overexpression. Overexpression was performed in LB broth supplemented with 100 mg/L 
ampicillin (except SaCoADR and SaYpdA, for which kanamycin at 30 mg/L was used 
instead) and grown at 37°C whilst shaking in non-baffled flasks. Once an OD600nm = 0.5-0.6 
was reached the cultures were then induced with IPTG at a final concentration of 0.5 mM. 
Cultures were then continued at 37°C for 4 hours.  Thereafter the cells were harvested by 
centrifugation at 8000 rpm.  
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Each cell pellet was resuspended in approximately 10 mL of sonication buffer (5 mM 
imidazole, 500 mM NaCl and 20 mM Tris–HCl, pH 7.9; 10 mL/1 g cell paste) and 
subsequently sonicated to elicit cell lysis. After centrifugation at 15 000 x g for 30 min, the 
crude extract (supernatant) was applied to a 0.45 µm syringe filter (AMICON) to remove any 
further debris. The clarified lysate was then applied to a previously prepared (Ni2+) 1 mL 
HisTrapFF metal affinity purification column using an ÅKTAprime purification system. After 
an initial wash step of 5-10% elution buffer to remove unbound protein, the protein of interest 
was then eluted by increasing the imidazole concentration to 500 mM. Protein elution was 
monitored by UV at 280 nm on the ÄKTAPrime. Residual imidazole was then removed from 
the purified protein fractions and buffer exchanged using a 5 ml HiTrap Desalting column (50 
mM potassium phosphate, 5 mM MgCl2, pH 8.0). Thereafter a 10% SDS-PAGE gel was run 
for each protein purified. Protein concentration of SaGAPDH and SaBrxB was determined 
using Bradford reagent (BIO-RAD). However, for SaYpdA and SaCoADR the concentrations 
were determined using the FAD molar extinction coefficient at 450 nm (11.3 mM−1.cm−1). 
Molar extinction coefficients of each were determined using literature and EXPASY 
Protpram.  Glycerol was added to the pure protein solution to a final concentration of 5%, 
after which the protein was aliquoted and stored at -80 °C.  
3.4.2 Enzyme characterization – general flavin spectra of SaYpdA 
SaYpdA was separately titrated with NADPH and NADH (0.5 – 5.0 mol NADPH per mol 
FAD) under anaerobic conditions at 25°C in 50 mM Tris-HCl (pH 7.5), and 150 mM NaCl. 
The titration was conducted in an anaerobic cuvette, sealed with a gas-tight rubber septum 
and repeatedly flushed with nitrogen gas. All reactants were flushed with nitrogen gas prior 
to titration. The reduction of the enzyme flavin by NADPH was monitored by collecting 
spectra from 800 nm to 240 nm on a Cary 60 UV-Vis Spectrometer (Agilent Technologies). 
3.4.3 Assessing potential protein partner/s of SaYpdA 
SaYpdA-GST was expressed and purified as described in protein expression and purification 
section. 
S. aureus JE2 (USA300) was grown in a large batch culture (2 litres) in LB broth. After 
reaching an OD600nm = 0.5, the cells were challenged with 1 mM H2O2 every 20 minutes over 
an hour. After a further 2 hours growth the cells were then spun down and the pellet stored 
until use for pull down experiments.  
Both pellets (E. coli expressing GST-SaYpdA and S. aureus JE2) were freeze thawed and 
sonicated immediately in 10 ml of binding buffer (140 mM NaCl, 2.7 mM KCl, 10 mM 
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NaHPO4, 1.8 mM KH2PO4, pH 7.3). The lysates were used in pull down experiments. Batch 
purification was done using glutathione sepharose 4B (GE Healthcare) and supplied product 
instructions. Briefly, GST-SaYpdA was bound to the GSH resin using binding buffer, followed 
by incubation of resin bound GST-SaYpdA with S. aureus JE2 lysate. The resin was washed 
several times with binding buffer to remove unbound proteins and finally GST-SaYpdA was 
eluted with elution buffer (50 mM Tris-HCl, 10 mM reduced glutathione, pH 8). The eluate 
was collected and analysed by 10% SDS-PAGE analysis. 
3.4.4 Assessing SaYpdA as a BSSB reductase. 
Each reaction consisted of 25 nM SaYpdA 100 µM NADPH in 50 mM potassium phosphate 
buffer, pH 8. The substrate BSSB was prepared using 10 mM ammonium bicarbonate 
solution for each 1 mM BSH and incubated overnight at room temperature. The mixture was 
dried overnight using a Speedvac concentrator. The oily mixture was then made up in 50 
mM potassium phosphate pH 8 to a stock concentration of 10 mM. The substrate BSSB was 
first placed into a quartz cuvette and the reaction initiated upon addition of reaction mixture 
(SaYpdA pre-incubated with 100 µM NADPH) and initial rates obtained from a decrease in 
absorbance at 340 nm using a Cary 60 UV-Vis Spectrometer for raw data shown in Figure 
3.16 A.  Technical repeats using 400 µM BSSB were done using a 96-well plate setup. In all 
reactions the substrate (BSSB) was placed in the wells of a clear flat-bottom 96-well plate 
and the enzyme mixture (25 nM enzyme, 100 µM NADPH in buffer) added thereafter to 
initiate the reaction. Initial rates were determined following the decrease in absorbance at 
340 nm using a Thermo Scientific Varioskan microplate spectrophotometer.  
3.4.5 SaGAPDH and BSH model system 
Prior to each reaction 100 µM SaGAPDH at a time was treated with 1 mM DTT on ice for 30 
minutes. Thereafter excess DTT was removed using Amicon centrifugal concentrators with 
MW 3,000 Da cutoff.  
All GAPDH activities were done using methods described in literature [63]. The activity was 
monitored spectrophotometrically in a 1 cm quartz cuvette at 340 nm and 25°C by the 
production of NADH. All readings were done on a Cary 60 UV-Vis Spectrometer. 
For GAPDH reaction (DTT-treated, reduced GAPDH): The oxidation of G3P to 1,3-
bisphosphoglycerate was measured in an assay mixture containing 1.25 mM NAD+ and 
0.25 μM GAPDH in argon-flushed 20 mM Tris-HCl, pH 8.7, with 1.25 mM 
ethylenediaminetetraacetic acid (EDTA) and 15 mM sodium arsenate. After pre-incubation, 
the reaction was initiated by the addition of 0.25 mM D,L-G3P. Sodium arsenate was used 
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as a co-substrate to form unstable 1-arseno-3-phosphoglycerate, which subsequently 
degrades forcing the reaction in the forward direction. Initial rates were determined using the 
linear slope of the first 30 seconds. The reaction was complete after 2 minutes. Percentage 
of residual GAPDH activity was calculated by comparison to the activity of the untreated 
enzyme [63, 148]. 
For bacillithiolation reactions - 40 μM reduced GAPDH was oxidized with 10 mM H2O2 or 
HOCl in the presence or absence of 10-fold excess BSH (400 µM) and incubated for 5 
minutes on ice. The residual BSH, H2O2 or HOCl was removed by centrifugation through 
Amicon centrifugal concentrators with 3,000 Da cutoff. The resulting GAPDH-SSB, collected 
from the retentate, was then tested for GAPDH activity as described above. 
For de-bacillithiol reactions (Brx reactions): 2.5 μM of GAPDH-SSB was incubated with 
12.5 μM BrxB on ice for 30 minutes to allow for de-thiolation to occur. The same procedure 
was used to test the de-thiolation activity of 25 μM BSH, 25 μM CoA or 25 μM SaYpdA by 
using these instead of BrxB in the same reaction setup. After completion of the 30 minute 
incubation, the residual GAPDH activity was measured in the presence of BrxB, BSH, CoA 
or YpdA measuring the forward reaction of GAPDH. 
3.4.6 SaGAPDH and CoA system 
The preparation of GAPDH-SCoA S-thiolation as well as de-thiolation experiments involved 
the same procedures used with GAPDH and BSH described above.  
3.4.7 SaCoADR activity towards GAPDH-SCoA 
GAPDH-SCoA was prepared as described previously. (CoAS)2 was prepared according to 
literature [147]. All reaction buffers used for SaCoADR reactions consisted of 100 µM 
NADPH and 100 µM substrate in 50 mM potassium phosphate at pH 7.4. Enzyme reactions 
were carried out at 25°C as follows: a solution containing 25 nM SaCoADR, 100 µM NADPH 
in reaction buffer was added to a clear flat-bottom 96-well plate already containing either 
(CoAS)2 or GAPDH-SCoA respectively. Initial rates were determined following the decrease 
in absorbance at 340 nm. All absorbance readings were done using a Thermo Scientific 
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Chapter 4 
EFFORTS TOWARDS THE CHEMOENZYMATIC 
PRODUCTION OF BACILLITHIOL (BSH) 
 
4.1 Introduction 
Many organisms produce cysteine derived low-molecular weight (LMW) thiols which play a 
role as cofactors and as cysteine reservoirs, as well as in redox homeostasis and enzyme 
protection and regulation [1-3]. The most well-known LMW thiol is glutathione (GSH) which 
is the predominant thiol in eukaryotes; however, many organisms lack glutathione and 
therefore employ surrogate LMW thiols [1]. Gram-positive bacteria with GC rich genomes 
such as Actinobacteria lack GSH and make use of mycothiol (MSH) as their predominant 
LMW thiol [4-6]. Other Gram-positive bacteria with low GC content genomes such as 
Firmicutes make use of the LMW thiols coenzyme A (CoA) and bacillithiol (BSH) (Figure 4.1) 
[2, 7-9]. In other organisms, specialized LMW thiols such as ergothioneine, trypanothione, γ-
GC or ovothiol are employed.  
Initially the major LMW thiol in Staphylococcus aureus—which lacks GSH—was assumed to 
be either Cys or CoA. However, neither of these thiol species are present at levels similar to 
those seen for GSH in GSH-producing organisms [7, 10]. Instead, it is now accepted that the 
major LMW thiol produced by Firmicutes bacteria is BSH. BSH was discovered just over 10 
years ago and has been implicated in a number of functions analogous to GSH [2, 7-9, 11]. 
The many roles of BSH include the reduction of SNO compounds, the removal of toxic 
compounds (e.g. fosfomycin, methylgloxal), acting as a potential virulence factor, and 
maintaining metal homeostasis and protecting and regulating proteins through S-
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Figure 4.1 Major LWW thiol compounds found in bacteria. Glutathione (GSH, also found in eukaryotes 
and Gram-negative bacteria), coenzyme A (CoA, found in all organisms), bacillithiol (BSH, found in 
Firmicutes) and mycothiol (MSH, found in Actinomycetes). Redrawn from [2]. 
 
The genes involved in BSH biosynthesis have been identified in several Bacilli species by 
homology to the enzymes involved in MSH biosynthesis, and by using the EMBL String web-
based tool [8, 25]. The String web-based tool identifies interacting partners of a protein query 
utilizing a number of criteria including co-localization in genomes via operon structural 
similarities, co-occurrence across genomes via phylogenomic profiling, correlated 
experimental data and published literature [25]. The network of BSH associated and 
interacting partners is shown in (Figure 4.2). A number of other genes were identified to 
have some association with BSH biosynthesis, including panE and coaX which are involved 
in pantothenate biosynthesis. Some genes associated with BSH biosynthesis do not have an 
assigned function [8]. 
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Figure 4.2 EMBL STRING interaction network of proteins that have an associated function with BSH 
biosynthesis. Green lines indicate co-localization of operon structures, blue lines indicate statistically 
significant co-occurrence across multiple genomes, pink lines indicate experimentally determined, and 
aqua lines indicated published literature. 
 
Structurally, BSH shares some resemblance to the scaffold of MSH, with the most noticeable 
differences being the replacement of the inositol group by L-malate. Additionally, the amine 
of its cysteine moiety is not acetylated. The biosynthesis of BSH also follows similarities to 
MSH (Figure 4.3).The biosynthesis of BSH is carried out in three steps with the first reaction 
catalyzed by BshA involving the coupling of L-malate to glucosamine via the donor UDP-N-
acetylglucosamine (UDP-GlcNAc) to form GlcNAc-Mal (Figure 4.3A). The second enzyme 
BshB hydrolyzes the GlcNAc acetyl group resulting in GlcN-Mal. The final step involves the 
coupling of cysteine via its carboxyl to the free amine of glucosamine to form BSH; this is 
catalyzed by BshC. 
The biosynthesis of MSH (Figure 4.3 B) follows a similar sequence of reactions in which 
MshA couples 1-myo-inositol-1-phosphate to the glucosamine donor UDP-GlcNAc to form 
GlcNAc-Ins-P, which is subsequently dephosphorylated by MshA2 to form the first major 
intermediate of the pathway, GlcNAc-Ins. MshB then hydrolyzes the acetyl group of GlcNAc 
resulting in GlcN-Ins. A cysteine is added via its carboxyl group to GlcN-Ins by MshC to form 
Cys-GlcN-Ins. The final step in the biosynthesis of MSH includes acetylation of the amino 
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Figure 4.3 Biosynthetic pathways for BSH and MSH. (A) Biosynthesis of BSH begins with the coupling of 
L-malic acid to GlcNAc via BshA (L-malic acid glycosyltransferase) to GlcNAc-Mal. Thereafter the 
GlcNAc-Mal is deacetylated by BshB (an N-acetyl hydrolase) to form GlcN-Mal. The final step involves the 
addition of a cysteine via BshC (cysteine adding enzyme). (B) The biosynthesis of MSH follows a similar 
pathway with the exception of two additional steps. A dephosphorylation step occurs after the initial 
coupling which is hypothesized to be carried out by MshA2. An additional acetylation after the addition 
of cysteine is carried out by MshD. Redrawn from [7]. 
Some of the enzymes involved in the biosynthesis of BSH have already been studied (Figure 
4.4). Initially five candidate genes were classified to encode for the glycosyltransferase 
BshA, which is involved in coupling UDP-GlcNAc and L-malate. However, only one of these 
genes—ypjH—shared some similarity to MshA (~20% identity). The glycosyltransferase 
activity of the YpjH protein was confirmed using purified enzyme and substrates UDP-
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GlcNAc and L-malate [8]. Furthermore, ypjH null mutants produced very little GlcNAc-Mal 
and BSH confirming that ypjH indeed encodes for BshA, and that it is essential for BSH 
biosynthesis [8]. Interestingly, despite BshA and MshA sharing low identity their active site 
architecture is still conserved. However, their N-terminal regions differ, most likely due to the 
difference in binding malate versus inositol functional moieties respectively. Upstream of 
bshA are two zinc-dependent deacetylases, ypjG (encoding BshB1) and yojG (encoding 
BshB2). A bshB1 null mutant showed a 2-fold decrease in BSH production; whilst a bshB2 
null mutant showed normal BSH levels. However, in a double bshB1/bshB2 mutant BSH 
levels were undetectable [8]. The zinc-dependent deacetylase activity has been 
demonstrated for both BshB1 and BshB2; however, BshB1 appears to play the major role in 
BSH biosynthesis [8, 9]. 
The last enzyme in the BSH pathway involves a cysteine-adding enzyme named BshC. The 
gene encoding for BshC, originally annotated as yllA, was identified using the String web-
based tool that showed it was co-localized with bshA and bshB in the majority of BSH 
producing organisms. The protein sequence of BshC shows no recognizable domains and 
has no appreciable similarity to MshC, which also performs the ATP-dependent addition of 
cysteine to GlcN-Ins in MSH biosynthesis [8, 26]. Further confirmation of BshC’s involvement 
in BSH biosynthesis was determined using bshC null mutants which showed an 
accumulation of GlcNAc-Mal and undetectable levels of BSH compared to the wildtype. 
Complementation of bshC restored BSH biosynthesis [8]. Enzyme activity studies using 
purified BshC under conditions similar to MshC have shown no activity [7, 8, 27-31]. Thus it 









































Figure 4.4 Biosynthesis of bacillithiol (BSH). Enzymes involved in each reaction: (A) Coupling of UDP-
GlcNAc to L-malate by glycosyltransferase BshA, (B) N-acetyl hydrolase BshB and (C) cysteine adding 
enzyme BshC.  
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To date there are three X-ray crystal structures reported of the enzymes involved in BSH 
biosynthesis, namely those of B. subtilis BshA (PDB: 5D01), B. cereus BshB (PDB: 2IXD) 
and B. subtilis BshC (PDB: 4WBD). The structure of BshA shows characteristic features of 
glycosyltransferases which include the GT-B fold, consisting of two “Rossmann-like” 
beta/alpha/beta domains separated by a deep inter-domain region with a kinked C-terminal 
α-helix that crosses over from the C-terminal domain to contact the N-terminal domain [29, 
32]. The X-ray crystal structure of BshA also contains the product GlcNAc-Mal bound to the 
active site. BshB, like other zinc-dependent deacetylases such as MshB and LpxC, form part 
of the LmbE-like metalloenzyme family that contains a conserved PIG-L (N-acetyl-d-
glucosaminylphosphatidylinositol deacetylase) structural domain. These enzymes utilize an 
essential metal ion/s in the hydrolysis of various substrates that contain an N-
acetylglucosamine core. The structure of BshB contains an acetate and zinc ion coordinated 
in the active site [31, 33, 34]. Kinetic studies of BshB show that zinc is essential for the 
enzyme’s activity [8, 31]. The crystal structure of the last enzyme in the BSH biosynthetic 
pathway BshC contains glycerol and citrate within the active site as well as an ADP moiety 
bound in a second binding pocket [30]. The structure of BshC (Figure 4.5) provides some 
clues as to the potential binding mode of the GlcN-Mal, as well as some unexpected results 
that may provide insight into the lack of activity of BshC. The active site is formed within a 
Rossman fold where the two carboxylate groups of the bound citrate molecule interact with 
protein side chains, which might suggest the potential binding of the carboxylates of the 
malyl moiety of either GlcN-Mal or the BSH product. The remaining carboxylate of the citrate 
molecule extends into a solvent filled pocket. A glycerol molecule was also found to be 
bound near the active site citrate in a separate pocket. The active site is also solvent 
exposed and would appear to accommodate ligands larger than citrate and glycerol (Figure 
4.6). Interestingly the two homodimers interact with one another via a 4-helix bundle, with no 
direct interaction between the domains bearing the active sites.  
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Figure 4.5 X-ray crystal structure of BsBshC (4WBD) homodimer. Location of glycerol, ADP and citrate 
are indicated. Red/orange coiled-coils show 4-helix bundle connecting the two homodimers. Light 
blue/shy blue indicates the core Rossman fold of BshC. Dark blue and light yellow/straw indicate coiled-
coiled domains found in a number of BshC orthologs. [30].  
 
 
Figure 4.6 Space filled model of the X-ray crystal structure of BsBshC. The fairly large active site pocket 
shows both glycerol and citrate bound. An ADP molecule was found to be bound at a separate solvent 
exposed site on the protein as indicated [30]. 
Interestingly, no nucleotides were added in the purification or co-crystallization experiments, 
suggesting that the ADP was bound during expression of the protein in E. coli and remained 
bound through the purification process. The electron densities for the adenine, ribose, and α-
phosphate portions of ADP are well-defined, however the electron density for the β-
phosphoryl group is somewhat ambiguous which might suggest a disordered or highly 
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mobile group, and it is thus possible that a group other than phosphate is present at this 
position. Other cofactors that contain the adenosine group include NADH and dephospho-
CoA. Considering that the synthesis of BSH and CoA might be positively correlated (due to 
the association of some CoA biosynthetic genes with those of BSH biosynthesis), it is 
possible that BshC makes use of CoA or de-phospho-CoA as an additional substrate. This 
would further support the conclusion that BshC is unique in its catalytic mechanism.  
Furthermore, the observation that the 4-helix bundle puts the two monomers at a 
considerable distance from one another suggests a structural arrangement that might 
facilitate the binding of an extra protein partner that might be required for catalysis. Further 
studies will be needed in order to confirm these hypotheses. 
Studies on the enzymes and processes that produce and rely on BSH—including inhibitor 
discovery initiatives—require significant amounts of the compound. Due to the failure to date 
to obtain active BshC, Hamilton and co-workers reported the full chemical synthesis of BSH, 
as well as a partial chemoenzymatic synthesis that bypasses this step [28]. This has led to 
BSH becoming commercially available from several sources (such as JEMA Biosciences). 
However, obtaining BSH in either manner requires a significant investment of time and/or 
money. Based on the experience of our laboratory with several of the MSH biosynthetic 
enzymes and in the study of their inhibition, we therefore set out to reconstitute the BSH 
biosynthetic pathway from S. aureus with a dual goal: first, to confirm the activity of the 
putative enzymes, and second to establish if these enzymes can be used to produce BSH in 
a biocatalytic fashion. In this chapter our efforts in this regard are described. 
4.2 Results and discussion 
4.2.1 Cloning and plasmids used 
The genes expressing bshB (A0A0E1VJH9_STAA3) and bshC (BSHC_STAA8) were 
amplified from genomic DNA from the S. aureus USA 300 strain introducing NcoI (5′) and 
XhoI (3′) sites flanking the genes of interest. After digestion with NcoI and XhoI, the gene-
containing fragment was successfully inserted into pET28a(+) that was predigested with 
NcoI and XhoI. The gene encoding BshA (A0A068A5A2_STAAU) was similarly amplified, 
and it was attempted to clone and insert it in to the BspHI and XhoI sites of the predigested 
pET28a(+) plasmid. However, after several attempts, we were not successful in being able 
to amplify the gene of interest. Literature also suggests difficulty in cloning and/or purifying 
MshC from a number of species [4]. Although not analogous to BshC, our experience 
highlights a common problem in cloning from GC rich genomes. However, since the BshA 
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protein is the best characterized of the three biosynthetic enzymes, and shows high levels of 
structural and mechanistic similarity to its MshA counterpart, we decided to rather focus our 
efforts on the less studied enzymes in the pathway, namely BshB and BshC. 
The identities of all the newly and successfully cloned plasmids were confirmed by DNA 
sequencing. The plasmids all expressed C-terminal His tagged proteins, which was 
subsequently exploited for their purification by immobilized-metal affinity chromatography 
4.2.2 Protein expression and purification  
The SaBshB and SaBshC expression plasmids were each separately transformed into E. 
coli BL21* (DE3) cells to be used in heterologous expression. All proteins were expressed by 
growing the appropriately transformed E. coli cell in LB broth at 37oC, with induction of 
protein expression being achieved using 0.5 mM IPTG. Proteins were obtained from cells 
after at least 12 hours of expression (i.e. post-induction), by harvesting and lysis followed by 
purification using immobilized metal affinity chromatography (IMAC) The purified protein was 
analysed by SDS-PAGE as shown in Figure 4.7. Both proteins expressed well and gave high 
yields of pure protein. 
 
Figure 4.7 10% SDS-PAGE analysis of the purification procedure of SaBshB and SaBshC. Molecular 
weight marker shown with respective kDa increments. SaBshB: Lane 8-crude lysate, lane 7-IMAC faction, 
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4.2.3 Efforts towards enzymatic reconstitution and activity 
Reconstitution of the partial pathway was first attempted using SaBshB and either GlcNAc-
SMal (the thioglycoside analogue of the native BshB substrate, GlcNAc-OMal) or GlcNAc-
OMe as alternative substrates of the enzyme. These substrates were synthesized by a 
previous member of the group, Dr Ndivhuwo O. Muneri, as part of a different project [35]. 
Different approaches were attempted in assessing the enzyme’s deacetylase activity on 
these substrates, and the ability of the putative product to be converted by SaBshC. These 
approaches included first incubating SaBshB with substrate, followed by removal of the 
protein by precipitation before the supernatant was then analyzed for product formation in 
the presence of SaBshC, as well as incubating the two enzymes together. The effect of 
adding a variety of co-substrates were also investigated on the outcome of the reactions. 
Since the substrates and products do not contain a chromophore, and we did not have 
access to any HPLC instruments with detectors other than UV-Vis or fluorescence, all 
reactions were analysed by TLC, and visualized using a variety of staining techniques. The 
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Table 4. Using various ratios of SaBshB:SaBshC and the substrates GlcNAc-OMe/SMal towards the 
chemoenzymatic synthesis of BSH. 
TLC Spot Number (From left to right) New 
spot 
A - Ninhydrin Stain 
 
1- Authentic BSH (JEMA 
Biosciences). 
2- SaBshB, SaBshC (1:1) with 
GlcNAc-SMal, ATP, Cys. 
3- SaBshB, SaBshC (1:1) with 
GlcNAc-OMe, ATP, Cys. 
 
No. 
B - Ninhydrin Stain 
 
1- GlcNAc-OMe. 
2- SaBshC with lysate of SaBshB 
reaction and GlcNAc-SMal, ATP, 
Cys. 
3- SaBshB with GlcNAc-OMe. 














4- SaBshB, SaBshC (1:1) with 
GlcNAc-OMe. 
5- SaBshB, SaBshC (2:1) with 
GlcNAc-OMe. 
6- SaBshB, SaBshC (3:1) with 
GlcNAc-OMe. 
7- SaBshB, SaBshC (1:2) with 
GlcNAc-OMe. 
8- SaBshB, SaBshC (1:3) with 
GlcNAc-OMe. 
9- SaBshC batch 1 with GlcNAc-
OMe, ATP, Cys. 
10- SaBshC batch 2 with GlcNAc-







Conclusion: SaBshB showed activity towards GlcNAc-OMe, most likely forming GlcN-OMe. 
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Table 5. Evaluating the effect of adding of NADPH, serine and/or glutamate to SaBshB:SaBshC reactions. 
TLC Spot Number (From left to right) New 
spot 









8- SaBshB, SaBshC (1:1) with 
GlcNAc-OMe, serine, ATP. 
9- SaBshB, SaBshC (1:1) with 
GlcNAc-OMe, glutamate, ATP. 
10- SaBshB, SaBshC (1:1) with 
GlcNAc-OMe, serine, glutamate, 
NADPH, ATP. 
11- SaBshB, SaBshC (1:1) with 
GlcNAc-OMe, serine, glutamate, 
NADPH, ATP. 
No 
E - Ninhydrin Stain 
 










Conclusion: The crystal structure of BsBshC showed an unusual surface binding pocket of 
an ADP moiety. Thus NADPH was added to reactions to determine if this would promote 
catalysis; however, this was not successful. Other cysteine ligases in the PDB make use of 
substrates serine/glutamate in their catalytic mechanism; these substrates were also added 
in the event that SaBshC functioned in a manner similar to other cysteine ligases. However, 
none of these compounds promoted product formation. Black arrow shows new product 
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Table 6. Assessing the effect of adding the cofactors NADPH or NAD+ in combination with GlcNAc-SMal 
to SaBshB:SaBshC reactions. 
TLC Spot Number (From left to right) New 
spot 









8- SaBshC GlcNAc-SMal, Cysteine, 
ATP, NAD+. 
9- SaBshB, SaBshC (1:1) with 
GlcNAc-SMal, serine, glutamate, 
NADPH, ATP, cysteine.   
10- SaBshB, SaBshC (1:1) with 
GlcNAc-SMal, serine, NADPH, 
ATP, cysteine. 
11- SaBshB, SaBshC (1:1) with 
GlcNAc-SMal, glutamate, NADPH, 
ATP, cysteine. 
12- SaBshB, SaBshC (1:1) with 
GlcNAc-SMal, NAD+, ATP, 
cysteine. 
13- SaBshB with GlcNAc-SMal, NAD+, 
ATP, cysteine. 
None 
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Table 7. Using Ellman’s reagent in identifying the formation of thiol-containing products, such as BSH. 
TLC Spot Number (From left to right) New 
spot 










8- SaBshC with GlcNAc-SMal, 
cysteine, ATP, NAD+. 
9- SaBshB, SaBshC (1:1) with 
GlcNAc-SMal, serine, glutamine, 
NADPH, ATP.   
10- SaBshB, SaBshC (1:1) with 
GlcNAc-SMal, Serine, NADPH, 
ATP, Cysteine. 
11- SaBshB, SaBshC (1:1) with 
GlcNAc-SMal, glutamate, 
NADPH, ATP, cysteine. 
12- SaBshB, SaBshC (1:1) with 
GlcNAc-SMal, NAD+, ATP, 
cysteine. 
13- SaBshB with GlcNAc-SMal, 
NAD+, ATP, cysteine. 
None. 
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Table 8. Evaluating the effect of adding various metals and NADH or NAD+ to SaBshB:SaBshC reactions. 













8- SaBshB co-incubated with 
GlcNAc-OMe, MnCl2. 
9- SaBshB, SaBshC (1:1) co-
incubated with GlcNAc-
OMe, MnCl2, NAD+, ATP, 
Cysteine. 
10- SaBshB, SaBshC (1:1) co-
incubated with GlcNAc-
OMe, NADH, ATP, 
Cysteine. 
11- SaBshB, SaBshC (1:1) co-
incubated with GlcNAc-
OMe, MnCl2, NAD+, ATP, 
Cysteine. 
12- SaBshB, SaBshC (1:1) co-
incubated with GlcNAc-
OMe, ZnCl2, NAD+, 
Cysteine. 
13- SaBshB, SaBshC (1:1) co-
incubated with GlcNAc-
OMe, NAD+, ATP, 
Cysteine. 
14- SaBshB, SaBshC (1:1) co-
incubated with GlcNAc-




I – Ninhydrin stain 
 






Conclusion: Black arrow shows product formed from SaBshB reactions. The addition of 
NADH to SaBshB:SaBshC reaction favors the formation of a new product spot (red arrow).  
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A number of different conditions were tested towards the chemoenzymatic production of 
BSH using GlcNAc-OMe and GlcNAc-SMal as starting materials. Thin layer chromatography 
analysis was carried out on each reaction condition as well as separate reaction 
components. Different protein ratios of SaBshB to SaBshC were also assessed. There was 
indeed a new product spot that formed on the TLCs that migrated above the GlcNAc-OMe or 
GlcNAc-SMal spot as indicated by an arrow in TLC B, C, E and I. This spot only appeared 
when SaBshB was present with substrate GlcNAc-OMe or GlcNAc-SMal. Moreover, the new 
product spot had an Rf value that was different to the substrates GlcNAc-OMe/GlcNAc-S-Mal 
and migrated higher on the TLC. The TLC of authentic BSH analysed using the same 
solvent conditions and stained with ninhydrin stain (TLC A) gave a light brown spot. When 
stained with ninhydrin, the new product spot from the SaBshB reactions showed a similar 
yellow color to that of BSH, in comparison to the substrates GlcNAc-OMe and GlcNAc-SMal 
that gave in red/orange product spots. This suggests that SaBshB was able to deacetylate 
both of the alternate substrates.  
The second reaction involving the cysteine ligating enzyme SaBshC was tested under 
several different conditions, including co-incubation of SaBshB and SaBshC in different 
ratios (1:1, 1:2, 1:3 SaBshB:SaBshC), and using the SaBshB supernatant as starting 
material for the SaBshC reaction. There are a number of X-ray crystal structures of serine-
/glutamate-cysteine ligases (PDB: 3IG5, 3NZT, 1V4G, 2GWC) that are unrelated to SaBshC 
but that use utilize cysteine and/or glutamate and serine as part of their catalytic cycle. 
However, the addition of glutamate and serine to reaction conditions of SaBshC did not 
appear to promote any further product formation. The X-ray crystal structure of BshC 
contained an ADP moiety bound to the protein in a pocket that is not the active site, and 
therefore a number of adenosine cofactors such as NAD/NADP, NADH/NADPH were added 
to the SaBshC reaction. Interestingly a new product did form upon the addition of NADH (red 
arrow in TLC H, Table 8). The reaction sample analysed in TLC H, as well as starting 
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Figure 4.8 HPLC chromatogram of a reaction mixture containing SaBshB, SaBshC (1:1) co-incubated with 
GlcNAc-OMe, NADH, ATP, Cysteine. Peak 1: GlcNAc-OMe (2.40 min), Peak 2: ATP/GlcN (2.45 min), Peak 
3: NADH (3.6 min), Peak 4: cysteine-related adducts (2.42 min, 3.69 min, 4.75 min), Peak 5: Unknown 
product (5.98 min), Peaks 6: related to GlcNAc-OMe. Chromatograms of the starting materials analysed 
separately are shown in materials and methods. 
A new peak indeed appeared at a retention time 5.98 minutes; this peak seemed to be 
unrelated to any of the substrates used by comparison to known standards. Unfortunately, 
the identity of this new product is currently stil unknown, as further analysis remains to be 
performed. Taken together, the actual conditions required for full BshC catalysis still remains 
elusive. 
4.3 Conclusion 
The results presented in this chapter showed the first successful expression and purification 
of soluble S. aureus BshB and BshC. The activities of both were assessed using various 
conditions. The SaBshB reaction involves the deacetylation of a GlcNAc substrate. A 
number of different reaction conditions involving SaBshB and the alternate substrates 
GlcNAc-OMe or GlcNAc-SMal were assessed. Indeed the formation of new product spots 
was observed for reactions containing SaBshB and either of the substrates GlcNAc-OMe or 
GlcNAc-SMal, indicating deacetylation of these substrates. The SaBshC reaction is 
hypothesized to involve the ATP-dependent addition of cysteine to the amine group of the 
deacetylated GlcNAc-Mal. The crystal structure of BsBshC suggests that BshC requires an 
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additional protein partner or an adenosine contains cofactor. However, the unique binding 
location of the ADP on SaBshC might suggest that this binding pocket is an allosteric site. 
Further studies will be needed to assess this hypothesis. 
The reactions involving SaBshC were performed using a variety of conditions. Considering 
the active site is formed around a Rossman fold core, different nucleotide cofactors were 
also added to the reactions. These included NAD+, NADP+, NADH and NADPH. 
Interestingly the addition of NADH did indeed make a positive difference in promoting the 
formation of a new product in the SaBshC reaction. The HPLC chromatogram of a sample of 
the supernatant of the NADH containing reaction showed a new unidentified peak. The 
apparent further activity in the presence of NADH as well as the information from the 
BsBshC crystal structure suggests that SaBshC requires an as yet to be determined ADP-
containing cofactor for its active conformation which would suggest that its cysteine ligase 
activity occurs via an unusual mechanism. 
The lack of activity of SaBshC thus impedes further studies on the biocatalytic production of 
BSH. Yet, understanding the biosynthesis of BSH remains an important goal, as it will aid 
the elucidation of the roles of other enzymes and processes that rely on BSH. 
Further investigation should be done in order to assess the possibility of other plausible 
cofactors that might bind in the Rossman fold of the SaBshC’s active site. Furthermore, the 
hypothesis that SaBshC might require additional protein partners such as SaBshA or a co-
incubation of all three enzymes in order to produce BSH will be the focus of future studies. 
The work contained in this chapter was not done to address a specific aim, but rather to 
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4.4 Materials and methods 
Unless otherwise stated, the majority of all chemicals and compounds were purchased from 
Sigma-Aldrich. GlcNAc-OMe and GlcNAc-SMal were previously synthesized by Dr Ndivhuwo 
O. Muneri [35]. Cloning was performed with the help of Dr Andrea Schenkmayerova. 
4.4.1 Cloning and plasmids used 
SaBshB – S. aureus bshB gene (A0A0E1VJH9_STAA3) was cloned from strain USA300 
with NdeI and XhoI sites flanking the gene. The PCR reaction included 1 µL Kapa Hotstart 
buffer,  10 µM forward primer, 10 µM reverse primer, 1 ng genomic DNA, 25 µL of 2x 
Hotstart Ready Mix made up to a final volume of  25 µL with distilled, deionized water. The 
PCR program involved an initial denaturation step at 95°C for 3 minutes. This was followed 
by 25 cycles of 98°C for 20 seconds, 55°C for 1 minute 30 seconds, 72°C for 5 minutes. The 
reaction mixture was subjected to gel electrophoresis on a 1% agarose gel and 
subsequently visualized through gel staining with NANCY™-520 gel electrophoresis stain 
and viewed on a UV gel reader. The band corresponding to the bshB gene (~660bps) was 
excised and purified using a Thermo Scientific DNA gel extraction kit. The bshB gene was 
subsequently used to generate the pET28a-SaBshB plasmid. Briefly the pET28a plasmid as 
well as the SaBshB-encoding gene was digested separately with NdeI and XhoI (New 
England Biolabs) for 1 hour at 37°C without shaking. The restriction digestion of pET28a and 
bshB gene was subjected to gel electrophoresis on a 1% agarose gel and subsequently 
visualized through gel staining with NANCY™-520 gel electrophoresis stain and viewed on a 
UV gel reader. The NdeI/XhoI cut plasmid band and gene band were then excised and 
purified using a Thermo Scientific DNA gel extraction kit. Ten ng each of NdeI/XhoI cut 
pET28a and bshB were incubated with 1µl of T4 DNA ligase and ligase buffer for 1 hour at 
37°C without shaking. Thereafter 1 µL of the plasmid-insert construct was added to 80 µL of 
chemically-competent Mach 1 cells, and incubated on ice for 30 mins. The cell mixture was 
heat-shocked at 42°C for 45 seconds, and then cooled on ice for 5 mins. Approximately 900 
µL or pr-ewarmed LB broth was added to the transformation mixture and incubated at 37⁰C 
and shaking for 1 hour. The sample was then centrifuged at 4500 RPM for 10 mins. Half of 
the supernatant was discarded, with the cell pellet being re-suspended in the remaining 
supernatant. The resuspended cells were then plated onto LB plates containing 30 mg/L 
kanamycin and incubated overnight at 37°C. Colonies were then selected and digestion 
checks done using 1% agarose gels to assess which colony liberated the gene of expected 
size. The positive colonies were then sent for sequencing for confirmation. The correctly 
sequenced colonies were grown up overnight at 37°C in 5ml LB containing 30 mg/L 
kanamycin. Thereafter the pET28a-SaBshB plasmid was isolated and purified using a 
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Thermo Scientific plasmid extraction kit. The plasmid was then used for transformation into 
respective cloning/expression cells for further use. 
SaBshC- S. aureus bshC gene (BSHC_STAA8) was cloned from strain USA300 with NdeI 
and XhoI sites flanking the gene. The same procedure described above was used in the 
generation of the pET28a-SaBshC plasmid. The plasmid was then used for transformation 
into respective cloning/expression cells for further use. 
4.4.2 Protein expression and purification 
All purified and sequenced plasmids were then transformed into E. coli BL21(Star)DE3 for 
protein overexpression. Overexpression was performed in LB broth supplemented with 30 
mg/L kanamycin and grown at 37 °C whilst shaking in non-baffled flasks. Once an OD600nm = 
0.5-0.6 was reached the cultures were then induced with IPTG at a final concentration of 0.3 
mM. Cultures were then continued overnight at 37 °C.  Thereafter the cells were harvested 
by centrifugation at 8000 rpm.  
Each cell pellet was resuspended in approximately 10 mL of sonication buffer (5 mM 
imidazole, 500 mM NaCl and 20 mM Tris–HCl, pH 7.9; 10 mL/1 g cell paste) and 
subsequently sonicated to elicit cell lysis. After centrifugation at 15,000 x g for 30 min, the 
crude extract (supernatant) was applied to a 0.45 µm syringe filter (AMICON) to remove any 
further debris. The clarified lysate was then applied to a previously prepared (Ni2+) 1 mL 
HisTrapFF metal affinity purification column using an ÅKTAprime purification system. After 
an initial wash step of 5-10% elution buffer to remove unbound protein, the protein of interest 
was then eluted by increasing the imidazole concentration to 500 mM. Protein elution was 
monitored by UV at 280 nm on the ÄKTAPrime. Residual imidazole was then removed from 
the purified protein fractions and buffer exchanged using a 5ml HiTrap Desalting columns 
(50 mM HEPES, pH 7.4). Thereafter a 10% SDS-PAGE gel was run for each protein 
purified. Protein concentration was determined using Bradford reagent (BIO-RAD). Purified 
proteins were aliquoted and stored at -80°C until further use. 
4.4.3 Efforts towards enzymatic reconstitution and activity 
All enzyme assays were done in reaction buffer: 50 mM HEPES, pH 7.4. Each reaction was 
done in a total volume of 5 ml reactions. Final concentration of enzyme and substrate used 
was 500 µM and 1 mM respectively. Each reaction was incubated at 37oC overnight without 
shaking. A sample of 500 µL of each was aliquoted and enzyme precipitated with 50% 
acetonitrile and heating at 80°C for 10 minutes. The resultant mixture was centrifuged at 
8000 rpm for 30 minutes and the supernatant was spotted on TLC (aluminium-backed Merck 
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silica gel 60 F254).  Solvent system used was n-butanol: acetic acid: H2O (12:3:5). Spots 
developed using staining solutions including; ninhydrin stain (0.3 g ninhydrin in 100 mL n-
butanol, 3 mL acetic acid), sulfuric acid stain (5% in methanol), permanganate stain (3 g 
potassium permanganate, 20 g potassium carbonate + 5% aq. NaOH). 
4.4.4 HPLC chromatography 
All enzyme assays were done as described above. Approximately 800 µL of each starting 
material stock solution and reaction sample were separately aliquoted and precipitated with 
50% acetonitrile and heating at 80°C for 10 minutes. The resultant mixture was centrifuged 
at 8000 rpm for 30 minutes and 500 µL of the supernatant was then subjected to HPLC 
analysis. 
HPLC analysis was performed on an Agilent 1100 instrument using a Luna® 5 µm C18 100 
Å column (250 x 4.6 mm). The column was equilibrated with 95% 50 mM CH3COONH4 (pH 
5.5) and 5% Acetonitrile. This was followed by elution at a flow rate of 1 mL/min with 95% 50 
mM CH3COONH4 (0 – 5 min isocratic), linear gradient increase to 20% Acetonitrile (5 – 6 
min), linear gradient increase to 40% Acetonitrile (6 – 10 min), isocratic elution at 40% 
Acetonitrile (10 – 15 min), linear gradient increase to 60% Acetonitrile (15 – 16 min) and 
finally isocratic elution at 60% ACN (16 – 20 min). Compounds were detected at 254 nm. 
HPLC chromatograms of starting materials used are shown below. 
 
Figure 4.8.1. HPLC chromatogram of starting material GlcNAc-OMe. GlcNAc-OMe peak retention times: 
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Figure 4.8.2. HPLC chromatogram of starting material Glucosamine. Glucosamine peak retention times: 
2.42 min, 2.92 min, 3.68 min,  10.22 min, 15.40 min, 19.08 min, 21.69 min, 22.35 min.    
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Figure 4.8.4. HPLC chromatogram of starting material NADH. NADH peak retention time: 3.67 min.  
 
 
Figure 4.8.5. HPLC chromatogram of starting material Cysteine. Cysteine peak retention times: 2.42 min, 
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